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SUM MAR Y 
The work described in this thesis was in the field 
of Forensic Toxicology, which is the study and practice of 
toxicology for legal purposes. Three different 
application areas were considered: (a) the analysis of 
drugs in blood by gas chromatography-mass spectrometry 
(GC-MS) following isolation from the biological matrix by 
solid phase extraction procedures, (b) the analysis of 
paint solvents in blood by gas chromatography (GC) and 
GC-MS following dynamic headspace elution from blood, and 
(c) an evaluation of Thermospray/Plasmaspray (TSP/PSP 
LC-MS) liquid chromatography-mass spectrometry as the 
basis of drug screening techniques in forensic toxicology. 
(a) In the first of these areas, a sensitive, specific 
and reliable method was developed for the analysis of 
basic drugs in blood, using morphine and buprenorphine as 
model compounds which are also drugs commonly abused in 
the Glasgow area. A novel extraction procedure was used, 
based on a commercially available chemically-modified 
silica containing surface-bound benzenesulphonylpropyl 
groups, which served as a cation exchange resin. Several 
methods for the initial treatment of the biological matrix 
were examined and the one selected involved absorption of 
the blood sample on diatomaceous earth and solvent elution 
of the crude extract containing any drugs present in the 
sample. This extract was then purified using the cation 
exchange res in: conditions suitable for the efficient 
retention of basic drugs and subsequent elution were also 
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examined and developed. The extraction efficiencies for 
morphine were 92±5% and 95±4% at concentrations of 
35 and 560ng/ml blood, respect' 1 f lve y, or buprenorphine 
83±6% and 87±5~ respectively, and for other drugs 
at concentration of 0.5 and 8ng/ml 
were better than 85%. ---- --
The end-step analytical technique chosen for this 
method was GC-MS, because of analytical and legal 
requirements with respect to sensitivity and specificity. 
The polar nature of the model compounds, and of many other 
drugs likely to be encountered in this field, required 
chemical modification of the substances prior to gas 
chromatography. A comparison was made of three silyl 
ether derivatives the trimethylsilyl (TMS) , ethyl-
dimethylsilyl (EDMS) and tert-butyldimethylsilyl (MTBS) 
ethers. The conditions required for derivative formation 
were examined, including the choice of s i lyl donor 
reagent, solvents, temperature of reaction and time to 
completion. The EDMS donor, diethyltetramethyldisilazane, 
was selected on the basis of the mild reaction conditions 
required for the test compounds and also because this 
reagent caused less interference during GC-MS analysis. 
EDMS ethers gave satisfactory gas chromatographic 
behaviour and the presence of prominent ions at high mass 
was shown to be advantageous for spec if i c and sens it i ve 
detect ion by S IR-MS wi th 1 itt Ie background in ter fer ence. 
The developed method was considered to be useful for both 
clinical and post-mortem blood samples containing morphine 
and buprenorphine down to the low picogram/millilitre 
level, and therefore adequate for the intended purpose. 
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The method was subsequently applied to 13 samples 
submitted for analysl'S to th D 
e epartment of Forensic 
Medicine and Science and found to be satifactory. 
(b) In the second area of application, dynamic head 
space (DHS) elution was used for the analysis of paint 
solvents in blood. Volatilised solvents were trapped on a 
Tenax-GC cartridge and were subsequently analysed by 
GC-MS. The extraction efficiency of this method for 
C -C 8 12 n-alkane hydrocarbons, which were present in 
the paint materials, was better than 90% and sensitivity 
down to pg/ml levels was obtained. 
Solvent extraction procedures for these 
hydrocarbons were evaluated using high purity solvent. 
The extraction efficiency was better than 85%. Analysis 
of extracts by GC or GC-MS suffered from interference from 
the solvent front which reduced the sensitivity. 
The DHS method was applied to a pilot study for 
occupational monitoring of a group of painters to assess 
the presence of paint solvents in their blood. Two venous 
blood samples were collected at the beginning and at the 
end of a working week from each subject. They showed the 
presence of several solvents similar to those present in 
paint material and the levels in the second series of 
samples were higher than those of the first series. The 
differences between the levels in the two series were 
statistically significant for n-nonane, n-undecane and 
alkylbenzenes. The levels in the first sample indicated 
incomplete clearance of these solvents from the body 
during the weekend, and the second samples indicated 
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solvent uptake during the working week. Solvent 
contamination in the extraction system was tackled by 
several approaches but still hindered the accurate 
estimation of solvent levels in blood. 
(c) In the third area of application, the operating 
parameters which control the sensitivity of the mass 
spectrometer 
evaluated. 
using the TSP/PSP LC-MS interface were 
These included the effects of the probe 
temperature and discharge voltage on sensitivity and mass 
spectral fragmentation pattern and the effects of the 
mobile phase constituents on sensitivity and mass spectral 
peak stability. Solvent 
acetate buffer and an 
systems 
organic 
containing ammonium 
modifier such as 
acetonitrile produced the best results in plasmaspray 
LC-MS. 
Three model HPLC-MS analyses were developed for 
mixtures of basic drugs, barbiturates and opiates using 
both the plasmaspray positive and negative ion modes. 
During the development of the mobile phases, the 
optimization of chromatography by organic modifiers was 
assessed. The quality of chromatography obtained was not 
always as good as expected in conventional HPLC, but the 
combination of chromatographic and mass spectral data 
could be used for identification and quantification 
purposes. 
A compilation of PSP mass spectra of drugs commonly 
encountered in forensic toxicology was produced. These 
mass spectra provided mostly molecular weight information 
with little structural information. 
1.1 
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C HAP T E R ONE 
FOR ENS I C T 0 X I COL 0 G Y 
INTRODUCTION 
Toxicology can be defined as the study of the 
adverse effects of chemical agents on the biological 
system [1]. This avoids the traditional definition. lithe 
basic science of poison". where a precise definition of a 
poison is difficult to establish. In general a poison is 
any chemical substance that is capable of producing 
harmful effects on the living organism [2]. The group of 
simple chemicals and harmful plant poisons which were the 
causes of poisoning in previous times has expanded 
tremendously in recent years to include the new hazardous 
products therapeutic drugs, illicit drugs. industrial 
chemicals and pollutants. All share the potential of 
causing harm as well as the possibility of misuse and 
abuse. Forensic Toxicology is the study and practice of 
toxicology for legal purposes [3]. It involves 
ascertaining the circumstances surrounding those cases 
where drugs or other poisons are involved. 
motoring offences where drug-taking is 
for example. 
implicated or 
suspected, fatalities following an overdose. poisoning 
where there is a suspicion of criminal intent [4] and the 
investigation of sudden or suspicious deaths in which 
there is no obvious cause of death. 
In addition, the toxicologist can playa major role 
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as a member of a health care team and, through vigilance, 
can help to improve the general well-being of the 
community. By compiling accumulated data it is possible 
to monitor drugs of abuse. solvent abuse in the general 
public. persons under a rehabilitation programme, drug 
doping in sport and exposure to chemicals in industry and 
the environment. 
The 
clinical 
suspected 
supportive 
toxicologist may also became involved in 
toxicology. 
poisoning. 
in cases of acute overdose or 
Although treatment should be 
in all cases to start wi th, quick 
identification of poisons which require specific treatment 
(by antidotes) will greatly influence the morbidity and 
prognosis of the outcome. Examples of these poisons are 
methanol, ethylene glycol. opiates, salicylates, 
paracetamol. cyanide and organophosphorus pesticides. The 
results of the analysis can be used for prognostic 
purposes as well as the diagnosis. 
Finally. as a scientist. the forensic toxicologist 
also shares in the collective responsibility for the 
advancement of knowledge by continuing scientific 
research. as well as disseminating his knowledge through 
other teaching and educational obligations. 
1.2 METHODOLOGICAL APPROACH 
Most forensic toxicological analyses present a 
great challenge by virtue of the variety of analytes and 
the quality and quantity of the available sample material, 
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which is frequently limited, e . 11 specla y In putrefied, 
mummified or severely burned bodies. The following stages 
can be included to determine the nature of the analyte and 
the toxicological significance attributed to it. 
1.2.1 Isolation and purification of the toxic substance 
from the biological material. This can be a tedious 
procedure, espec ia lly if the poi son is unknown. A search 
for an unknown poison, can be an infinite task. 
Comprehensive screening for poisons in one procedure would 
be ideal but is not possible. Toxic substances can be 
classified into the following groups [5]. 
(i) Gaseous and volatile substances 
(ii) Metals 
(iii) Toxic anions 
(iv) Non-volatile organic substances such as 
organic acids and bases, neutrals, amphoteric 
substances and quaternary ammonium compounds. 
So, for example, in cases of suspected drug overdose, the 
most commonly encountered drugs are usually screened. 
Limiting factors can be time, amount of sample and 
instrumentation availability. The literature continually 
supplies new specific or general screening procedures. 
1.2.2 Identification of the isolated toxic substance or 
substances by one or more of the analytical tools 
available, followed by corroborative tests to confirm the 
identity. 
1.2.3 Measuring quantitatively the identified material in 
the biological sample. 
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1.2.4 Reporting the analytical findings. This may 
include an assessment of the sensitivity, 
reproducibility of the applied procedure. 
1 . 2 . 5 Interpretation of the results. To 
specificity and 
reach a correct 
and accurate interpretation, the following inter-related 
factors have to be collectively considered. 
(i) Analytical results: A negative result does not 
mean that the sample is absolutely free from all poisons. 
Rather it means that it is negative for a particular 
analyte or that if this is present, it is below the 
detection limit of the assay. Sample storage can also 
affect the result, when measuring cyanide in blood. The 
quantity of cyanide recovered will vary when storage is at 
room temperature, in the fridge or ln the freezer [6]. 
Similar effects are seen in the analysis of volatiles. 
Other factors affecting storage are exposure to light and 
the presence of preservative in the sample [7]. 
(ii) Factors relating to the patient or deceased, such 
as age. sex. weight. recent and past medical history, 
especially relating to 
drug may have developed 
intake 
a 
of drugs. Tolerance to a 
condition in which the body 
cells protect themselves against toxic substances by 
developing a resistance to them [8]. This state of 
decreased responsiveness occurs as a result of exposure, 
usually long term. to a given drug or its congeners [9]. 
(iii) Pharmacokinetic factors. These include: 
time and amount of drug taken, taking into 
consideration that in drug overdose, the drug does 
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not necessarily follow the same pharmacokinetics as 
at therapeutic levels [10]; 
route of drug intake: blood levels in fatal 
cases are usually lower following intravenous 
injection than when administered by other routes. 
This reflects the importance of the rate of drug 
entry to the systemic circulation rather than the 
final concentration [9]; 
distribution between different metabolic 
compartments. which can reflect the time of drug 
intake and survival time; 
presence of more than one drug, with the 
possibility of interactions between them which can 
affect the pharmacologic response as potentiation. 
Additive synergistic or antagonistic effects may 
occur. such as the synergistic effect on the 
toxicity of barbiturates caused by the presence of 
alcohol [11]. which can increase the effective 
toxicity of each drug when present in combination. 
(iv) Metabolic factors. which are affected at the same 
time by the route of administration. the presence of 
multiple drugs, leading to enzymatic induction or 
inhibition and whether the analyte is the parent drug or a 
metabolite and the relative quantities of the parent and 
the metabolites. The parent:metabolite ratio may be of 
value to indicate the time of drug intake and to 
differentiate acute from chronic overdose. 
In the case of heroin. morphine and 6-monoacetyl 
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morphine are the major and minor metabolites observed 
respectively. Heroin is usually not detected but may be 
inferred as the drug administered from the presence of the 
metabolites. 
(v) Previously recorded results. Many compiled data 
collections are available indicating therapeutic, toxic 
and fatal levels of substances in biological tissue 
[12-16]. Pharmacology and pharmacopoeia textbooks 
[17,18], as well as compilations from the toxicologist's 
own laboratory and other forensic toxicology departments 
are available for consultation during interpretation. 
Particular consideration should be given to the type of 
sample and the method of analysis used if a valid 
comparison is to be obtained. 
(vi) Other factors. The clinical presentation, 
histopathological findings and the scene of the incident 
in fatal cases must be considered when trying to establish 
whether the fatality was primarily due to the toxic agent, 
or caused by medical complications of poisoning, or merely 
associated with that toxic agent, where the death 
(suicidal. homicidal or accidental) could be directly or 
indirectly from the influence of that agent. For example, 
a traffic accident can be caused by driving under the 
influence of drugs or a drowning caused by incoordination 
and loss of control following volatile solvent abuse 
[19]. Detailed discussions of interpretation criteria can 
be consulted in several excellent text books now available 
[4,9,12]. 
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1. 3 . METHODOLOGICAL DEVELOPMENT 
Forensic toxicology l'S a powerful' , SClence WhlCh has 
always rapidly adopted the most sensitive tools that 
modern technology offers, t b bl o e a e to cope wi th a wide 
range of ana lytes wi th varying degrees of potency. An 
overview of these techniques wi 11 be presented. Details 
of the available techniques have been published [12,20,21] 
as have historical overviews of forensic toxicology 
[22,23]. 
The methodological approach adopted early ln this 
century was the laborious technique known as Stas-Otto 
extraction to isolate organic poisons from biological 
tissue and fluids, followed by identification of the 
isolate by a series of colour tests, for example, 
Trinder's test for salicylate lS a rapid spot test 
procedure. These chromogenic reagents are utilized as 
visualizing reagents (Dragendroff and iodoplatinate) for 
thin layer chromatography (TLC) and for post-column 
reactions for high performance liquid chromatography 
(HPLC) detection in recent years. Reliable 
spectrophotometers were developed during the 1940's. They 
were utilized for identification and quantification of 
barbiturate and anti-malarial drugs [22] and later, in the 
1960' s, were applied to other classes of drugs such as 
benzodiazepines and antidiabetic drugs. During this 
period the extraction procedure was modified to include 
the acid hydrolysis of the sample and purification of the 
extract by back-extraction procedures, following pH 
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adjustments. into an organic solvent. Solvent extraction 
is laborious. tedious and time and material consuming. It 
is being replaced in recent years by various types of 
solid phase extraction material which are commercially 
available. Solvent extraction is still used for tissue 
homogenates. As methods become more sensitive, the need 
to use liver (high concentrations of drugs, large amount 
of sample) decreases. Thin layer chromatography was a 
major advance in the 1950's. for the separation of drugs 
with a variety of developing systems and visualizing 
methods. The relative mobilities of substances on TLC 
plates values) are used to give a tentative 
indentification. Recent valuable collections of 
values for standardized TLC systems are available for 
accurate and precise identification [12,24,25]. 
In the 1960' s. gas chromatography (GC) was applied 
to analytical toxicology. It offered sensitive detection 
of a small amount of sample. as well as specificity and 
accuracy in quantitation. Added specificity and 
sensitivity were obtained by the use of a specific 
detector such as the ni trogen-phosphorus detector (NPD), 
the electron capture detector (ECD) and the mass 
spectrometer connected to the gas chromatograph (GC-MS). 
The latter offers the highest sensitivity and unequivocal 
identification. Also during this period, column 
d d to become HPLC, which offers a chromatography a vance 
wide range of separation and detection capabilities for 
analytical toxicology. A recent development 1S the 
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availability of instruments with a dynamic interface 
between a liquid chromatograph and the mass spectrometer 
(LC-MS) . 
Immunoassay procedures were developed in the past 
two decades and are based on immune response antibodies. 
Detection based on radiolabelled analyte, or enzyme 
substrate or a fluorescence marker, started to offer 
sensitivity and rapidity when screening for drugs in a 
small sample of biological material. Recent immunoassay 
procedures can offer specificity and quantitation at a 
very low concentration [26]. These procedures frequently 
do not require extensive sample preparation and can be 
automated to handle the increasing load on the analysts. 
Their importance is in their ability to screen for a group 
of drugs and therefore to act as a presumptive test. 
positive results should be confirmed by another method. 
The present study was designed to cover several 
aspects of forensic toxicology in three major areas. 
(a) A relieable method was developed for the anlaysis 
of basic drugs, using morphine and buprenorphine as model 
compounds which are also drugs more commonly abused in the 
Glasgow area. 
based on a 
A novel extraction procedure was used, 
commercially available chemically-modified 
silica containing surface-bound benzenesulphonylpropyl 
groups, which served as a cation exchange resin. 
prepared in this way were subsequently treated 
chemical derivatives and analysed by GC-MS. 
(b) occupational exposure to solvents in 
Extracts 
to form 
paint. 
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Monitoring hazardous occupational exposure to chemicals is 
one of the forensic toxicology services. The acute 
toxicity of solvent in cases of volatile solvent abuse IS 
well known. Also, the accumulation of solvent in 
biological systems due to chronic exposure is becoming a 
recognized hazard. Methods were developed for the 
analysis of paint solvents at low levels in blood and a 
pilot study was conducted with a workforce of painters to 
isolate, identify and quantify the solvents in their blood 
and to monitor changes in the course of the working week. 
(c) Evaluation of thermospray and plasmaspray LC-MS as 
a technique for f orens ic toxico logy. Factors influencing 
the production of ions in an LC-MS ion source were 
investigated and optimised. The thermospray and 
plasmaspray mass spectra of representative members from 
several commonly encountered groups of drugs were recorded 
under a range of conditions. 
2.1 
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C HAP T E R TWO 
MASS SPECTROMETRY AND CHROMATOGRAPHY 
INTRODUCTION 
This chapter provides a brief background to the 
principals of mass spectrometry. chromatography and the 
interfacing of these two systems. which are related to the 
work presented in later chapters. More detailed 
descriptions are given in References 27-29. 
2.2 MASS SPECTROMETRY 
Mass spectrometry (MS) has become one of the most 
powerful analytical methods for the structural 
identification of organic compounds [27.29-32]. At 
present the mass spectrometer is an indispensible tool in 
the fields of organic chemistry. pharmacology, 
biochemistry, pollution studies and toxicology, including 
forensic toxicology. 
It is an instrument that produces ions from a 
molecule, separates these ions as a function of their 
mass-to-charge (m/z) ratio and records and displays the 
relative abundance of these ions. The mass spectrometer 
may be conveniently divided into five basic components as 
shown in Figure 2.1. 
2.2.1 sample Inlet systems 
The interior of a mass spectrometer is under a high 
vacuum (10- 5 _10- 6 Torr) in order to minimize the number of 
by l·ons and thereby maximize the collisions undergone 
1. SAMPLE INLET 
SYSTEM 
a. GC 
a. HPLC 
c. Solid probe 
d. Direct inlet 
Atmospheric 
or higher 
2. IONIZATION 3. ION SEPARATION 
SYSTEM SYSTEM 
l 
Interface 10-5!10-6Torr 
4. ION DETECTION 
SYSTEM 
Figure 2.1 The basic components of mass spectrometer. 
S.DATA HANDLING 
SYSTEM 
Chromatogram 
Mass spectra 
Library search 
SIR 
Background sUbstraction 
Reconstructed ion 
-chromatogram 
Library search 
Identification 
Quantification 
Data storage 
I-' 
N 
- 13 -
number of ions reaching the detector. The inlet system 
must enable the sample to be introduced wi thout loss of 
vacuum and must be capable of ha dl· n lng gas, liquid or 
solid samples. A mass spectrometer can have one or more 
of these inlets. 
(I) Direct Insertion Probe 
The solid sample is placed in a small glass tube at 
the end of the probe, then the probe assembly is inserted 
through a vacuum lock into the ion source. The sample is 
vaporized directly into the source, either by the heat of 
the source or by a probe heater, to give optimum 
volatilization of the sample without producing thermal 
decomposition. The probe temperature can be programmed to 
vapourise higher boiling components if the sample is a 
mixture. The advantage of the probe is that it allows 
rapid analysis for a pure sample. Samples containing a 
mixture of compounds require a combination of 
chromatography with mass spectrometry to obtain pure mass 
spectra. 
( I I) Direct Inlet 
These usually take the form of a heated, evacuated 
reservoir connected to the mass spectrometer via a 
molecular leak capillary. It is ei ther employed for the 
introduction of liquid samples, such as a reference 
compound, or for gas samples where a precision calibrated 
chamber with a set of valves is used for accurate pressure 
and volume ratio measurements. 
(III) GC Interface 
This will be discussed in section 2.4.2 
( IV) 
2.2.2 
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HPLC interface 
This will be discussed 1n Chapter 5 
Ionization Systems (Ion Source) 
Mass spectrometry requires that the 
analysis first be ionized. The ion 
molecules for 
source system 
(Figure 2.2) incorporates ion lens plates to focus the ion 
beam as well as extracting and accelerating the ions into 
the analyser. Two types of ionization will be discussed , 
namely, electron impact (El) and chemical ionization (Cl):-
2.2.2.1 Electron Impact 
Electron impact is the most widely used method of 
ionization. The vaporized sample molecules are bombarded 
with a stream of electrons which will ionize and fragment 
the molecules. The fragmentation of the molecule is 
reduced by using lower electron energies so that, although 
there is less total ionization current, there is a larger 
proportion of the fragments in the higher mass ions. 
operation at low electron energy can lead to great 
variation in fragmentation pattern. However, the majority 
of EI work has been done at 70eV, where the fragmentation 
pattern at this relatively high electron energy does not 
vary so much. The excess energy absorbed causes 
fragmentation of sample molecules to produce both positive 
and negative ions which can be represented by the 
following equations: 
I. positive Ions 
(i) formation of the molecular ion 
Parent molecule ABCD + e ~ ABCDt + 2e Equation 1. 
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Figure 2.2 Schematic diagram of an EI ion source. 
A .. Filament B .. Filament shield 
c .. Source block D .. Repeller 
E .. Trap F .. Source slit 
G .. Focussing plates H .. Accelerating slit 
(ii) 
ABCD"!" 
AB+ 
where 
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fragmentation of the molecular 
• A+ + BCD. or A. + BCD+ 
--+ AB+ + CD. or AB. + CD+ 
• ABC+ + D. or ABC. + D+ 
• A+ + B or A + B+ 
ABCD: represents a radical ion 
ions 
Equation 2. 
Equation 3 . 
Equation 4. 
Equation 5. 
A., etc., represent a radical. 
+ AB , etc., represent an even-electron' Ion. 
II. Negative ions 
( i) production of an ion pair 
AB + e--~.~A+ + B -+ e Equation 6. 
(ii) capture of an electron with dissociation 
AB+e-.... ~ A+B Equation 7. 
(iii) capture of an electron 
AB + e- • AB Equation 8. 
Ions with a life time more than 10- 5 sec will be 
detected intact. Those with very short life times, less 
than 10- 6 sec will decompose in the source of the mass 
spectrometer and will not be detected. The ions of 
intermediate life time (10-5_10-6sec) are accelerated 
from the source of the mass spectrometer with mass (M1 ) 
but decompose to a smaller ion of mass (M2 ) before 
reaching the detector. In the case of a magnetic sector 
instrument, a broad metastable peak (M*) is observed at a 
non-integral m/z value represented by the relationship: 
M* = M2 for M+--+M+ + M (neutral) 
1 2 
Equation 9. 
M1 
The presence of a metastable ion can confirm a 
- 17 -
hypothesis for a fragmentation reaction. 
2.2.2.2 Chemical Ionisation 
Chemical ionisation is one of the 'soft ionization' 
techniques, where the molecular ion or quasimolecular ion 
is obtained and fragmentation is kept to a minimum, which 
is not always obtainable in electron impact. The sample 
is mixed with a large excess of a reagent gas (R), such as 
methane or isobutane, which is ionized by electron impact 
to give the primary ion R+. This reacts with further 
reagent gas molecules to produce a number of 
chemically-reactive secondary ion species. The secondary 
ions subsequently react with sample molecules (M) by a 
transfer of a proton to produce new ions with a mass one 
greater than the molecular weight. An adduct of the 
molecule wi th the reagent gas can also be formed. These 
reactions are represented in the following equations: 
R + e Equation 10. 
(R + H)+ + M • (M 
+ 
+ H) + R Equation 11. 
• 
(M - H) + RH2 Equation 12, 
M + [R + H]+ --• [M + 
(R + H)] + Equation 13, 
using a mass spectrometer source equipped with 
d h ' 1 l'onl'sation facilities, both electron impact an c emlca 
spectra can be recorded alternatively throughout the 
analysis, thus providing both molecular weight and 
. l'nformation from a single analysis, fragmentatlon 
Mostly positive ions are generated, Negative ions 
are 3 or 4 orders of magni tude less numerous 
than the 
positive ions, However, an increase in negative ion 
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sensitivity of several orders of magnitude can be obtained 
using negative ion CI for compounds with high electron 
affinity. 
Other soft ionization techniques include field 
desorption, field ionization, atmospheric pressure 
ionization and fast atom bombardment. Each increases the 
range of sample types which may be studied by mass 
spectrometry. 
2.2.3 Ion Separation Systems 
After leaving the ion chamber in the source, the 
ions are accelerated with an acceleration potential (V) 
of about 8KV into the mass analyser where they are 
separated according to their m/z ratios by employing a 
magnetic sector or quadrupole filter. The ions follow 
path of radius (r). Ions of different m/z may be brought 
to focus at a detector (Figure 2.3) by variation of the 
magnetic field (H) according to the following equation: 
Equation 14. 
Ions of all m/z ratios can be obtained by scanning the 
magnetic field (Equation 14.) at a fixed value of r & V. 
Alternatively the mass spectrum may be scanned by varying 
V while the magnetic field is held constant. In the 
double focussing mass spectrometer, 
an electrostatic 
analyser (ESA) is added before the magnetic analyser but 
after the ion source to provide an initial energy focus to 
the ions leaving the source by restricting the range of 
their initial velocities . It consists of two curved 
. h It (approximately 500V) between pIa tes wi th a hIg vo age 
t-hom 
ThAV ;:}rp usually driven with one positive and the 
Energy limit slit Magnetic sector 
............................... 
. " ........... .-
r 
Ion source 
f'igure 2.3 Schematic diagram of an Electrostatic analyzer 
Magnetic analyzer sector of a double focussing mass spectrometer. L 
path radii in ESA and magnetic sectors respectively. 
focus 
:; 
C ollecto r 
(ESA) sector 
and r are the 
and 
ion 
r-' 
~ 
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other negative with respect to ground so as to give zero 
mean potential along their centreline. The ions will pass 
through the ESA if 
mv2 = II 
L d 
Equation 15. 
where m is the ion mass, v 1S the ion velocity, z is the 
charge on the ion, L is the ESA mean radius, E is the 
differential ESA voltage and d is the ESA gap. This leads 
to:-
L = 2d (~mv) 2 Equation 16. 
Ez 
L = 2d u Equation 17. 
Ez 
where U is the kinetic energy of the ion, which means that 
ESA is an energy analyzer. The beam passing from the ESA 
through the energy limiting slit can be input to the 
magnetic analyzer. 
The equation of motion of an ion passing through 
the magnetic sector (Equation 14) can be restated as 
mlz = Equation 18. 
The resolution (R) is the ability of the mass spectrometer 
to separate adjacent masses by a given amount and is 
expressed by the following equation: 
Equation 19 
where Ml is the mass at which resolution is to be 
measured and ~M is the peak width for a 10% valley 
between the peaks. The ion beam must be double focussed 
to perform high resolution mass spectrometry. 
- 21 -
2.2.4 Ion Detection and Amplification 
Detection is usually by an electron muliplier or by 
a conversion dynode and photomultiplier. The current 
generated is amplified typically by a factor of 10 6 . 
The output is recorded by the data handling system. 
2.2.5 Data Handling Systems 
Most modern mass spectrometers are equipped with 
computer systems which can control the instrumental 
parameters of the mass spectrometer as well as process the 
vast amount of data it generates, especially when the mass 
spectrometer is connected to a chromatograph [27,33-35]. 
It allows manipulation of the data, including background 
subtraction, library matching and plotting of 
chromatograms and spectra. 
2.3 CHROMATOGRAPHY 
All forms of chromatography involve the separation 
of compounds as a result of a partition between two 
different phases, one mobile and the other stationary, and 
by exploiting differences in their physical or chemical 
properties. Each compound in a mixture partitions to a 
different degree between the two phases so that, as they 
are carried along over a bed of the stationary phase, a 
separation occurs. The longer this process is allowed to 
continue, the greater the separation achieved until the 
components emerge from the bed one by one into a detector. 
Although there are many forms of chromatography available, 
only high performance liquid chromatography (HPLC) and gas 
chromatography (GC) will be discussed. 
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2.3.1 GC and HPLC 
The basic components of GC and HPLC instruments are 
listed in Table 2.1. 
Table 2.1: Basic components of GC and HPLC instruments. 
GC HPLC 
1. Carrier gas source Solvent reservoir 
2 . Sample inlet Pump 
3 . Column Injector 
4 . Detector Column 
5 Oven Detector 
6 . Recorder Recorder 
The chromatogram obtained in both systems (Figure 2.4) 
contains the analytical data for the components of a 
mixture. Qualitative information appears in the 
characteristic retention time of each compound. 
Quantitative information is contained in the peak height 
or area. A chromatogram is also a valuable measure of the 
performance efficiency of the chromatographic system which 
produced it. The retention time (or retention volume 
in HPLC) is a characteristic of a given sample/ 
chromatographic system combination expressed in absolute 
terms. When it is related to a non-retained sample 
(usually solvent) it is called the relative partition 
coefficient or capacity factor (k'): 
k' 
Equation 20. 
Where and are as defined in Figure 2 . 4 . 
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Figure 2.4 Schematic diagram of GC and HPLC 
chromatogram showing the measureable parameters. 
to=elution time of the unretained solute, ta and 
tb=retention time of peaks a and b, Wa and Wb=peak 
width at half height of peak a and b. 
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The separating ability of the column for components a and 
b is called the resolution (R): 
= 
and the separation factor rab is given by: 
rab = 
Where 
kb 
k' 
a 
and 
= ex 
are the capacity 
Equation 21. 
Equation 22. 
factor for 
components a and b respectively and ex is the selectivity 
factor. The column efficiency is measured by (h), the 
"height equivalent to a theoretical plate" (HETP): 
h = column length 
N 
Equation 23. 
where N is the number of theoretical plates, which 
measures the column efficiency in producing narrow peaks 
and is given by: 
N = 5.54 ~2 Equation 24. 
The linear velocity of the mobile phase (u) is given by: 
-
u = column length Equation 25. 
to 
These parameters can be calculated and then used as 
a guide to the operation of the column and for determining 
the changes that can be made to achieve optimum 
performance for a given analysis. They are also dependent 
on the specific mobile phase and stationary phase used and 
the physical characteristic of the column. The co lumn 
parameters are described in the Van Deemeter equation: 
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h = A + B/u + Cu Equation 23. 
where u is the flow rate of the mobile phase and A, Band 
C are constants which are related to the physical 
processes occurring within the column. A full discussion 
of the equation is given in the literature [36-38]. 
2.3.2 GC Columns 
GC columns mostly fall into two distinct 
categories: packed and capillary columns. 
2.3.2.1 Packed Columns 
Packed columns have, in general, low efficiencies 
and separating capabilities but have a higher capacity for 
the sample material. Table 2.2 presents a comparison 
between essential parameters of packed and capillary GC 
columns. 
Table 2.2: Essential parameters of capillary and packed 
GC columns. 
Parameter Packed Capillary 
Length (m) 2-5 10-50 
I. D. (mm) 2-4 0.2-0.5 
Thickness of stationary phase ()lm) 1-10 0.05-5 
Capacity per peak 10).lg 100ng 
up to up to 
Total plates 5000 150,000 
Carrier gas All H2 ' He 
Carrier gas flow rate (ml/min) 20-50 0.5 5 
Carrier gas pressure (p.s.i) 10-40 3 15 
Gas chromatography can be subdivided according to 
the stationary phase into: 
I. Gas-solid chromatography 
The stationary phase is an active solid which is 
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used for separation of low molecular weight materials. An 
example of such phases is Tenax-GC which is used both as a 
chromatographic phase and as an absorbent for volatile 
substances prior to analysis. Carbon monoxide in blood is 
commonly measured using another solid phase, molecular 
Sleve SA. 
II. Gas-liquid chromatography 
The stationary phase (liquid) is coated on a 
support material. The latter should have a very large 
surface area and uniform particle size, 
and should be mechanically robust and 
The mos t common support part ic les 
diatomites. 
free from fines, 
chemically inert. 
are formed from 
The stationary phase is selected to suit the 
analysis required from non-polar, moderately polar and 
polar liquid phases such as SE-30, OV-17 and OV-225 
respectively. 
obtained with 
Higher efficiency and lower column bleed is 
a low loading of the stationary phase 
percent of the support material), in the range (weight 
1-8%. 
2.3.2.2 Capillary columns 
Capillary columns are available in glass, stainless 
steel and fused silica. 
used now due to the 
The first two are not frequently 
fragility of the glass and the 
presence of active sites on the stainless steel. The 
coating of the stationary liquid phase inside the 
capillary column can be in three forms [39]: 
(i) Wall coated open tubular (WCOT) 
(ii) Support coated open tubular (SCOT) where the film 
" 
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of the stationary phase is stabilised by support particles 
adhering to the inner surface of the column. 
(iii) Porous-layer open tubular (PLOT) 
Chemical bonding of the stationary phase to the 
column (chemically bonded columns) provides stability of 
the phase and the columns will retain their efficiency 
longer than non-bonded columns. 
Fused silica columns are flexible and. with an 
external coating of polyimide polymer. are extremely 
rugged. Both polar and non-polar stationary phases with 
high efficiency are available. They have superior 
resolution which can separate complex mixtures with narrow 
peaks. considerably enhancing the detection limit. 
Derivatization of 
compounds might be 
volatile and easily 
polar compounds and non-volatile 
required to convert them to more 
chromatographed compounds. Active 
protons such as those found in acids. amines. alcohols and 
phenols are reacted to form more inert ester. ether or 
silyl derivatives. 
2.3.3 HPLC Columns 
Conventional HPLC columns are usually constructed 
from straight. high quality. polished stainless steel or 
glass tubing with the following dimensions: lO-30cm long. 
4 . 5 - 5 mm I. Dan d 6. 3 mm 0 . D . The y are us u a 11 y pac ked wit h 
stationary phase under high pressure. The stationary 
phase consists of rigid, porous particles 3-l0pm in 
diameter. Small particles allow rapid diffusion of 
solutes between mobile and stationary phase and provide 
high column efficiency within the pressure capabilities of 
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the HPLC pump. An adequate flow rate can be obtained 
without exceeding the pressure limits of the column which 
might distort the packing material. Microbore columns 
(narrow-bore packed columns) are available for microcolumn 
HPLC [40] but their application in forensic toxicology is 
limited. 
2.3.4 separation mechanisms in liquid chromatography 
(i) Liquid-solid (adsorption) chromatography 
This is based on the competition for sites on the 
active adsorbent surface of the stationary phase (e.g. 
silica gel), between molecules of the sample and those of 
the mobile phase or its components. The mobile phase 
(eluent) is usually less polar than the stationary phase. 
Such systems are described as normal phase. 
(ii) liquid-liquid (partition) chromatography 
The stationary liquid phase is coated on an inert 
support. It must be immiscible with the mobile phase. 
Partition is called normal phase, when the stationary 
phase is more polar than the eluent; eluant systems use 
non-polar organic solvents in which the sample has limited 
solubility, modified by a good solvent for the sample 
which would, if present in excess, cause rapid elution of 
the components from the column. 
(iii) reversed phase chromatography 
is more 
example 
bonded 
In reversed phase chromatography the mobile phase 
polar than the stationary phase. The most common 
of this type of stationary phase 1S chemically 
silica with C18 hydrocarbon substituents. Mobile 
phases are based on water to which a water-miscible 
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organic solvent is added to modify the elution 
characteristics of the sample. 
(iv) Ion exchange chromatography 
The sample interacts with anionic or cationic 
groups on the solid stationary phase. An anion exchanger 
possesses positively charged sites while a cation 
exchanger bears negatively charged sites. The degree of 
sample retention is decided by the pH of the mobile phase, 
the concentration of buffer solution in the mobile phase 
and the presence of any counter ions which could compete 
with the sample for the charged sites on the ion exchange 
surface. Secondary mechanisms can also be present, such 
as hydrophobic interaction, and these should be considered 
when selecting the eluant. 
(iv) Steric exclusion chromatography 
The separation relies on the different rates of 
diffusion or permeation of molecules of different size 
through the porous matrix of the stationary phase. Large 
molecules, unable to enter the pores, elute first, 
followed by progressively smaller species. 
2.4 INTERFACING CHROMATOGRAPHY WITH MASS SPECTROMETRY 
General detectors of GC and HPLC are not within the 
scope of this presentation. They have been extensively 
discussed in text books [38,41-45]. The use of mass 
spectrometry, interfaced with GC and HPLC, as a detection 
system, IS presented. HPLC-MS is discussed in Chapter 5. 
2.4.1 Gas Chromatography-Mass Spectrometry 
The combination of GC with mass spectrometry 
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(GC-MS) has achieved a considerable importance ln the 
field of chemical analysis and detection [26,46,47]. It 
is now a well-established, routinely-used technique. The 
chromatography provides the separation of substances, 
while MS provides universal detection and unequivocal 
identification, especially ln the field of forensic 
toxicology. Detection limits are in the range 
10- 9_10-12 g by SIR, which cannot be obtained by many 
other detection methods. 
2.4.2 GC-MS Interfaces 
The eluent leaving the GC column is at atmospheric 
pressure whi Ie the MS ion source operates at -5 10 Torr. 
So for the direct connection of GC and MS, the volume or 
pressure of the carrier gas must be reduced to avoid 
destroying the high vacuum condition. The ideal interface 
device would remove all the chromatrographic mobile phase 
and transfer all the solute to the ion source without 
degrading chromatrographic elution. A comparison of GC-MS 
interfaces is presented in Table 2.3 and schematic 
diagrams of them are shown in Figure 2.5 
2.4.2.1 capillary column direct interface 
The flow rate of a capillary column is in the range 
0.5-3ml/min, which can be accommodated by the vacuum 
system of the MS while still maintaining a suitable 
pressure in the ion source, so it is possible to introduce 
the fused silica capillary column directly into the ion 
source. Fused silica tubing can also be used to interface 
glass or metal capillary columns. All of the sample 
eluted from the GC enters the MS ion source. 
1 
a 
2 
a----. 
3 
a------.. 
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Figure 2.5 Schematic diagram of GC-MS interfaces. 
1 .. Effusive. 2 .. Jet separator and 3 .. Membrane separator. 
a is the effluent from the GC column. b is vacuum pump, c 
is ion source, d is sintered glass and e is silicone 
rubber membrane. 
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TABLE 2.3: comparative performance of GC-MS interfaces [27] 
Classification Efficiency 
X 
Ideal 
Direct split 
Jet 
Effusive 
Permeable 
membrane 
Direct 
Infinite 
1 
100 
100 
1000 
1 
yield 
% 
Delay 
sec. 
100 0 
1-100* 1 
40 1 
50 1 
Y Inert 
1 yes 
1 Yes 
1-2 Yes 
Carrier 
Gases 
All 
All 
1-2 Maybe He,H2 
80-95 Var- 3 
iable 
Maybe Inor-
ganic 
100 1 Yes 
X Concentration in MS source/concentration in GC peak 
yield % = quantity in MS source/quantity ln GC peak x 100. 
Y = peak width in MS/peak width from CC 
* = split ratio 
2.4.2.2 Packed column interfaces 
The flow rate of a packed column (20-50ml/min) is 
too high to be introduced directly into the MS. One of 
the interfaces described below is required: 
(i) Effusive interface 
The effluent of the GC passes into a tube of porous 
glass enclosed in a vacuum. The light carrier gas 
(helium) will preferentially pass through the sintered 
glass of ultrafine porosity into the vacuum region and be 
pumped away. The ability of a molecule to pass through 
the small pores in the glass is inversely proportional to 
its mass, so few sample molecules of high molecular weight 
compounds will be lost. This interface is unsuitable for 
small molecular weight compounds and it has a large dead 
volume which broadens the chromatographic peak shape. 
(ii) Jet orifice interface 
The effluent from the GC passes though a small 
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jet orifice where the gas stream increases in velocity and 
passes into a vacuum region in the direction of a 
colI e c tor 0 r i f ice. T his i s abo u to. 5 mm a par t f r om and 
directly in line with the first orifice. and is connected 
directly to the ion source. The molecules with greater 
momentum (and lower diffusion coefficient) pass into the 
orifice while the lighter molecules with less momentum 
(higher diffusion coefficient) such as the helium atom are 
preferentially pumped away in the vacuum region. This 
type of interface can be used for capillary column 
interfacing as well. if make-up gas is added to the column 
effluent before the separation. 
(iii) Permeable membrane interface 
The GC effluent is passed over one surface of a 
silicone rubber membrane. while the other side is open to 
the ion source vacuum. The organic molecules dissolve on 
its surface and permeate through into the vacuum region of 
the MS. The carrier gas is vented to atmosphere. 
(iv) Direct split interface 
'rhe effluent of the GC is split in the interface 
(by venting a portion to atmosphere) to accommodate the 
pumping capacity of the MS. The remainder enters the MS 
source directly. 
Other techniques combining chromatography with mass 
spectrometry include supercritical fluid chromatography-
mass spectrometry (SPC-MS) [48] • whi le techniques for 
sample component discrimination without chromatography 
include the recently developed techniques of tandem mass 
spectrometry (MS-MS) and Fourier transform mass 
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spectrometry (FTMS) [32,48]. They provide high mass 
capabilities and low detection limits. 
2.5 DATA ANALYSIS 
The data generated by GC or LC-MS are utilized for 
both identification and quantitation of the analyte. 
2.5.1 Identification 
A mass spectrum of a compound under a specific set 
of experimental conditions is as unique as a fingerprint. 
Identification of the unknown spectrum can be performed by 
one or more of the following methods. 
2.5.1.1 Fundamental interpretation of the 
fragmentation pattern to propose a chemical structure for 
the compound [29,49-52]. 
2.5.1.2 Comparison of the mass spectrum with 
libraries of reference spectra including: 
I. Eight Peak Index (Mass Spectrometry Data 
Centre)[53]. 
II. Environmental Protection Agency National 
Institute of Health (EPA-NHS) mass spectral data base [54]. 
III. wiley-NBs (National Bureau of Standards) mass 
spectral data base for computer library search [55]. The 
computer can perform rapid and accurate library matching, 
although the basis for comparison can be complex. Both 
data storage space and search time are considered for the 
type of search. Three types of comparison purity, 
mixture and reverse fit can be used. A purity search 
makes a direct comparison between the unknown and the 
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library. A mixture search looks for library entries which 
match a subspectrum of the unknown. A reverse search 
looks for library entries which best contain the unknown. 
IV. 
from 
Smaller libraries which are constructed by the user 
commonly encountered drugs found in previous 
analyses [56]. 
V. 
VI. 
Other textbooks and pUblications [12,51,57]. 
The most common and reliable method is by running 
an authentic standard at the same time and under the same 
conditions. 
2.5.2 Quantification 
Quantitative analysis using mass spectrometric 
detection was enabled by coupling it with gas 
chromatography which provides the separation necessary for 
reliable quantitation. The vast data generated during 
acquisition is 
manipulation. 
are tha t the 
stored in the data system for further 
The principal requirements for quantitation 
ions chosen are specific to the compounds 
quantified and they should preferably be the principal 
ions in the mass spectrum of the analyte. More than one 
ion can be monitored for each compound of interest. 
However, the detection limit becomes increasingly poor as 
the number of ions is increased. Accurate quantitation 
requires incorporating an internal standard (I. Std) . The 
most effective I. Stds. in GC-MS are isotopically labelled 
analogues of the substance being analysed. Such compounds 
will have the same chemical and physical properties as the 
analyte, and are effective monitors of sample extraction 
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and detector efficiency as the ratio of the analyte 
response (peak area or height) ln the sample or reference 
standard to the I. Std response during quanti tat ion will 
compensate 
variables 
for variation in extraction losses or other 
by mass during the analysis. Quantitation 
spectroscopy can be performed by one of three scanning 
modes: 
I . Repetitive scanning mode. This includes the 
computer-reconstructed total ion 
chromatogram or 
specific masses as 
reconstructed lon 
discussed above. 
current 
chromtograms 
This is the 
(TIC) 
for 
least 
sensitive mode and is avoided where a low detection limit 
is required. However. it is highly specific Slnce the 
characteristic mass spectrum of the analyte is obtained in 
addition to the retention time. 
II. scanning over a limited mass range. This is 
similar to the above method but higher sensitivity could 
be obtained while lower numbers of masses are scanned. 
I I I . Selective ion recording (SIR). This mode provides 
the highest sensitivity and can give a thousand-fold 
increase in detector response over the full scan mode. 
However. it can be the least specific when only one mass 
is being moni tored. It is advisable to moni tor two or 
three ions. characteristic of a specific compound. They 
will share same retention time. peak shape and will be 
represented in known relative abundances. which decreases 
the possibility of unexpected interference. 
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C HAP T E R T H R E E 
M 0 R PHI N E AND B U PRE NOR PHI N E 
3.1 INTRODUCTION AND LITERATURE REVIEW 
3 . I . 1 INTRODUCTION 
Morphine 1S used clinically to produce analgesia. 
It is obtained from opium where it is the major alkaloid 
and constitutes about 10% of the opium weight [58,59]. 
Opium 1S obtained from the milky exudate of the incised 
unripe seed capsules of the poppy plant papaver 
somniferum. Major areas of opium production are currently 
Afghanistan, Pakistan and south-east Asian countries such 
as Burma, Thailand and Laos [60,61]. 
Morphine 
effects on the 
and related drugs produce their major 
central nervous system (eNS) and the 
bowel. The effects include analgesia, drowsiness, change 
1n mood, respiratory depression, decreased gastro-
intestinal motility, nausea, vomiting and alterations in 
the endocrine and autonomic nervous systems. A detailed 
pharmacological discussion is given 1n the literature 
[62]. Normal therapeutic analgesic 
range from 10-20mg given parenterally. 
doses of morphine 
Peak plasma levels 
are recorded after 30-40 minutes and the effects last 4-6 
hours. The corresponding blood and serum levels range 
from 10-100ng/ml [62]. 
Buprenorphine is a relatively new drug with mixed 
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agonist and antagonist opiate action. It is 25-40 times 
more potent than morphine at the therapeutic dose of 
0.4-0.8mg sublingually and 0.3-0.6mg parenterally. Its 
concentration in plasma peaks at two hours after oral 
ingestion and persists for more th d [ ] an a ay 62.63. 
After intravenous injection at 6pg/kg. buprenorphine 
concentrations are in the range 2-50ng/ml within the first 
three hours [64]. Little is known about the toxicity of 
buprenorphine in man. The median lethal single doses 
(LD 50 1 s) for buprenorphine in mice were 24-29mg/kg, 90 to 
97mg/kg and 260 to 261mg/kg for intravenous. intra-
peritoneal and oral administration respectively [63]. 
Morphine is important from both a medical and a 
legal viewpoint 
in users the 
as a major drug of abuse which displays 
effects of tolerance. addiction and 
withdrawal syndrome. Tolerance leads to decreased 
intensity of the pharmacological effects and shortened 
duration of action. Cross tolerance is the extension of 
this phenomenon to all drugs belonging to the class and 
can develop between all opioids [8.65]. A habitual 
morphine user can take 20-30 times the therapeutic dose. 
In contrast buprenorphine shows a much lower 
physical dependence liability than morphine [63]. It was 
tested and used for substitution of morphine in heroin 
addicts [66.67]. However. buprenorphine does show 
withdrawal symptoms. albeit milder than those seen in 
other opiate withdrawal. The marked symptoms appear after 
two weeks of wi thdrawal of buprenorphine. Recently 
buprenorphine was reported to be abused [68]. 
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3 . I .2 FATALITIES AND MORPHINE TISSUE LEVELS 
The correlation between levels of morphine ln 
various tissues and fatal poisoning has been discussed 
frequently in the literature. Histological and 
pathological criteria for the diagnosis of death due to 
intravenously administerd narcotics have been 
described [69]. 
The survival periods of 22 acute heroin fatalities 
were divided into short, intermediate and long term after 
the last heroin injection according to different 
microscopic features in relation to the morphine level in 
blood [70] (Table 3.1.1). 
Table 3.1.1 Acute heroin fatalities: morphine levels in 
blood and microscopic changes in relation to survival time 
[70] . 
survival 
Time 
Short Term 
< 3 hours 
Intermediate 
term 
3 - 24 hours 
Long term 
> 24 hours 
Blood Level 
jlg/ml 
0.1-0.93 
0.03-0.1 
0.06 
Microscopic 
Changes 
In the lung: minimal to 
extensive haemorrhages and 
oedema 
varying degree of 
leukocytic infiltration 
ranging from focal and 
mild reaction to a picture 
indistinguishable from 
diffuse lobar pneumonia 
pulmonary responses from 
organizing pneumonia to 
interstitial fibrosis. 
Most tissue showed some 
degree of arterial 
granulomas and polarizable 
foreign materials. 
The authors in this study refer to characteristic criteria 
of refractile crystalline granulomas in the lung and skin, 
increased lymphocytic 
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infiltrate in the portal and 
periportal areas and benign lymphoid hyperplasia. These 
are not diagnostic for morphine fatalities [71]. However, 
morphine blood levels tend to be lower with longer 
survival periods which is explained by the metabolic 
removal of morphine, but others found these levels are not 
always consistent [71]. 
The minimum lethal tissue concentration of morphine 
was reported as 0.2-0.3Ug/g in blood and muscle [72]. 
This is not always true. In a study of 114 cases of death 
due to intravenously administered narcotics [71], morphine 
was the only drug found in 35% of the cases at 
concentrations ranging from zero to 1.4~g/ml with a median 
of 0.06)lg/ml. 
morphine was 
The value of the median was lowered when 
present in combination with alcohol or 
sedative and hypnotic drugs to 0.04 and 0.03~g/ml in blood 
respectively. 
Current views on the mechanism of action of 
morphine and other opiates' are based on the presence of 
receptor sites at the point of action [62,73]. The 
rna j or i ty of opia te receptors are loca ted in the bra in. 
The brain is the site where most, if not all, the effects 
of morphine originate. A comparison between blood levels 
of morphine and tissue levels at different sites of the 
brain in 21 cases where the death was attributed to 
narcotics overdose and in which the levels were in the 
fatal concentration range mentioned above, showed that in 
more than half of the cases, the highest concentrations 
were 
are 
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found in the brain stem and the thalamus [74]. These 
the sites where many of the adverse effects of 
morphine originate. for example. the location of the 
respiratory centre is in the brain stem. and respiratory 
arrest is nearly always the cause of death in morphine 
overdose [62.70.75]. 
Morphine distribution in various tissues was 
compared in two cases of heroin-induced suicide [76]. The 
blood concentrations of morphine were almost similar 
(0.64 and 0.63}1g/ml). but wide variation was found for the 
other tissues. High tissue and blood levels of morphine 
were reported in an exhumed body where the dea th was due 
to an overdose of injected morphine [77]. An unusually 
high blood morphine level of SJlg/ml in a heroin addict 
[7S]. and an even higher level of 120pg/ml in a case of a 
sudden death of a heroin body packer [79] have been 
reported. In the latter case. several condoms containing 
heroin. caffeine and acetylcodeine which were being 
smuggled inside the digestive tract had spilt their 
contents into the stomach and leaked into the peritoneum. 
Post-mortem blood morphine levels in 16 cases of 
heroin-related death. ranging from 0-4. 7Jlg Iml. were 
compared with those of patients receiving morphine as an 
analgesic on life-support machines. which ranged from 
0-0.39pg/ml [SO]. A high incidence of cases was observed 
where morphine had unquestionably contributed to the cause 
of death but at low concentrations. similar to those seen 
in patients receiving morphine for therapeutic purposes. 
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This study shows the disadvantages of setting rigid 
therapeutic. toxic and fatal levels for morphine In 
blood. The wide range of morphine levels in post-mortem 
tissue quoted in the literature illustrates the importance 
of considering the post-mortem pathological findings at 
autopsy as we 11 as other pert inent c ircums tances a t the 
time of death. such as the history of drug use. tolerance, 
presence of other drugs and absence of other significant 
causes of death for the proper interpretation of observed 
morphine levels. 
3 . 1.3 METABOLISM AND EXCRETION 
About one third of morphine and 96% of 
buprenorphine circulating in blood at therapeutic levels 
is bound to plasma protein [62]. The free morphine 
accumulates in the parenchymatous tissues of spleen. 
kidneys, lung and liver. A very small percentage passes 
the blood-brain barrier but heroin and 6-monoacetyl 
morphine pass the barrier more easily than morphine due to 
their higher lipid solubility [62]. Heroin IS rapidly 
hydrolysed in blood (half life is less than 20 minutes) 
[81] to monoacetyl morphine (MAM), which in turn IS 
hydrolysed to morphine. 
Detoxification of morphine and buprenorphine occurs 
by conversion to water-soluble molecules through 
conjugation with glucuronic acid to morphine-3-g1ucuronide 
and morphine-6-glucuronide (M3G and M6G) and 
buprenorphine-3-g1ucuronide, respectively, or with 
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sulphate to morphine-3-sulphate [81,82]. An illustration 
of the metabolic pathways is shown in Figure 3.1.1. Minor 
biological reactions OCcur in the formation of codeine and 
N-dealkYlation of morphine to normorphine and 
buprenorphine to N-desalkylbuprenorphine [63]. 
The main dose of morphine (85-90%) IS excreted in 
urine in small amounts as free morphine and in larger 
amounts as the conjugated forms. Also, 7-10% of the 
administered dose is excreted in the faeces as a result of 
biliary excretion of the conjugate from the liver [62]. 
Most (90%) of the urinary excretion takes place within 24 
hours, although traces can be detected for well over 48 
hours. Enterohepatic circulation may account for the 
persistent excretion of M3G in urine. The presence of MAM 
as well as morphine in urine indicates heroin intake 
[83]. While buprenorphine-3-glucuronide and the 
N-dealkylated form can be detected in urine, most of the 
buprenorphine is excreted unchanged in faeces. 
3 . I .4 SAMPLING AND INTERPRETATION 
Almost all biological tissues have been used for 
the analysis 
account the 
of morphine. 
availability 
Each method 
of tissues 
has 
and 
taken 
fluids 
into 
and 
preference with respect to the ease of sampling and 
importance of the selected medium for the analysis or the 
final toxicological interpretation. For example, hair IS 
considered a convenient 
investigating past chronic 
non-invasive 
heroin 
sample 
intake 
for 
[ 84] . 
Heroin 
~ 3-0-hydrolysis 
6-Acetylmorphine 
~ 6-0-hydrolysis 
Morphine 
" ~N-D 
'\-M"" ~ 
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N~rmo['phine 
o D 
o M 
o M 
O-D 
Norcodeine 
Codeine 
Name R1 R2 
-
Heroin CH3CO CH3CO 
6-Acetylmorphine H CH3CO 
Morphine H H 
Codeine CH3 H 
Normorphine H H 
Norcodeine CH3 H 
Morphine-3-glucuronide Gluc H 
Morphine-6-glucuronide H Gluc 
Urinary excretion product 
6-Acetylmorphine 
6-Acetylmorphine-3-glucuronide 
Morphine-6-glucuronide 
Morphine-3-glucuronide 
Free morphine 
Morphine-3-sulphate 
Free normorphine 
Normorphine conjugates 
Free norcodeine 
Norcodeine conjugates 
Free codeine 
Codeine conjugates 
~ 
CH3 
CH3 
CH3 
CH3 
H 
H 
CH3 
CH3 
Figure 3.1.1 Heroin (diamorphine) and morphine metabolic path-
ways in man and their excretion products in urine. N-D=N-demethyla-
tion, N_M=N_methylation.O-H=o-methylation, O-D=O-demethylation. 
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Cerebrospinal fluid (CSF) [71 85] d . 
, an vltreous humor are 
useful 
as free morphine can be 
detected and the samples are free from contamination. 
post-mortem samples, 
Bile and urine are helpful in drug screening 
procedures, since high concentrations of morphine are 
present and persist for a few days after discontinuation 
of the drug intake [71]. However, morphine concentrations 
in urine show no correlation with lethality [72]. 
Morphine can be detected in urine after therapeutic 
codeine intake: both morphine and M3G appear in urine as 
well as codeine and its glucuronide. The ratio of these 
two metabolites is a helpful indication of codeine intake 
[86] within 24 hours [4]. 
The blood concentration of a drug usually presents 
the best correlation with its pharmacological effects, so 
blood, plasma and serum are considered as the specimens of 
choice [81]. The blood level can also be indicative of 
recent heroin usage and this is consistent with the idea 
that death from heroin injection is a result of a 
pharmacological response. High ratios (50-100%) of 
unconjugated morphine to the total (morphine and morphine 
glucuronide) suggest a rapid death after opiate injection, 
while low ratios may be due to a longer interva 1 between 
injection and death or to the accumulation of 
glucuronide in chronic use of opiate [87]. 
The inclusion of different media 
morphine 
for the 
toxicological analysis of morphine as well as clinical 
and pathological findings will support the final 
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interpretation. The following paragraphs gIve some 
helpful remarks for this consideration. 
The presence of traces of morphine in the bile and 
its absence in the urine in a fatality due to morphine or 
heroin injection suggest a prior morphine intake which is 
not related to the most recent injection. The absence of 
morphine in both urine and bile in a very abrupt death 
could be explained by the excretion into bile and urIne 
being precluded due to a sudden and intense cardiovascular 
collapse with subsequent lack of perfusion of the liver 
and kidneys [88]. with a longer survival time after the 
injection. both fluids could have high concentrations of 
the drug. The presence of morphine in urine and absence 
in bile suggests that this injection was the first for 
several days [70.71]. 
3 . I . 5 
3.1.5.1 
(a) 
MORPHINE AND BUPRENORPHINE ANALYSIS 
Extraction From Biological Material 
Solvent Extraction 
Drugs of the opiate type are polar. Their 
hydrophilic nature necessitates a rigorous extraction 
procedure to isolate them from biological media with 
sufficient purity 
quantification of the 
methods. 
for the identification and 
isolate by various chromatographic 
At the biological pH (pH 6-7.5) the morphine and 
buprenorphine mo lecules have a 
protona t ion of the amine group. 
low lipophilicity due to 
The pK a values are 8.0 
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and 9.9 for amine and phenol group, . respectIvely, and 
log P (octanol/pH 7.4) is -0.1 [12]. To Increase the 
apparent lipophilicity of morphine, biological samples 
should have a pH in the range 8.5-10 so that the free base 
can be extracted into an organic solvent. This pH range 
gives the optimum extractability [84]. Various buffering 
and ion pairing reagents have been utilized for that 
purpose (Tables 3. 1.2 and 3), but none of these shows 
particular superiority over the others. 
Previously, most methods depended on solvent-
solvent extraction (Tables 3.1.2 and 3) where the aqueous 
biological sample was mixed with a suitable internal 
standard and the mixture was adjusted to the required pH 
with a buffer or an ion-pairing reagent. Extraction was 
performed with an organic solvent (Tables 3.1.2 and 3), 
usually twice with 3 to 4 times the volume of the aqueous 
layer. The organic solvent collected after centrifugation 
was back-extracted with an acid solution (e.g 0.05 M 
sulphuric acid) for further purification from endogenous 
material in the biological sample. Then the acid portion 
was alkalinized to the previous pH and extracted again, 
usually twice, into an organic solvent which was finally 
concentrated for the subsequent chromatographic method. 
The organic solvent should be efficient 1 n 
extracting the drug from the biological material and 
should be readily volatile. Most methods depend on 
chloroform with the addition of an alcohol (e.g 
b t 1) to 1· ncrease the polarity of the isopropanol or u ano 
Table 3.1.2: Summary of representative methods for the analysis of morphine in biological samples. 
Ref Matrix Quantity Buffer Extraction Derivative Method of Recovery Detection 
ml pH Analysis '0 Limit 
90 Plasma 1 4M NaOH 14 Ethyl acetate* PFB GC-MS Sng/ml 
TFA GC-ECD 
91,92 Blood 0.5 0.8M 8.9 Ethyl acetate:prop- HPLC,ECD 81 Ing/ml 
anol (9:1 v/v)*,** 
93 Blood 0.1-0.2 Phosphate 8.7-9 Acid aluminium oxide PFP GC-ECD 83 Ing 
buffer column 
ethyl acetate 
94 Blood 0.5 NaHC03 Chloroform:isoprop- TFA GC-MS 1.Sng/ml 
anol (4:1 v/v) SIR l-Sng/ml 
95 Plasma 1 Ammonium 9 Extrelut Column* PFP GC-ECD 98 Ing/ml 
Chloride i sobutanol: DCMtl (5:95 v/v) ~ 
96 Plasma, 1 0.5M 9.3 Sep-Pak C18 CD HPLC UV 84-90 Sng/ml 
urine Ammonium Cartridge,purified 
Sulphate over another similar 
& Ammonia cartridge 
97 Blood 10 2M NaOH 9 Chloroform:isoprop- HPLC- 80 10 
Urine anol* Fluorescence 
98 Blood, 2 Phosphate 9.9 Toluene:hexane:iso- TFA GC-MS 55-60 20ng/ml 
Tissue buffer amyl alcohol SIR 
& Urine (78:20:2 v/v/v)* 
II DCM: dichloromethane. 
* included back extraction step 
** 
tissue hydrolysis was included 
*** different solvent systems were tested 
Table 3.1.2 (conlinuation) 
Ref Matrix Quantity Buffer Extt'act ion Derivative Method of Recovery Detection 
ml pH Analysis % Limit 
99 Plasma 0.5 0.2M 9 Bond-Elut C18 HPLC-ECD 95 3ng/ml 
Borate 
83 Urine 1 saturated 9.5 C18 Cartridge PFP GC-MS 2ng/ml 
Anunon i um SIR 
Chloride 
Solution 
59 Serum 0.1-1 0.05M 9 Bond-Elut C18* TMS GC-MS 90-95 
CSF borax CI-SIR 
100 Biolo- 5-10 Na2co3 9 1.Toxi-Tube HPLC- 77-90 60pg gical 
-NaHC03 2.Chloroform-2- Fluorescence on column ~ Tissues ~ 
Fluid propanol (4:1 v/v) 
101 Urine 10 Anlnlonium 9 1sobutanol:DCM* TFA GC-MS 58 2ng 
Chloride PFP,HFP on column 
102 Urine Extrelut 2-propanol-DCM HPLC- 71-78 1ng/ml 
(15'0 v/v) Fluorescence 
103 Plasma 0.4 NaHC03 9.3 Clin-Elute-CE101 HPLC-ECD 91 2ng/ml 
10MNaOH Cartridge 
104 Urine 1 0.5M 9.3 Sep-Pak C18 HPLC- >80 Ing/ml 
Plasma Anunon i um Cartridge Fluorescence 
Chloride 
-ECO 
Table 3.1.3: Summary of the main methods used for the analysis of buprenorphine, based on solvent extraction. 
Ref 
105 
106 
107 
108 
109 
64 
110 
Matrix 
Plasma 
Plasma 
urine 
Faeces 
Serum 
urine 
Plasma 
Plasma 
Urine 
Quantity 
ml 
1 
2 
1 
2 
10 
1 
1 
Buffer pH 
0.2M NaOH 12.4 
Carbonate 9.4 
K2P04 10 
1M NaOH 
20'10 Na,OH 
O.SN 
ammonium 
hydroxide 
O.lM 
Borate 
7.5 
9.1 
Extraction 
Ether* 
Toluene:2-butanol* 
(8:2 v/v) 
Ethyl acetate:heptane 
(4: 1) *** 
Ether 
Bond Elute C18 
Ether *** 
Ether 
Benzene* 
* Acid back extraction purification step was included. 
** Several solvents and/or combinations were tested. 
*** enzyme hydrolysis was included. 
Derivative 
HFB,TMS 
PFP 
PFP 
Method of 
Analysis 
GC-MS 
SIR 
GC-MS 
SIR 
GC-ECD 
HPLC-UV 
TLC 
HPLC-UV 
HPLC-ECD 
HPLC-ECD 
Recovery 
'10 
30 
44-80** 
98-100 
21-35 
88-119 
88-104 
Detection 
Limit 
2ng/ml 
150pg/ml 
10ng/ml 
2ng on 
column 
7.Sng/ml 
0.2ng/ml 
10ng/ml 
1ng/ml 
lJ1 
o 
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extracting solvent. In a study to select a solvent 
system for morphine extraction from biological tissue, 
chloroform: isopropanol (4: 1 v/v) was found to be the best 
amongst solvent systems tested because of its extraction 
efficiency (which was over 92%) and its relatively high 
volatility [89]. A solvent:sample ratio of 3:1 was 
recommended. I n genera 1. more po lar so 1 vents wi 11 gl ve 
high extraction efficiencies. less adsorption to the glass 
surfaces and render the adjustment of the medium pH less 
critical. but on the other hand will extract more of the 
endogenous material. Low polari ty solvents require 
critical optimization of the medium pH and, although they 
give lower efficiencies. the extract 
with respect to matrix interference. 
is usually cleaner 
Solvent extraction 
procedures 
volumes of 
require 
solvent 
rather long analysis 
and are complicated 
times, large 
by emulsion 
formation and the need for several centrifugation steps. 
For total morphine estimation the extraction 
procedure has to be preceded by hydrolysis of the 
biological sample to free the morphine and normorphine 
from their conjugates. This is accomplished by enzyme 
hydrolysis (glucuronidase and sulphatase enzymes), under 
the optimum pH. temperature and incubation time conditions 
for these enzymes. About 80% recovery can be obta ined 
after the reaction 
Alternatively. acid 
has proceeded 
hydrolysis can 
for 40 hours 
be carried out 
[ 89] . 
using 
concentrated hydrochloric acid (sample:acid 10:1 v/v). 
The mixture is heated or refluxed in boiling water for 
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30 mln or autoclaved under more than 
and 
one atmospheric 
the amount of pressure. The effect of temperature 
hydrochloric acid added were found to be interdependent 
to a sample hydrolysed at [ 89] : more acid must be added 
lower temperatures to obtain equivalent recovery in the 
same time. Although acid hydrolysis was more efficient 
and faster than enzyme hydrolysis, acid hydrolysis of the 
sample might destroy heat-labile drugs present in the 
matrix, including morphine itself. 
(b) Solid Phase Extraction 
Solid phase extraction (SPE) methods have started 
to replace conventional solvent extraction procedures for 
most drugs in urine, plasma and other clear biological 
fluids. They have proved to be efficient, require 
relatively short analysis times, have low solvent 
consumption, have no solvent emulsion problems and do not 
require centrifugation for the procedure. The extracts 
are sufficiently clean for most chromatographic techniques. 
Solid phase extraction is a physical extraction 
process 
solid 
that involves a partition between a liquid and a 
phase, where the solid phase has a greater 
attraction for the isolate than the medium in which the 
drug is dissolved. 
Various materials which have been used in SPE for 
the analysis of narcotics were reviewed elsewhere 
[85,111]. Here, some examples of SPE materials applied to 
morphine analysis are presented. 
XAD-2 is a neutral styrene-divinylbenzene 
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copolymer [112] having the capacity to adsorb organic 
material from aqueous solution. In one 
buffered sample 1S mixed with a slurry, 
washing of the resin and extraction with 
method, the 
followed by 
an organic 
in prepacked 
columns and a clean up step into acid solution can be 
solvent. The material can also be used 
included [113,114]. 
Diatomaceous earth (Extrelut and Clin-Elute) has 
been applied to the extraction of various drugs [115]. 
The sample is first applied to a prepacked column of the 
material. The aqueous layer is adsorbed on the Extrelut, 
leaving the drug of interest buffered to its optimum pH 
for the extraction and elution with a small aliquot of 
organic solvent. These materials were applied for 
morphine extraction from plasma [95,103] and urine [102]. 
The eluate was back extracted into acid and re-extracted 
over Extrelut as the first step. 
Silica can be modified by chemically bonding 
different functional groups on the surface, providing a 
wide range of selective properties for the extraction 
procedure. A summary of the principles of different modes 
of SPE on these materials has been described [116]. The 
most common sorbents applied to morphine extraction have 
been the reversed phase packing materials (silica bonded 
to long-chain hydrocarbons), for example C18 (octadecyl) 
silica [83,85,99,104]. 
The sorbent has to be solvated before applying the 
buffered sample. Large amounts of sample can be applied 
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and concentrated in this way, followed by washing and 
finally elution of the isolate in a small fraction of 
solvent and buffer for further identification. 
Optimization of the conditions in each step is usually 
required for each drug. 
The extraction of morphine and buprenorphine from 
whole blood us ing bonded phases has not yet been 
reported. The nature and constituents of blood require 
prior treatment before application to these phases. 
3.1.5.2 Analytical Techniques 
(a) Immunoassay Methods 
Immunoassay methods are the most commonly applied 
techniques for the screening of drugs, including morphine 
and buprenorphine, in biological samples. Various types 
of immunoassays for the ana lys is of na r cot ics were 
reviewed [85]. They were applied to pharmacokinetic 
studies of morphine and the study of morphine distribution 
between different body fluids in post-mortem material 
[75,76,78,111] as well as the measurment of buprenorphine 
levels in plasma [106,117-119] and buprenorphine kinetics 
[106,118]. The results of immunoassay procedures were 
also compared with routine chromatographic methods for 
screening purposes [75,111,114,120-122]. 
An immunoassay procedure does not require 
extraction and purification of most biological fluids. It 
is experimentally simple, sensitive and readily automated, 
thus allowing a large number of assays to be carried out 
at one time. The recent commercial radioimmunoassay (RIA) 
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method (Coat-A-Cont) [26.123] quotes a sensitivity of 
O.12ng/ml and O.3ng/ml of free morphine and buprenorphine, 
respectively. in an assay which uses 25)11 of urine. A 
radioreceptor assay for opiates including morphine and 
buprenorphine has been introduced [124]. It 1S based on 
the principle that opiates in CSF or plasma compete with 
3H-buprenorphine for binding to opiate receptors in the 
rat brain. Its sensitivity reached 100 pg of morphine and 
buprenorphine. The drug has to be extracted from the 
plasma or CSF to remove the interference in the binding 
caused by plasma protein and sodium ions. 
In spite of the benefits of immunoassays mentioned 
above. they should be used in conjunction with other. 
chromatographic. procedures due to their cross reactivity 
as a result of binding of the antibodies to morphine, its 
metabolites and other chemically related compounds in the 
sample. This cross reactivity 1S determined by the 
reactive group to which the antibodies were originally 
raised by either modification of the N-methyl or 
6-hydroxyl group on the morphine molecule [121]. The 
cross reactivity is beneficial in forensic toxicology as a 
presumptive screening procedure for a drug and its 
metabolites. The commercial Coat-A-Cont kit for RIA is 
very specific for morphine. In a study of the relative 
cross reactivity for morphine and 23 other 
structurally-related drugs [122]. it was found that the 
relative cross reactivities for related drugs in spiked 
blood samples were negligible. Due to the specificity of 
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this method for morphine it is considered to be a 
quantitative analysis for morphine rather than a general 
screening procedure for opiates. Any positive result 
obtained in any of the immunoassay methods should be 
confirmed: samples with negative results can be excluded. 
(b) Chromatographic Techniques of Analysis 
A summary of various chromatographic procedures 
utilized for morphine analysis will be presented. Reviews 
of methods for morphine and other opiates analysis are 
also available in the literature [58,81,85,112]. 
(i) Thin Layer Chromatography 
Thin layer chromatography (TLC) IS 
employed 
morphine 
for screening and detection of drugs 
commonly 
including 
and buprenorphine. Recently, valuable 
collections of R f values were published for a wide range 
of drugs and different systems of elution [12,24]. The 
more recent publication presented standardized systems for 
reliable and accurate identification of unknown drugs. 
Different visualizing techniques were applied: 
spraying of chromogenic reagents [125], converting 
morphine to a fluorophore by reacting it 
chloride to achieve higher sensitivity [126] 
wi th dansyl 
or by adding 
anti-morphine antibodies in TLC-immmunoassay [127]. The 
latter suffers from lack of specificity for morphine due 
to cross reactions as in other immunoassays and it IS not 
easy to set 
reI iable and 
up. In general, TLC is relatively rapid, 
economical but lacks sufficient sensitivity 
for morphine and related drugs in a small amount of sample 
at low concentration. 
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( i i) High Performance Liquid Chromatography 
Ultraviolet (UV) spectroscopy is another screening 
procedure. It is an inexpensive, nondestructive method 
but it lacks sensitivity due to the low extinction 
coefficient of morphine and lacks the specificity required 
for most of the narcotic drugs. It utilizes the ability 
of the phenol moiety of morphine and structurally- related 
drugs to absorb UV light. Combining UV to HPLC 
compensates for the lack of specificity in UV 
spectroscopy, by virtue of the separation of the compounds 
and the possibility of using the retention time for 
identification [108.109,128,129]. 
The sensitivity of HPLC was improved by converting 
the morphine molecule to a fluorophore (pseudomorphine) by 
a precolumn reaction with potassium hexacyanoferrate [102] 
or dansyl chloride [84,100,104] or by postcolumn reaction 
[97] . 
Chemiluminescence (CL) detection with postcolumn 
reaction creates the possibility of monitoring HPLC 
effluent for morphine and similar drugs which can be 
oxidised to produce pseudomorphine [130]. This process is 
blocked in the presence of a substitute group (methyl for 
codeine and acyl in heroin) at the C-3 position hydroxyl 
group. The process requires careful selection of pH, 
buffer, the nature and concentration of the oxidizing 
material and the flow rate of the reactant to produce CL 
in the flow cell. The sensitivity once the parameters are 
optimized can reach 0.7 pg per injection. 
Electrochemical 
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detection provides invaluable 
sensitivity for HPLC detection of morphine and related 
drugs. When the free pheno I ic oxygen is ava i lab Ie for 
oxidation, sensitivity reaches 1-10 ng/ml of biofluid 
[64,91,92,103,104,110]. 
HPLC analysis usually does not require rigorous 
cleaning procedures or derivatization of polar drugs, so 
morphine and its metabolites M3G and M6G could be detected 
simultaneously [91,104]. 
The tedious optimization of the operating condition 
for fluorometric derivatization and detection, the 
frequent contamination of the electrodes in ECD, the 
interferences from the matrix and the huge influence of 
the mobile phase composition have 
extensive application in routine assays. 
(iii) Gas Chromatography(GC) 
decreased their 
Gas chromatography is extensively employed as a 
screening procedure for morphine and other narcotics as 
well as for confirming the positive results of the 
preliminary screening methods (TLC, UV, RIA). Both packed 
and capillary columns have been used, the latter providing 
better resolution and sensitivity. Due to the polarity of 
morphine, the extracts for morphine analysis have to be 
derivatized before application to the GC column, to 
decrease adsorption on the column. This leads to an 
improvement in sensitivity and better chromatography. 
silylation by the addition of two trimethylsilyl groups 
(TMS) at the two hydroxyl groups is a commonly used 
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der iva t i za t ion procedure. Commer c ia 1 reagents, ready to 
use for quick silylation directly after the addition and 
warming of the mixture, have been applied to morphine, 
reproducibly giving one stable derivatization product. 
Representative of these reagents are Tri-Sil Z (a 
mixture of trimethylsilyl-imidazole in pyridine) [74,88], 
BSA (N,O-[bistrimethylsilyl]-acetamide) [72,85,131], BSTFA 
(N,O-[bistrimethylsilyl]-trifluoro-acetamide) [59, 85] and 
MSTFA (N-methyl-N-[trimethylsilyl]-trifluoro- acetamide) 
[98,132]. These are all powerful TMS donors. 
Acetyl derivatives for morphine have been reported 
using acetic anhydride [114,132], trifluoroacetic 
anhydride (TFA) [81,90,94,101], pentafluoropropionyl 
anhydride (PFPA) [83,95,101,133,134] and for buprenorphine 
[107,135], heptafluoropropionyl anhydride (HFPA) [101], 
heptafluoro-benzyl anhydride (HFBA) [85,136] and hepta-
fluorobutyryl anhydride [101]. 
Derivatization with acetic anhydride produced one 
product for morphine, namely 
stability was tested up to 72 
diacetyl 
hours at 
morphine. Its 
room temperature 
and was found satisfactory [101]. Derivatization with TFA 
gave both 3,6-di-TFA morphine and 3-TFA morphine and 
heptafluorobutyrylation similarly produced two morphine 
derivatives; both showed spontaneous breakdown to 
morphine. pentafluoropropionylation gave only 3, 6-di-PFP 
morphine but was not stable; it transformed to 3-PFP 
morphine and morphine [101]. Buprenorphine was converted 
to a stable product for GC analysis by a mild acid 
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hydrolysis which resulted in ring formation between the 
side chain and methoxy group after the loss of methanol 
[107,135]. The phenolic hydroxyl group is derivatized as 
described above. 
Any of the above 
morphine is suitable for 
ionization detector (FID) 
derivatization procedures for 
detection by the general flame 
[72,74,131,132] where an aliquot 
of the product is 
silylated derivative 
directly injected, 
liable 
especially the 
to hydrolyse on 
improved by us ing 
which is 
exposure to moisture. Sensitivity is 
the selective nitrogen phosphorus detector (NPD) 
[114,137]. Care is taken to remove solvents containing 
nitrogen which will contaminate the 
acetylation reactions which give 
detector. Following 
stable products, the 
excess of the reagent is either evaporated or the products 
are extracted into a suitable solvent. Fluoroacyl 
derivatives have a strong electron affinity and are 
readily detected by an electron capture detector (ECD) 
which can take the sensitivity to low nanogram levels 
[85,95,136]. 
iv. Mass Spectrometry 
Detection 
chromatography 
by mass 
(GC-MS) 
spectrometry coupled to 
offers an insight into 
gas 
the 
molecular structure, provides sufficient sensitivity and 
offers the best available technique for unequivocal 
identification of opiates in biological material. The use 
of deuterium-labelled compounds as internal standards 
would be preferred, but their availability is quite 
limited. 
- 61 -
All the morphine derivatives suitable for GC 
analysis can be detected by mass spectrometry [83.90.101. 
131.134]. Selective ion recording (SIR) enhances the 
sensitivity of detection by a factor of 10 2 _10 3 or 
more when monitoring the effluent of a GC column [138] by 
spending more time monitoring one or more of the 
characteristic masses. which usually represent the most 
intense mass or masses for each compound. compared to the 
sensitivity in full scan mode. Specificity can be 
increased by scanning more than one mass for the compound 
of interest in SIR and comparing their intensity ratios 
and the retention time with those of standards to provide 
identification and quantification of the analyte. 
Mass spectrometry in the SIR mode has been applied 
to morphine and related drugs in both electron impact (El) 
[94.98.105.106.133] and chemical ionization (Cl) [81.85. 
88.136]. modes of ionisation: sensitivities down to 
1ng/ml of sample were obtained for morphine and 150pg/ml 
for buprenorphine [106]. 
In the present study solid phase extraction 
procedures based on ion-exchange materials were evaluated 
for the extraction of basic drugs. Morphine and 
buprenorphine were used as model substances of current 
importance in forensic toxicolgy. Extracts were analysed 
by GC-MS following derivatisation with a novel silylation 
reagent. 
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3.11 E X PER I MEN TAL 
3.11.1 MATERIALS AND REAGENTS 
3H-Morphine with a specific activity of 962 
GBq/mmol (26Ci/mmol) was obtained from Amersham 
International PLC (U.K.). Its radioactivity purity was 
greater than 98% by TLC, on a precoated silica gel plate 
(Merck), developed in methanol:ammonia (100:1.5, v/v). 
The plate was moni tored wi th a Panax Radio-TLC-Scanner. 
Solvents were of glass distilled grade. Solvents involved 
in derivatization processes were dried by boiling under 
reflux over calcium hydride and then distilled. These 
were toluene, acetonitrile (ACN), pyridine, benzene and 
dimethylformamide (DMF) . All drugs were from the 
Department of Forensic Medicine and Science collection, 
individually supplied by the manufacturers. 
(tert-butyldimethylsilyl)trifluoroacetamide 
N-Methyl-N-
(MTBSTFA) , 
hexamethyldisilazane (HMDS) , and dimethylchlorosilane 
(DMCS) were purchased from Pierce and Warriner (U.K.) Ltd. 
Ethyldimethylchlorosilane was purchased from Lancaster 
Synthesis Ltd. (U.K.). Analytichem Bond Elut® cartridges 
were obtained from Jones Chromatography (U.K.) and Lipidex 
5000 was f rom Packard Limi ted, U. K. Outdated whole blood 
was obtained from the Blood Transfusion Unit, Western 
Infirmary, Glasgow, and used for the preparation of spiked 
standards. Whole blood for preliminary assessment of 
morphine extraction was obtained from two rabbits weighing 
about 4.5kg each which were injected intramuscularly with 
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morphine (2mg) and 3 H . 
-morphlne (74000 dPm) in 
water (2ml). At 20 minutes after the injection, blood 
(20ml) taken from the ear vein of each rabbit over a was 
period of 30 minutes and collected in heparinised 
containers. These were stored at 4°C. 
(a) Instrumentation 
Two magnetic sector mass spectrometers were used. 
The first was a VG model 16F instrument operated at 4 KV. 
It was connected to a Perkin-Elmer model Sigma 3B gas 
chromatograph fitted with a capillary column (Chrompack 
cp-sil 5, 25m x 0.32mm ID with a 0.4)lm film thickness). 
The injector oven temperature was 300°C. Samples were 
applied using a split/splitless injection (Grob type) 
procedure in which the split valve was closed for 1 min 
following injection. The fused silica capillary interface 
to the mass spectrometer was kept at The 
spectrometer was operated under the following conditions: 
multiplier 3 KV, emission 200 pA, electon energy 70 eV, 
scan range in full scanning mode 600-20 (exponential down 
scan), scan rate 1.5sec/decade and inter-scan delay Isec. 
The second instrument was a VG model 70-250S 
ope rat e d at 8 KV. It was connected to a Hewlett Packard 
model HP5980 gas chromatograph equipped with an OV-l fused 
silica capillary column (25m x O. 2mm I.D. phase thickness 
0.2pm from Hewlett Packard). 
(b) Glassware 
All glassware was cleaned in detergent, washed with 
water, dried, silanized with 10% DMCS in toluene and then 
rinsed in methanol. 
3.11.2 
- 64 -
APPLICATION OF MORPHINE TO BOND ELUT SCX 
CARTRIDGES 
Bond-Elut SCX cartridges (3ml capacity) with the 
cation-exchange functional group benzenesulfonylpropyl, 
were attached to a Vac-Elut box, which can hold up to 
10 cartridges. Vacuum was applied using a water pump and 
the cartridges were conditioned as recommended by the 
manufacturer with 2ml methanol followed by 2ml of water 
and 1ml of the solvent in which the ana lyte was 
dissolved. Aqueous solutions containing morphine and 
3H-morphine were prepared from 1ml of water, 1ml of 
3 h' H-morp lne (2775 Bq/ml in methanol) and 8ml of an 
unlabelled morphine standard (l.18~g/ml in methanol). The 
resultant final concentration was 0.94).lg/ml, morphine and 
/ 1 3 h' 277 Bq m H-morp lne. Aliquots (5ml) were applied to 
conditioned columns. The vacuum pressure generated by the 
water pump was kept between 5-10PSI and the cartridge was 
not allowed to dry out between successive appl ications. 
The sorbent was washed with methanol (2-5ml) and drained 
by passing air for 30 sec. Final elution was performed 
with one of the following eluents to establish the best 
solvent to elute morphine from the sorbent which would be 
effective in a small volume. 
(a) 
(b) 
(c) 
(d) 
(e) 
0.2-1ml of the silanising reagent HMDS:DMCS: 
pyridine (2:1:3 v/v/v). 
0.5ml of warm derivatizing solution as in (a). 
1ml of 10% ammonia in methanol (v/v). 
5% of triethylamine (TEA) in methanol (v/v). 
1ml of 10% TEA in methanol (v/v). 
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(f) 1ml of 10% TEA in ACN:MeOH 1:1 (v/v) . 
(g) 2ml of 10% TEA solution (v Iv) . 
(h) Iml of 10% diethylamine (DEA) 1n ACN:Meth 1:1 (v/v) . 
The following washing steps were added: acetone and 
pyridine before elution with the derivatizing solution and 
ACNlmethanol before elution with solvents containing them. 
The solvents in the different stages were collected 
separately. Assessment of losses in each step and of the 
recovery in the final elution stage were performed as 
described in the next section. 
3.11.3 RADIOACTIVITY COUNTING AND QUENCH CORRECTION 
Quench correction was required for the calculation 
of the efficiency of the radioactivity measurements 
performed on a Packard Tricarb 2000 scintillation 
Counter. Quenching experiments were carried out for each 
of the media in which the radioactivity required to be 
estimated. Each experiment was conducted as follows: to 
6 vials. each containing 4ml of scintillation fluid 
(Ecoscint). was added O.lml of the 3H-morphine 
solution. They were well mixed and were kept in darkness 
for 30 mins before measuring the radioactivity. Then 
vials with similar values were chosen for each 
experiment. To each vial. 1n duplicate. 0.2ml of the 
sample or its corresponding blank solvent was added. 
Nothing was added to two vials. The radioactivity was 
measured aga in. The scintillation counter was set on a 
f 2m1'n or preset count of 2000 counts. preset time 0 Both 
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were corrected to give finally the counts per minute 
(CPM). Efficiency was calculated by the following formula 
Efficiency Percentage = q/a x 100 
. .. . .. . . . .. . .. .. Equation 3-1. 
where q and a are the radioactivity measurements of the 
quenched and unquenched samples respectively. 
The total radioactivity of each sample was 
calculated for the total volume of that sample. taking 
into consideration the Efficiency Percentage. 
3.11.4 APPLICATION OF BLOOD TO BOND-ELUT COLUMNS 
Assessment of a reasonable mode of application of 
blood samples to the selected sorbent (Bondelut SeX) was 
performed using rabbit whole blood. A 1ml aliquot of 
blood was utilized for each of the following experiments 
(a) Direct application of the blood diluted with 1ml of 
water. 
(b) Direct application of the blood diluted with 5ml of 
water. 
(c) The blood was diluted in 10mi of water and the 
solution was ultrasonicated for 20 min 
(d) The blood was deproteinised by adding 1ml of blood 
drop-wise into 10ml of methanol in an ultrasonic bath and 
leaving there for 20 min. followed by centrifugation for 
15 min at 3500 RPM. The solvent layer was applied to the 
column. 
The sorbent was conditioned as described in the 
before applying the previous section 
radioactivity of the effluent fractions was 
described in section 3.11.3. 
sample. The 
estimated as 
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3 . I I . 5 MORPHINE RECOVERY BY SOLVENT EXTRACTION 
The following experiments were conducted to select 
a quick and efficient solvent extraction procedure for 
morphine. which would provide an extract suitable for 
application to a Bond Elut SCX cartridge. 
(a) Protein precipitation 
Three experiments were performed as follows: 
in a 15ml screw-capped test tube 1ml of rabbit blood was 
added drop-wise into 6ml of methanol in an ultrasonic bath 
and ultrasonicated for 20 min. The methanol layer was 
collected after centrifugation and the residue was 
resuspended in another 6ml of methanol. The mixture was 
vortex mixed for 30sec then the solvent layer was 
separated as above and added to the first methanol 
supernatant. 
(b) Protein Precipitation Under Basic Conditions 
Five experiments were conducted as described in (a) with 
the difference that O.Sml of 20% ammonia in water was 
added to the methanol before addition of the blood. 
(c) Ammonium Carbonate/Ethyl Acetate 
Five experiments were performed, each of which was 
conducted by adding freshly crushed fused anhydrous 
ammonium carbonate to the blood. About 0.S-O.8g were 
required to saturate 1ml of blood. It was extracted twice 
with 6ml of ethyl acetate by vortex mixing for 30 sec then 
the solvents were collected after centrifugation. 
(d) ff ( pH9) was added to 1ml of blood. 1M borate bu er 
Four experiments were performed. Each sample was 
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extracted twice with 6ml of ethyl acetate as described in 
( c) . 
The extraction efficiencies for each experiment 
were determined by estimation of the radioactivity of each 
extract as described in Section 3.11.3. They were 
calculated using the following formula: 
Percent Extraction efficiency = (calculated activity in 
the extract/the activity 
present in Iml of blood) x 
100. 
Equation 3.2 
The radioactivi ty present in the blood was estimated as 
described in Section 3.11.3. where Iml of blood was 
diluted into 20ml of water. Blanks of human and rabbi t 
blood were similarly treated before the preparation of the 
sample for counting. 
3.11.6 APPLICATION OF BLOOD EXTRACT TO SCX CARTRIDGE 
The recovered solvent extracts of the preViOUS 
section (5b) were applied to conditioned SCX columns. 
washed with ACN/MeOH (5ml) and eluted with 10% TEA in 
ACN/MeOH (2ml) . The radioactivity was estimated in the 
eluate collected after the application. washing and 
elution steps. 
3.11.7 EXTRACTION WITH LOW MOLARITY BUFFERS 
For these experiments human whole blood was the 
medium used for the evaluation of low molarity (0. 1M) 
buffers. A working standard of morphine and 3H-morphine 
at concentrations of 1.55pg/ml and 2775Bq/ml of blood. 
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respectively, was prepared. 
assessed for the extraction: 
The following buffers were 
O.lM ammonia and O.lM borate 
in water and O.lM ammonia in MeOH. Extraction was 
conducted in a lSml screw-capped test tube where Iml of 
blood and Iml of the buffer were mixed. The blood was 
extracted twice by vortex mixing for 30 sec with 6ml of 
the extracting solvent (ethyl acetate:isopropanol 9:1, 
v/v). The collected solvents layers were applied to SCX 
cartridges as described In the previous section. 
Radioactivity measurements were carried out for each step. 
3.11.8 SELECTION OF A SILYLATING REAGENT 
Morphine (S)lg) was placed in a screw-capped 1 dram 
glass vial. Eighteen samples were prepared and were 
divided into three groups. Each group was derivatized 
with one of the following reagents: 
(a) Derivatizing solution prepared from HMDS, DMCS and 
pyridine in the ratio of 2:1:3 v/v/v. 
(b) Tri-Sil Z (trimethylsilylimidazole in pyridine, 
1.SmEq/ml) 
(c) MTBSTFA in pyridine (1:1, v/v). 
100 pL of the reagent was added to each vial. The closed 
vials were kept on a heating block at 60°C for IS min. 
Four vials of each group were evaporated to dryness on the 
heating block under a gentle stream of nitrogen. The 
remaining vials were kept intact. The residues were 
reconstituted In 100 )11 of hexane or ethyl acetate, two 
vials for each group. The products were analysed by GC-MS 
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using the VG-16F instrument with the GC oven temperature 
programmed from 200-300°c at aD/min and left at the 
upper temperature for 3 min. Total ion current (TIC) 
chromatograms were obtained for each sample. 
3.11.9 CONDITIONS FOR SILYLATION WITH MTBSTFA 
Several 1 dram vials were prepared containing 23pg 
of morphine. The following conditions were assessed to 
force the silylation with MTBSTFA to completion to give 
3.6-bis-MTBs-morphine. 
(a) The effect of the solvent: 6 vials were divided 
into 3 groups. The morphine in each group was 
reconstituted in 50 pI of one of the following solvents: 
acetonitrile. dimethyl formamide or pyridine. This was 
followed by the add i ton of 50 pI of MTBSTFA. The via 1 s 
were placed on a heating block at 60°C for 30 min. 
(b) Time required to complete the reaction: several 
samples were derivatized as in (a) using DMF as the 
solvent for the reaction. The samples were kept on the 
heating block for 15. 90 or 150 min before analysis. 
(c) Solvent and reagent ratio: the ratio of MTBSTFA 
present to solvent required to optimize the derivatization 
was assessed by preparing duplicate samples with 10-100% 
of MTBSTFA in DMF. The reagent (100pl) was added to each 
vial and the vials were kept on the heating block for 1 hr 
before the analysis. 
(d) Effect of temperature: 
wi th 100 }II of 60% MTBSTFA in 
morphine was derivatized 
pyridine. Two duplicate 
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samples were kept in heating blocks for 1 hr at 
temperatures of 60° and 100°C, respectively. 
(e) Effect of catalyst: four morphine samples were 
der iva t i zed wi th 100 )11 of 40% MTBSTFA in pyr id ine and 
20)11 of etherate gas were added to two vials 
directly with the derivatizing reagent, and after 30 min 
on a heating block to the other vials. All samples were 
kept at 60°C for 1 hr. Each sample was diluted with Iml 
of water and extracted into 4ml of chloroform. The 
solvent was evaporated to dryness under a stream of 
nitrogen and the residue was redissolved in 100 )11 of the 
same solvent. 
The product of each of the above experiments was 
analysed by GC-MS as described in Section 3.11.8. The 
areas of GC peaks measured on reconstructed mass 
chromatograms for the masses m/z 342 and 456, representing 
the (M-57) ion for the mono- and the bis-MTBS morphine 
derivatives, respectively, were taken for comparison of 
the silylation conditions. 
3.11.10 INVESTIGATION OF THE INCOMPLETENESS OF THE 
REACTION 
These experiments were conducted to find out why 
the derivatization of morphine with MTBSTFA did not go to 
completion to give 3, 6-bis-MTBS-morphine and to establish 
which of the two hydroxyl groups was silylated ln 
mono-MTBs-morphine. 
(a) Sample preparation: 40 mg of morphine were 
dissolved in 2ml of pyridine and were derivatized with Iml 
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of MTBSTFA. The mixture was kept over a heating block for 
30 mins, then the volume of the solvent was reduced under 
a stream of nitrogen. A preparative TLC plate (20 x 20cm, 
silica gel, 2.5 mm thick) was first washed with the mobile 
phase (15% methanol in chloroform, v/v). It was air dried 
and reactivated in an oven at 60°C overnight. The 
residue of morphine derivative was applied in a line on 
the TLC plate. The plate was developed with the same 
solvent and dried. The chromatographic bands were 
localized by spraying the edge of the plate with acidified 
iodoplatinate reagent. The corresponding area of the 
silica gel of each product was scraped off separately. 
The silica was transferred to a glass filter funnel 
containing a plug of silanized glass wool and the products 
were eluted with 15% methanol in chloroform (v/v). 
(b) Morphine base was prepared by dissolving morphine 
HCI in water. The solution was alkalinized with O.lM 
ammonia and extracted into ethyl acetate:isopropanol (9:1, 
v/v) . 
(c) GC-MS 
Each of the isolated products was analysed by 
GC-MS. The operating conditions were as described in 
section 3. I I. 8. The puri ty of each isolate was assessed 
and its mass spectrum was obtained. The possible site of 
the MTBS group in the monoderivative of morphine was 
inferred with the help of its mass spectrum (see 
discussion). 
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(d) UV spectroscopy 
The ultraviolet spectra of free morphine, 
mono-MTBS- morphine and 3,6-bis-MTBS-morphine were taken 
in a neutral solvent (methanol) and in an alkaline solvent 
(10% sodium hydroxide solution) against the corresponding 
blank solution in a Hewlett Packard HP8451A diode array 
UV/VIS spectrophotometer. The spectra were recorded from 
190-450nm. 
(e) NMR spectroscopy 
NMR spectra of morphine and its derivatives were 
recorded. About 5mg of the bis-MTBS-morphine was 
dissolved in deuterated chloroform. Free morphine base 
and mono-MTBS-morphine were dissolved in deuterochloroform 
to which a few drops of deuteromethanol were added. 
(f) Derivatization of Mono-MTBS-morphine 
Two samples, each of about 25pg of mono-MTBS-
morphine, were re-derivatized, the first with 100pl of 40% 
MTBSTFA in pyridine and the other with 100 pI of Tri-Sil 
Z. They were kept on a heating block at 60°C for 1 hr 
before analysis of the products by GC-MS. 
(g) Derivatization of Codeine 
Codeine (5pg) was derivatized with 40% MTBSTFA in 
DMF (lOOpl). The sample was kept a t 60°C for 1 hour 
after which, Ipl of the mixture was analysed by GC-MS. 
(h) Derivatization of 6MAM 
6-Monoacetylmorphine was 
as described in the literature 
prepared from diamorphine 
[139]. An aliquot of the 
pro d u c twa s de r i va t i zed wit h 4 0 % MTB S T F A ina c e ton i t [ i I e 
(lOopl) at 60°C for 1 hour and luI was analysed by GC-MS. 
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3.11.11 SILYLATION WITH ETHYLDlMETHYLSILYL IMIDAZOLE (EDMS-I) 
EDMS-I was assessed as a new derivatizing reagent 
for morphine and buprenorphine in the following 
experiments. 
(a) Reaction Time 
Three samples of 5pg of morphine and 3pg of 
buprenorphine in 1 dram vials were prepared. 50pl of 
acetonitrile and 50pl of EDMS-I were added to each vial. 
They were kept on a heating block at 60°C for 0, 15. 
and 30 min, respectively, before GC-MS analysis. 
(b) Amount of Reagent 
100pl of a solution of the reagent in acetonitrile 
at concentrations of 20, 40 and 60% by volume were added 
to morphine and buprenorphine samples in 1 dram glass 
vials. The vials were warmed for 15 min at 60°C before 
GC-MS analysis. 
(c) Stability of the Product 
Three samples were derivatized with 40% EDMS-I in 
acetonitrile. The products were examined by GC-MS every 
other day for two weeks and compared qualitatively and 
quantitatively with freshly prepared samples. 
3.11.12 SYNTHESIS OF EDMS-I 
Synthesis of ethyldimethylsilyl-imidazole was 
conducted in two steps. 
(a) Preparation of Diethyltetramethyldisilazane (DETMDS) 
A 250ml three neck round bottom flask (RBF) was 
used for the reaction. The middle neck was connected to a 
- 75 -
venting tube containing calcium oxide granules. A 
thermometer was fitted through the second neck to monitor 
the reaction temperature and a gas leak was fitted to the 
third neck permitting small bubbles of ammonia to pass 
through the reaction mixture. The flask was placed in a 
liquid paraffin bath on a stirrer hot plate. Stirring of 
the mixture was accomplished with magnetic stirrer bars in 
both the flask and the paraffin bath. Liquid ammonia was 
placed in a 500 ml RBF which was cooled in a bath of 
acetone and dry ice. Ammonia gas effluent was passed 
through two Dreschel bottles, the first containing a layer 
of liquid paraffin to monitor the flow rate and the other 
(empty) bottle was to prevent the solvent from the 
reaction mixture sucking back. Dry toluene (80ml) was 
added to the reaction flask and the flask was purged with 
ammonia gas for a few minutes at 50-60°C before the 
addition of 109 of dimethylethylchlorosilane. The 
temperature was 
stirring for 45 
maintained 
min. The 
50-60°C with continous 
reaction was stopped by 
disconnecting the ammonia supply. 
(b) Preparation of EDMS-I 
Imidazole (4.64g) was added to the reaction mixture 
from (a) above. The mixture was refluxed for 12 hrs with 
continous stirring. Venting was through a drying tube 
containing calcium oxide granules. 
settling, the clear layer was 
distillation apparatus and the bulk 
recovered. The remaining solvent 
After cooling and 
transferred to 
of the to I uene 
which contained 
a 
was 
the 
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product was transferred to a three neck flask in a 
microdistillation apparatus. A gas leak tube to admi t a 
fine stream of nitrogen bubbles into the solvent layer was 
fitted to the first neck and a thermometer was placed in 
the second. A vacuum pressure generated by a rotary pump 
was applied via the receiver adapter. The distillate was 
collected through a 3-neck rotating receiver. The bulk of 
the product (8ml) was recovered at 105°C and a pressure 
of 10mmHg. 
EDMS-l was kept at 4°C in a Pierce reacti-vial 
fitted with a screw cap containing a teflon valve for 
sampling without exposure to air. 
3.11.13 DER1VAT1ZAT10N OF BLOOD EXTRACTS 
A standard solution of morphine in whole blood was 
prepared at a concentration of 0.46 ).lg/ml. To extraction 
tubes were added 1ml of this sample or 1ml of blank 
blood. Nalorphine ( 100).11 
2.5pg/ml) was added as an 
of a solution 
internal· standard 
containing 
(l.Std) to 
each sample and these were extracted as described in 
section 3.11.7. The extract residues were treated with 
SOul of 40% EDMS-I in acetonitrile and the vials were 
placed on a heating block at 60°C for 15 min before 
analysis. The analysis of the products was performed on 
the VG-16F GC-MS instrument using full scan and SIR 
modes as described earlier. Monitoring in SIR was 
on the molecular ions at m/z 457.2468 and 483.2625 of 
di-EDMs-morphine and di-EDMS-nalorphine respectively. The 
dwell time was 80msec per channel and the interchannel 
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delay (ICD) was 20msec. The SIR channels were calibrated 
and tuned using PFK reference masses at m/z 4S4. 9729 and 
492.9697. 
analysed 
blank of 
Aliquots of the following samples (lJlI) were 
to look for interference at the morphine peak: 
blood extracts, solvent, EDMS-I solution and 
sample residues. 
3.11.14 PURIFICATION OF THE DERIVATIVES 
Derivatized blood extracts were purified from the 
excess derivatizing agent over Lipidex-SOOO as follows: 
about 19 of the Lipidex material was packed under gravity 
flow into a silanized Pasteur pipette containing a plug of 
silanized glass wool as the bed support. The column was 
washed with Sml of MeOH:water:chloroform (90:10:20, v/v/v) 
to remove possible contaminants, then washed successively 
with lml of MeOH, 2ml of acetone and lml of ACN:dimethoxy-
propane (DMP) (8:2, v/v) to remove traces of water from 
the material. The derivatized sample was diluted with lml 
of the latter solution and applied to the on top of the 
column. The column was washed with a further lml of the 
same solvent and the combined filtrates were received into 
lml dram vial. The solvent was evaporated at 60°c under 
a stream of nitrogen. The residue was redissolved in SOpl 
of ethyl acetate and analysed by GC-MS. 
3.II.1S HIGH RESOLUTION SIR 
High resolution SIR mass spectrometry was evaluated 
as a means of reducing interference in the analysis of 
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morphine as the bis-EDMS derivative. The VG model 70-250S 
instrument was tuned on mass 454.9728 of PFK to a 
resolution of 1000, then the peak height was reduced to 
10% by closing the source exit slit. The peak was reduced 
by a further 50% using the collector slit and to give a 
resolution of 10000. The collector was opened slightly to 
obtain a flat peak top. The samples prepared in 
Section 3.11.13 were reanalysed under these conditions. 
3.11.16 CHEMICAL IONIZATION MASS SPECTROMETRY 
Isobutane chemical ionization mass spectrometry was 
evaluated as a means of obtaining an analysis of morphine 
and nalorphine free from troublesome interferences. The 
following parameters were adjusted to optimize 
sensitivity: the emission current, the electron energy 
setting and the isobutane pressure in the source. 
Morphine and nalorphine (5Ug each), in a 1 dram vial, were 
derivatized with EDMS-l (50Ul) as described earlier and 
lpl was injected into the GC-MS instrument. Full spectra 
were recorded and gas chromatographic peak heights were 
measured using reconstructed accurate mass chromatograms 
for masses 457, 458 and 354 for morphine and 483, 484 and 
380 for nalorphine, following adjustment of each parameter 
tested. 
3.11.17 GC-CI-SIR OF EDMS-MORPHINE 
The following masses 458.2706 and 484.2685 for 
bis-EDMS derivatives of morphine and nalorphine, 
respectively, were set for SIR. The isobutane reagent gas 
flow rate 
3.5 x 10-5 
gas was set 
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to give 
electron 
a source pressure of 
torr. The energy and emission 
current were set to 70 mV and 0.5 rnA, respectively. The 
analyses were conducted uSIng samples prepared as in 
Section 3.11.13 to look for any interference. Another 
experiment was conducted under similar conditions as 
described above, to assess the sensitivity of CI-SIR 
analysis. Monitoring was conducted this time on the 
masses 354.1889, 380.2045 and 536.3559 which were the most 
abundant masses of morphine, na lorphine and buprenorphine 
EDMS derivatives, respectively. 
3.11.18 EXTRELUT EXTRACTION 
Diatomaceous earth (Extrelut) was washed in 
methanol and ethanol and was dried 
About 19 of the material was packed 
plastic syringe with gentle tapping. 
was evaluated as a substitute for 
at room temperature. 
in a 10ml disposable 
This type of column 
the initial solvent 
extraction process in the following manner: blood samples 
(lml) and 100pl of nalorphine I. Std solution were mixed 
with lml of O.lM ammonia in test tubes. 
then applied to Extrelut columns held 
The samples were 
in a Vac-Elut box 
and allowed to stand for 5 min. The columns were divided 
into two groups: the first group was washed initially 
wi th 4ml of hexane. Both groups were then p laced over 
preconditioned Bond-Elut SCX columns via luer adapters and 
each was eluted with 6ml of the extraction solvent (ethyl 
acetate:isopropanol 9:1, v/v). The vacuum pressure was 
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maintained at 5-10PSI. Once the elution had stopped, the 
Extrelut columns were discarded. Washing and elution from 
scx and subsequent derivatization were completed as 
previously described. 
Blank blood samples and blood standards (0.46J.1g/ml 
morphine and 16ng/ml buprenorphine) were prepared in this 
way. The extracts were analysed by GC-MS on the VG 
70-250S instrument in the SIR mode. The recovery of 
morphine, nalorphine and buprenorphine from blood using 
both extraction procedures was calculated by comparing 
the peak areas of the extracts with those of non-extracted 
standards prepared in methanol at an equal concentration 
which represent 100% recovery according the formula: 
Percent Extraction Efficiency = (peak area of the blood 
extract/the peak area of 
the equivalent standard 
in MeOH) x 100 
........... Equation 3.3 
3.11.19 DERIVATIZATION WITH HMOS 
silylation with hexamethyldisilazne with no added 
catalyst was assessed by derivatizing morphine, nalorphine 
and buprenorphine samples wi th 50% HMDS in acetoni tr i Ie. 
The vials were kept at 60°C for 15 min. Samples ( lll1 ) 
were analysed by GC-MS in both SIR and full scan modes. 
The extent of the silylation was measured by comparison 
with similar samples prepared in HMDS:DMCS:pyridine 
2:1:3 (v/v/v). 
3.11.20 SYNTHESIS OF DETMDS 
Diethyltetramethyldisilazane was prepared as 
described for the preparation of EDMS- I, but on a larger 
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scale. using 30g of dimethylethylchlorosilane and 150ml of 
dry redistilled benzene. Benzene was used as a substitute 
for toluene. The following procedures were conducted to 
isolate the product EDTMDS: the bulk of the solvent 
containing the product was decanted from the reaction 
flask into a round bottom flask. The remainder of the 
reaction mixture was filtered through a filter paper 
placed in a Buchner funnel. Vacuum was genera ted by a 
water pump. so this step was conducted very quickly to 
minimize exposing the product to hydrolysis. The collected 
clear solvent was placed in a distillation apparatus and 
the bulk of benzene was removed by distillation. The 
remaining fluid (25ml) was transferred to a smaller 
distillation apparatus where the benzene residue was 
removed by distillation at 78°C. The product (14ml) was 
recovered at 172°C and stored at 4°C. 
3.11.21 DERIVATIZATION WITH DETMDS 
Experiments were conducted as in Section 18 to 
select conditions 
silylation based on 
for morphine and buprenorphine 
DETMDS. DETMDS was not soluble in 
acetonitrile 
acetonitrile 
at room 
containing 
temperature. Its 
a small amount 
solubility 
of toluene 
in 
was 
tested by increasing the ratio of the latter gradually 
until solubility was obtained. A solution was finally 
prepared from 40% of DETMDS in a solvent composed of 
acetonitrile and toluene 7:3 (v/v). It was stored at 
40C in a screw capped reacti-vial with a teflon sampling 
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valve. This mixture was used for the derivatization 
process with heating of the samples at 60°C for 15 min 
as in the preceeding experiments. 
DETMDS was assessed for its ability to derivatize 
other polar drugs commonly encountered in forensic 
toxicology containing 
Samples of each drug 
either hydroxyl or amino groups. 
(l~g) were derivatized as described. 
The mass spectra were recorded and the major ions of the 
spectra of the drugs were tabulated. 
3.11.22 RECOVERY AND REPRODUCIBILITY 
Five 
morphine at 
replicate samples 
concentrations of 
of blood 
0.56}lg/ml and 
spiked with 
35ng/ml as 
well as buprenorphine at concentrations of 8ng/ml and 
0.5ng/ml were extracted using the final modification of 
the extraction process, with Extrelut and hexane washing 
step included. Simi lar non-extracted morphine, 
and buprenorphine standards were prepared in 
The residues were silylated wi th 50~1 of 40% 
nalorphine 
methanol. 
DETMDS in 
acetonitrile:toluene 7:3 (v/v). Analysis was conducted by 
SIR mass spectrometry at a resolution of 1000, using two 
masses (442.2233 and 457.2468) for morphine, two (468.2390 
and 483.2625) for nalorphine and one (464.2620) for 
buprenorphine. The data system control of acquisition was 
set to monitor the three groups of ions during retention 
time intervals bracketing the three peaks of interest. In 
this way, only two ions were monitored at any time and 
sensitivity was increased. The dwell time for each mass 
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was 80 msec and the interchannel delay was 20msec. The 
extraction efficiency at each concentration was calculated 
using the formula given in Equation 3-3. The 
reproducibilities of the injection technique and the 
extraction were also estimated. 
3.11.23 COMPARISON OF THE EXTRACTION PROCEDURES 
Blood extracts from the developed method were 
compared with those from solvent extraction [80] and with 
the eluate from Extrelut. In these analyses, lml of blood 
concentration of 0.46).1g/ml was containing 
extracted. 
morphine at a 
The derivatized extracts were compared by SIR 
mass spectrometry of the EDMS derivatives. 
3.11.24 CALIBRATION CURVE 
Morphine and buprenorphine were added to whole 
blood at a concentration of 1.2pg/ml and 16.5ng/ml, 
respectively, and the solution was serially diluted in 
blood for the construction of a calibration curve. The 
preparation and analysis of the samples was conducted as 
described in section 3. I I. 22. The curve was constructed 
by plotting the morphine or buprenorphine concentration 
versus the ratio of response (peak area of morphine over 
the peak area of the I.Std). Linear regression analysis 
was used to get the best straight line. 
3.11.25 EXTRACTION OF OTHER BASIC DRUGS 
The final extraction procedure was assessed for the 
extraction of other opiates and basic drugs. Blood was 
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spiked wi th drugs as shown ln Table 3. I I 1.15. The blood 
Iml) were prepared as described in samples (volume 
Section 3.11.22. GC-MS ana lys i s was conducted using an 
oven tempera ture programme f rom 1200C 
8°C/min with a final isothermal period of 
measure the extraction efficiencies drug 
3 minutes. 
standards 
at 
To 
were 
prepared in methanol at the same concentrations. For the 
comparison, Iml of standard was evaporated to dryness and 
derivatized in the same manner as the blood extracts. 
Recoveries were calculated by comparing the peak areas in 
the TIC traces for the extracts and the non-extracted 
standards. Retention Indices were calculated using the 
retention times of n-alkanes (c C ) run under the 16- 28 
same conditions. 
3.11.26 APPLICATION OF THE EXTRACTION PROCEDURE 
During the course of this work, there was an 
opportunity to analyse 13 samples (blood or urine) that 
were submi t ted 
analysed for 
these samples 
to the Forensic Medicine Department to be 
morphine or buprenorphine. The origin of 
was either from Road Traffic Act or 
post-mortem cases. The samples were prepared and analysed 
by GC-MS as described in section 3.11.22. Also, syringes 
were submitted for analysis and were prepared by washing 
each syringe with 2ml of methanol, which was evaporated to 
dryness and the residue was derivatized directly with SOul 
of 40% DETMDS in acetonitrile:toluene (7:3, v/v) at 60°C 
for 1 hour. 
3.111.1 
An 
3H-morphine 
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3.111 RES U L T S 
APPLICATION OF MORPHINE TO BOND ELUT COLUMNS 
aqueous solution 
was used for 
containing 
preliminary 
morphine 
assessment 
and 
of 
Bond-Elut columns with cationic active groups (sex) before 
proceeding to biological samples, where the behaviour of 
morphine with respect to retention during application and 
washing as well as elution were studied. Conditioning of 
the sorbent with methanol and water was sufficient to 
reactivate the cation exchange 8ulphonic acid group. The 
applied morphine was completely adsorbed on the sorbent. 
There was no radioactivity detected in the eluate during 
the application stage or during washing with different 
solvents such as methanol, acetone, acetonitrile and 
pyridine. 
are listed 
The elution recoveries with the solvents tested 
in Table 3.111.1. Inclusion of a solvent 
containing acetonitrile for washing and elution led to a 
higher recovery of morphine. There was no significant 
difference in recovery between solvents containing 
ammonia, DEA or TEA in the final elution stage. A small 
volume (O.5ml) of a solution containing 10% TEA or DEA in 
methanol recovered more than 94% of the applied morphine 
and full recovery was obtained when the sorbent was eluted 
with 2ml of the same eluent. 
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Table 3.111.1 Recovery of 3H-morphine from 
SCX columns using different eluting solvents 
Eluting Solvent 
1. derivatizing reagent mixture. 0.5ml 
(HMDS:DMCS:pyridine 2:1:3) 
2. warm derivatizing reagent 0.2ml 
3. warm derivatizing reagent 0.5ml* 
4 . warm derivatizing reagent 1ml 
5 . 0.5ml* 5% TEA in methanol (v/v) 
6 . 0.5ml* 10% TEA in methanol (v/v) 
7 . 1ml* 10% TEA in methanol/acetonitrile 
8 . 2ml* 10% TEA in methanol/acetonitrile 
(1: 1 
(1: 1 
v/v) 
v/v) 
Bond-Elut 
Recovery 
76% 
21% 
93% 
92% 
94% 
96% 
99% 
100% 
9 . 1ml* 10% DEA in methanol/acetonitrile ( 1 : 1 v/v) 99% 
10.2ml* 10% Ammonia in methanol/acetonitrile(l:l v/v) 100% 
*methanol/acetonitrile 1:1 v/v wash was included 
3.111.2 APPLICATION OF BLOOD TO BOND-ELUT COLUMNS 
The red blood cells (RBC) in a whole blood sample 
should be disrupted before applying the sample to the 
selected solid phase sorbent. Dilution of the blood 
sample with water to haemolyse the RBC and a combined 
process of denaturation and protein precipitation with 
methanol were tried. Ultrasonication was applied to 
enhance the disintigration of the RBC into fine 
particles. Application of the blood which had been 
haemolysed with water to the column resulted in partial 
clogging of the sorbent, requiring high vacuum pressure, 
better than 50kPa/m2 (369mmHg), for even partial 
elution. Washing the sorbent with methanol was not 
efficient and the final eluates were coloured and turbid. 
The degree of colouration and turbidi ty were variable in 
extracts of blank samples prepared simultaneously, 
- 87 -
therefore quench correction and radioactivity estimation 
could not 
precipitation 
be carried 
produced 
out 
a 
accurately. Methanolic 
clear solvent after 
centrifugation, which was easily applied to the column. 
The washing and eluting of the sorbent also produced clear 
eluates. However, the efficiency of methanol 
precipitation for morphine extracion was only about 12%. 
There was no loss of the applied morphine in the washing 
eluate and all the applied radioactivity was recovered 
upon elution. 
Samples prepared without sufficient centrifugation, 
or those which were not decanted carefully onto the 
column, produced coloured 
haemoglobin-der i ved pigments. 
methanol worked as a solvent 
final eluates due to 
Protein precipitation with 
extraction for the sample 
prior to the application but in poor yield, so alternative 
preliminary solvent extraction procedures were assessed. 
3.111.3 SOLVENT EXTRACTION OF MORPHINE 
lml 
The extraction procedures 
of blood: efficiencies for 
presented in Table 3.111.2. 
were based on utilizing 
the solvents tested are 
Methanol as a protein 
precipitating agent and an extracting solvent had poor 
efficiency for morphine recovery, which was about 15%. 
The efficiency improved to about 70% when the sample was 
alkalinized with ammonia solution. However, the 
methanolic extract of the akalinized sample was slightly 
coloured, resulting in coloured eluate from the sorbent. 
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Table 3:11.2: Efficiency of morphine extraction 
blood wlth dlfferent solvent/buffer combinations 
from 
Solvent Buffer Solvent 
Average 
Amount Extraction Efficiency{%} 
Methanol none 2 x 6 ml 15 
Methanol 20% aqueous 
ammonia 2 x 6 ml 67 
Ethyl acetate ammonium 
carbonate 2 x 6 ml 12 
Ethyl acetate 1M borate 2 buffer x 6 ml 48 
Buffering with ammonium carbonate and extraction with 
ethyl acetate was complicated by emulsion formation. 
Also, the separation of the solvent was difficult and both 
the extraction efficiency and reproducibili ty were poor. 
Buffering the sample with 1M borate solution gave no 
problems with emulsions and produced clear solvent 
extracts with around 50% extraction efficiency. 
3.111.4 APPLICATION OF BLOOD EXTRACTS TO BOND-ELUT 
COLUMNS 
The solvent extracts described ln the previous 
section, where the blood was aklalinized with ammonia, 
were applied to Bond-Elut scx columns. 80% of the applied 
morphine was lost on application. The rest was lost with 
the wash eluate. The inability of morphine to absorb to 
the cation-exchange sorbent was due to the pH and ionic 
strength of the buffer used for the extraction. Adjusting 
the pH of the solvent was not practicable and dilution of 
the solvent with methanol, or dilute hydrochloric acid in 
methanol, failed to permit morphine adsorption. Low 
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molarity buffers were tried as replacements for the high 
molarity buffer to permit interaction between morphine and 
the sorbent. 
3.111.5 EXTRACTION WITH LOW MOLARITY BUFFER 
Due to the 1 imi ted recovery of morphine and the 
high quenching obtained with rabbit blood, the latter was 
replaced with spiked human whole blood. The results of 
ethyl acetate: isopropanol extraction are listed in Table 
3 . I I I .3. 
Table 3.111.3: Morphine extraction efficiency and 
elution recovery of extracts on Bond-Elut sex cartridges. 
Buffer used during extraction 
O.lM ammonia O.lM ammonia O.lM borate 
Extraction 
Efficiency * 
Application 
Loss 
Washing 
Loss 
Elution 
Recovery ** 
in H2O 
94.5 ± 3 
0 
0 
99 ± 5 
in MeOH in H2O 
92 ± 6 85 ± 7 
0 0 
0 0 
98 + 6 85 ± 6 
* Extraction with 2 x 6ml ethyl acetate:isoproponal 
(9:1 v/v) 
** Elution with 2ml 10% TEA in ACN:MeOH (1:1 v/v). 
The extraction efficiency for morphine when the 
sample was buffered with O.lM ammonia was more than 95\ 
The and with borate buffer the efficiency was about 85%. 
solvent extracts and the eluates for samples in which the 
buffer was prepared in methanol were slightly coloured. 
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There was no loss of radioactivity on application of the 
solvent to the SCX sorbent or on washing the sorbent. All 
the applied radioactivity was recovered ln the final 
eluate in 2ml of 10% TEA in ACN/MeOH. The ammonia buffer 
in water was selected for preparation of extracts for 
initial assessment of the end step (GC-MS) analysis. 
Solvent extracts of this type were subsequently replaced 
with a solid phase extraction procedure based on 
diatomaceous earth (Extrelut). 
3.111.6 SELECTION OF A SILYLATING REAGENT 
Two reagents for the preparation of trimethylsilyl 
ethers were tried for the derivatisation of morphine prior 
to GC and GC-MS. These were a solution of 
HMDS:DMCS:pyridine (2:1:3 v/v/v) and TMS-I in pyridine 
(1.5meq/ml. Tr i -S i 1 Z). Both TMS donor reagents produced 
a single product. bis-3.6-TMS-morphine. shown in 
Figure 3.111.1. 
In contrast. MTBSTFA resulted in two products for 
morphine which were identified by GC-MS. The major peak 
was the bis-3. 6-MTBS-morphine and the smaller peak 
mono-MTBS-morphine. Their mass spectra are shown in 
Figures 3.1II.2b and 2c. respectively. 
The chromatograms (Figures 3.III.la and 3.III.2a) 
obtained when the products were injected in the silylating 
reagent showed good chromatographic peaks for the 
derivatized morphine but 
from the silylating 
several unrelated siloxane peaks 
reagent were present. This 
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Figure 3.111.1 (a) TIC trace of morphine and 
nalorphine TMS derivatives (scan nos. 44 and 100 
respectively) where 100ng of each was applied on column. 
The oven temperature was operated from 200 0 to 300 0 C 
at SOC/min and the injector oven temperature was at 
300 0 C. 
(b) and (c) are the EI mass spectra of morphine and 
nalorphine TMS derivatives respectively. 
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Figure 3. I I 1.2 (a) TIC trace of morphine mono and 
bis-MTBS derivatives (scan nos. 114 and 235 respectively) 
where 5ug of morphine was derivatized with 100ul of 50% 
MTBSTFA in acetonitrile at 60 0 C for 1 hr and luI was 
analysed by GC-MS. The oven temperature was programmed 
from 200 0 to 300 0 C at SOC/min and the injector oven 
temperature was at 300 0 C. 
(b) and (c) are the EI mass spectra of mono and 
bis-MTBS-morphine respectively. 
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necessitated purifying the product from the excess 
derivatising reagent. The morphine silyl-ethers were 
hydrolysed when the products were evaporated to dryness 
and nothing was recovered intact in either hexane or ethyl 
acetate. The MTBS morphine derivatives were stable after 
evaporation. The chromatograms obtained when the residues 
were redissolved in hexane or ethyl acetate were cleaner 
and showed fewer siloxane peaks. Hexane redissolved about 
5% of the product while ethyl acetate redissolved about 
70%, as indicated by comparison with the peak areas 
obtained following injection of the products ln the 
reagent. These exper iments showed tha t MTBS der iva t i ves 
were resistant to hydrolysis and that the products could 
be purified from the excess reagent. 
Further experiments were conducted wi th MTBSTFA to 
try and obtain complete silylation of morphine, yielding 
bis-MTBS-morphine as the only product. 
3.111.7 S1LYATI0N WITH MTBSTFA 
(a) Solvent: reagent combinations 
The ions at m/z 342 and 456 represent the loss of 
the tertiary butyl group (57amu) from the molecular ions 
at m/z 399 & 513 of mono- and bis-MTBS-morphine 
respectively. They are the base peaks in the mass spectra, 
constituting 1.6% and 3.2%. of the total ion current 
(TIC) , respectively. These TIC values were used to 
calculate response ratios for the comparison of different 
reaction conditions. The effect of different solvents used 
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in the derivatization reaction is shown in Table 3.111.4. 
All of the reactions which were conducted in the 
three solvents produced a mixture of both MTBS-morphine 
derivatives. Acetonitrile was the poorest solvent for the 
production of bis-MTBs-morphine. DMF produced 30% of the 
monoderivative under the conditions tested. 
(b) Reaction Times 
The reaction time required to reach equilibrium was 
determined by leaving the derivatized samples in the 
heating block at 60 0 C for different lengths of time 
(Table 3.111.5) and was found to be about 1 hour. After 
t his tim e , the rat i 0 0 f m 0 no - MTB S - m 0 r phi n e / b i s - MT B S -
morphine produced was about 0.25 and was constant at the 
temperature and ratio of reagent/solvent used. 
(c) Reagent:solvent ratio 
The ratios of morphine-MTBS derivatives produced by 
varying the reagent:solvent ratio are listed in Table 
3.111.6. The total volume of the mixture was 100)11 for 
each sample. The resul ts show tha t wi th lower reagent 
ratios in the mixture, the ratio of mono/bis derivatives 
decreased to about 12%. subsequent reaction studies were 
conducted using 40% v/v reagent to keep it in excess 
without reducing the yield of the bis-derivative. 
e) Effect of Temperature 
A reaction temperature of was found 
to produce a higher ratio of bis-to mono-product than 
was obtained at Also, the total yield of 
derivatives was slightly higher at the upper temperatures 
(Table 3.111.7). 
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Table 3.111.4: Effect of different 
MTBS-morphine products. 
p e a k a r e a ( T 
SOLVENT M T B S - morQhine 
ACN 
DMF 
Pyridine 
* Ratio = mono 
bis 
Table 3 . I I I .5: 
MTBS-morphine 
REACTION 
TIME (min} 
15 
Mono-
189084 
4663 
10794 
Effect 
products. 
p e 
M T B S -
Mono-
1072 
bis 
12131 
15288 
13576 
of reaction 
a k a r e a ( T 
morQhine 
bis-
1873 
solvents 
I C ) 
R a t i 
15.6 
0.31 
0.46 
time 
I C ) 
R a t i 0 
0.57 
60 1925 increasing 7861 increasing 0.24 
90 2967 9176 0.23 
150 2318 9024 0.25 
on 
0 1< 
on 
* 
Table 3.111.6: Effect of the ratio of the derivatizing 
reagent to solvent on MTBS-morphine derivatives. 
p e a k a r e a ( T I C ) 
VOL ** M T B S morQhine R a t i 0 * 
% Mono- bis 
100 17884 1161 15.4 
80 5162 7973 0.65 
60 2473 6477 0.38 
50 1995 8518 0.23 
40 1413 19671 0.13 
20 901 7727 0.12 
10 477 3452 0.14 
** Vol% = (volume of reagent/volume of DM~) x 100 
- 96 -
Table 3.111.7: 
products. 
Effect of temperature on MTBS-morphine 
p e a k a r e a ( T I C ) 
'I'EMPERATURE M T B S morQhine R a t i 0 * Mono- bis 
60 0C 3218 7072 0.45 
1000C 3340 9285 0.36 
f) Effect of Catalyst 
The products had to be extracted from their 
reaction media when catalyst was added as direct injection 
of the mixture containing the silylated product was not 
practicable. No peaks could be detected due to an 
overloaded chromatogram. Each sample was diluted with 2ml 
of water to destroy the excess reagent and was then 
extracted with chloroform. The extraction efficiencies in 
chloroform were about 90% and 10% for the bis- and 
mono-MTBS-morphine derivative respectively. The silylated 
products were found to be stable during this extraction 
procedure. The addition of the catalyst (BF3 etherate) 
at the same time as the MTBSTFA or after the reaction had 
been running for 30 minutes. blocked the derivatization 
process (Table 3.111.8). 
Table 3.111.8: Effect of addition of catalyst on 
MTBS-morphine products 
p e a k a r e a ( T I C ) 
CATALYST Time of M T B S 
morQhine 
Addition Mono- bis-
BF3 0 min 0 0 
30 min 0 0 
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3.111.8 INVESTIGATION OF MTBS MORPHINE PRODUCTS 
The mixture of mono- and bis-MTBS-morphine 
derivatives was investigated by TLC to produce a system 
with sufficient separation between the two products, so 
that they could be easily separated on a preparative TLC 
plate. A solvent system of 15% methanol in chloroform 
showed two spots at Rf 
corresponded to mono and 
bluish and pinkish colours, 
values 0.4 and 0.54. They 
bis-MTBS-morphine and they had 
respectively with iodoplatinate 
reagent. Preparative TLC was used to isolate milligram 
quantities of the two products for further examination. 
(a) GC-MS 
An aliquot of each fraction obtained 
preparative TLC plate was analysed by GC-MS. 
of GC-MS of the separated products confirmed 
from the 
The results 
that the 
material with Rf value 0.4 was mono-MTBS-morphine 
traces of the bis derivative, while the other 
bis-MTBs-morphine with traces of the mono-derivative. 
with 
was 
(b) Ultraviolet spectrophotometry 
The UV spectra of free 
MTBS-products in both neutral and 
morphine and 
alkaline solutions 
its 
had 
absorption maxima as presented in Table 3.111.9. Bis-
MTBs-morphine so lution became opaque upon the addi t ion of 
10% NaOH solution which suggested the product had 
hydrolysed. It was filtered through a silanized glass wool 
before the uv spectrum was taken. Both MTBs-morphine 
products in 10% NaOH were extracted into chloroform 
were checked for their integrity on GC-MS. There was 
significant hydrolysis of either of these products. 
and 
no 
- 98 -
Tab I e 3. I I I . 9 UV a b so r p t ion rna x i rna f h' 
its MTBS derivatives 0 morp lne and 
UV Absorption Maxima (mu) 
MeOH 10% NaOH 
Free morphine 286 300 
Mono MTBS Morphine 286 298 
Bis MTBS Morphine* 288 300 
* slightly turbid 
(c) NMR SPECTROSCOPY 
NMR spectra obtained for free morphine and its 
silylated products showed that the morphine nucleus was 
intact and that no structural rearrangements had taken 
place in the mono-MTBS der iva ti ve which could expla in th 
failure to achieve complete derivatisation. Also the 
spectrum of the mono-derivative was not helpful in 
locating the silylated hydroxyl group. 
(d) Derivatization of Mono-MTBS-Morphine 
Further derivatization of this product with MTBSTFA 
produced both mono and bis-MTBS-morphine. while 
derivatization wi th HMDS produced mono-MTBS-morphine and 
MTBS-TMS-morphine. I n both ca ses the mono-MTBS-mor phine 
did not completely derivatize to a bis-derivative. 
(e) MTBS-Codeine 
The mass spectrum of the MTBS-derivative of codeine 
is shown in Figure 3. 111.3. I t cor res po n d s to 6 - MT B S -
codeine. The derivatization was not complete under the 
condition used (40% MTBSTFA in DMF. v/v. with heating at 
60 0 C for 1 hour). The ratio of the free codeine to the 
derivatized product was 0.08:1. 
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(f) MTBS-derivative of 6MAM 
An aliquot of 6MAM was derivatized with 40% MTBSTFA 
in acetonitrile (100)11) at 60 0 C for 1 hour and 1)11 was 
analysed by GC-MS. The spectrum of MTBS-6MAM is shown in 
Figure 3. I I 1.4. None of the free monoacetylmorphine was 
detected in the chromatogram. 
The interpretation of the results ln (a) to (f) 
above is considered in the Discussion, Section 3.1V.5. 
3.111.9 SILYLATI0N WITH EDMS-l 
Derivatization of morphine and buprenorphine with 
EDMS-I was complete for morphine on mixing with reagent at 
room temperature. warming the mixture on a heating block 
did not increase the yield of morphine product while 
buprenorphine required heating for 15 minutes to obtain 
complete derivatization (Table 3. III .10) .Variation of the 
derivatizing reagent in the solvent (acetonitrile) was 
tested in the range 20-50% by volume and was found to have 
no effect on the amount of products (Table 3.111.11). The 
ratio of 40% EDMS-I in acetonitrile (v/v) was chosen for a 
routine derivatization solution. 
Derivatization of morphine and buprenorphine with 
EDMS-I gave 
chromatographic 
(about 1/10th 
one product for each which had good 
peaks (Figure 3.111.5). A smaller peak 
of the main buprenorphine peak) eluted 
earlier than the buprenorphine product and corresponded to 
a degradation product of the derivatized buprenorphine. 
The buprenorphine degradation was investigated and was 
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Figure 3.III.5 TIC trace of a standard of 100ng 
of morphine, SOng of nalorphine and 100ng of 
buprenorphine as EDMS derivatives obtained under EI mass 
spectrometry. The oven temperature was programmed from 
200 0 to 300 0 C at aOC/min with a final isothermal 
period of 3 min and the injector oven temperature was at 
300 0 C. 
The scan range was 50-600, the scan rate was 
1sec/decade and the interscan delay was 1 sec. 
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Table 3.111.10: Effect of reaction tl'me at 0 
f 
' 60 C on the 
ormatlon of morphine and buprenorphl'ne EDMS ' derlvatives 
Tim e P e a k A rea 
(min) m/z 457 m/z 464 
0 12547 1460 
15 13158 4980 
30 13646 4621 
Table 3.111.11: Effect of EDMS-I concentration in ACN 
on morphine and buprenorphine EDMS products. 
EDMS-I/ACN P e 
Ratio 
(% v/v) m/z 457 * 
20 11022 
40 11216 
50 11300 
* molecular ion of bis-EDMs-morphine 
** M-57-32 for EDMS-buprenorphine 
a k A r e a 
m/z 464 ** 
5100 
5238 
5360 
found to be related to the injector temperature and 
conditioning of the GC column. Smaller amounts of the 
product were obtained by lowering the injector temperature 
but this also resulted in an 
overall loss of response and poorer chromatography of the 
rna in components. Priming the GC column with concentrated 
EDMS-buprenorphine also decreased the formation of the 
degradation product. 
For morphine, the single product corresponded to 
bis-3,6-EDMs-morphine. The mass spectrum is shown in 
Figure 3.1II.6a: the base peak was the molecular ion 
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Figure 3.I11.6 Electron impact mass 
bis-EDMS-morphine. EDMS-buprenorphine and the 
product of EDMS-buprenorphine. 
rot 535 
spectra of 
degradation 
CH 3 
(m/ z 457). The EDMS 
3-EDMS-buprenorphine, 
Figure 3.III.6b. Its 
representing the loss 
and methanol (32amu) 
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derivative of buprenorphine was 
its mass spectrum 1S shown 1n 
base peak was at m/z 464, 
of the tertiary butyl group (57amu) 
from the molecular ion at m/z 553. 
The buprenorphine degradation product, its spectrum is 
shown in Figure 3.III.6c, formed by loss of water from 
3-EDMS-buprenorphine. 
3.111.10 STABILITY OF THE PRODUCTS 
The products were kept in the silylating reagent for 
extended periods. Both EDMS-morphine and 
EDMS-buprenorphine were found to be stable over a two-week 
test period and no hydrolysis or degradation occurred. 
However, there was a noticeable 1ncrease in the 
reagent-derived siloxane peaks following the injection of 
the product in the reagent and these peaks increased wi th 
the age of the sample. The glass insert of the injector 
liner became dirty after only a few injections. Trials to 
get rid of the reagent by drying it under a stream of 
nitrogen and redissolving the residue in hexane, ethyl 
acetate or acetonitrile showed that the products had 
completely disappeared, presumably by hydrolysis. 
Similar results were obtained when morphine and 
nalorphine EDMS derivatives were purified over a column 
packed with Lipidex-5000. Morphine and nalorphine 
EDMS-products could not be detected by SIR within their 
retention time windows when an aliquot (lpl) of the residue 
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was analysed by GC-MS. Both compounds appeared in the next 
injection when a blank or ACN/reagent was introduced. This 
indicated that these products were hydrolysed in the 
purification procedure and rederivatized in the inlet by 
subsequent injection of the reagent. 
3.111.11 DERIVATIZATION OF BLOOD EXTRACTS 
Extracts of blood samples spiked with morphine at a 
concentration of 0.46pg/ml were prepared by mixing with 
nalorphine and O.lM ammonia buffer and extracting with 
ethyl acetate:isopropanol. The latter was passed over a 
conditioned Bond-Elut SCX column followed by elution with 
10% ammonia in methanol/acetonitrile. The final eluate was 
evaporated and the residue derivatized with EDMS-I in 
acetonitrile. 
Since it was not possible to purify the derivatized 
drug from the excess reagent, the samples were analysed 
directly by injecting an aliquot of the reaction mixture 
into the GC-MS. The peaks of morphine and buprenorphine 
EDMS-derivatives eluted with RRT's of 0.87 and 1.52, 
respectively, relative to EDMS-nalorphine. They were sharp 
and symmetr i ca 1 . Early eluting peaks started to tail if 
the oven temperature was started at a temperature higher 
A ghost peak appeared in the solvent blank 
at the same retention time as morphine after the injection 
of a positive sample. Two injections of ACN/EDMS- I were 
required to get rid of the interference. Blank blood 
extracts showed an interfering peak eluting at the same 
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retention time as EDMS-morphine which could affect area 
measurements of the morphine peak. These also showed an 
elevated base line compared with blank solvents or 
reagents. Other peaks appeared at regular intervals, the 
mass chromatogram of m/z 457 in both blanks correponding to 
siloxane material from the reagent and/or the column 
stationary phase. Examination of this interference by full 
scan GC-MS did not show a peak at the retention of morphine 
in the blank sample due to masking by high background. 
What was observed. however. was a large peak. of 
cholesterol-EDMS at the end of the run which produced an 
ion at m/z 457. This required the column to be held at the 
upper temperature of 300 oC. even if only morphine 
analysis was required. to remove possible subsequent 
interference in the next sample. 
High resolution SIR and chemical ionization SIR were 
subsequently tried as methods of eliminating the 
interference. although the extraction method had to be 
modified to get rid of the cholesterol. 
The results of EI-SIR at high resolution (10.000) of 
the samples prepared for the previous work, still showed an 
interfering peak in the blank. blood sample extract, but not 
in solvent and derivatizing reagent blanks. 
. f heml" cal l"onl"zation mass Dur ing the eva 1 ua t lon 0 c 
spectrometry. three of the parameters which modify CI 
sensitivity were optimised: the results are summarised in 
Table 3.111.12. 
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Table 3.111.12: Effect of .. varlatlon of emission current 
electron energy (eV) and reag~nt gas pressure on CIM~ 
sensitivity and fra~mentatlon patterns for 
EDMS-derivatives of morphlne and nalorphine the 
Peak heights of mass chromatograms 
Morphine Nalorphine 
Emission* 
Current (mA) 
0.2 
0.5 
2.0 
eV 
50 
70 
90 
** (Volts) 
457 
1651 
5017 
8696 
5054 
4076 
4616 
Gas Pressure *** 
1.3 x 10- 5 
3.5 x 10-5 
4 x 10- 5 
458 
4138 
7315 
4320 
3779 
3833 
354 
1964 
7248 
11790 
6018 
7317 
5535 
483 
1324 
3578 
5971 
3500 
2767 
2973 
m/z 
484 
861 
3212 
4937 
2766 
2627 
2970 
380 
990 
5038 
7364 
3388 
4711 
3023 
3845 2595 3154 
3804 3134 4543 
300 4100 3240 
Noise 
Level 
clean 
1000 
1200 
800 
clean 
720 
600 
613 
680 
5 x 10- 5 
7 x 10- 5 
4941 3600 4987 
5207 4517 6791 
4414 4300 7200 
4092 7802 4487 
4253 3525 8255 
2737 4398 845 
2409 4437 1300 
ga~ pressure was 3.8 x 10- 5 Torr and eV 50V. 
gas pressure was 3.8 x 10- 5 Torr and emission was * ** 
0.5mA. 
*** eV was 50v and emission was 0.5mA. 
Noise Level = level of the base line. 
The C1 mass spectra of morphine and nalorphine 
bis-EDMS-derivatives as well as EDMS-buprenorphine are 
shown in Figure 3. I I 1.7 and their GC-MS chromatogram is 
showin in Figure 3.111.8. The most intense ions were at 
m/z 354 and 380. respectively. representing the loss of 
ethyldimethyl silanol from the quasimolecular 
lons 
(M + H)+ of morphine and nalorphine EDMS derivative, 
respectively. The most intense ion of EDMS-buprenorphine 
was m/z 536 representing the loss of water from the 
- 108 -
EDM lee- 3 4 
913 BIS-EDMS-MORPHlNE 
Be 
713 
sa 
se 3 4 
413 
313 EDMS 
213 
113 
13 
450 see 
lee EDMS 
913 BIS-EO~S-HALORPHINE 
813 
713 
613 
513 
~ 413 
E-i 313 H 
Cf)20 
Z 
223 
fi1 Ie 
E-i a e~~~~~~~~~~.A~~~~~~L1~-1--
~ 
1013-
90 
813 
713 
sa 
513 
413 
313 
20 
Ie 
2 3 
E[)IIIS -BUPR£NORPH I HE 
5 
EDMS 
5 
CH3 
506 
e~ .. ~~~~~~~~ __ ~~~~~~LL~~~~~~ 
2513 300 3513 4ee 4513 5ee 5513 150 21313 
CH 3 
+ 457 mo 
+ mO 483 
I 
HO-C-CH I 3 
C(CH3)3 
m/z + mO 553 
Figure 3.111.7 chemical ionization mass spectra of 
bis-EDMs-morphine bis-EDMs-nalorphine and, EDMS-huprenor-
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Figure 3.111.S TIC trace of a standard of 100ng of 
morphine, 50ng of nalorphine and 100ng of buprenorphine as 
EDMS derivatives obtained under CI mass spectrometry. The 
oven temperature was programmed from 200 0 to 300 0 C at 
SOC/min with a final isothermal period of 3 min and the 
injector oven temperature was at 300 0 C. 
The scan range was 50-600, the scan rate was 
lsec/decade and the interscan delay was 1 sec. 
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quasimolecular ion. Other ions (m/z 207, 223, 281, 297 
and 355) were background l·ons . th ln e mass spectrum. 
Variation of the parameters such as gas pressure affected 
the relative intensity of (M + H) and the ion representing 
the loss of silanol from the quasimolecular lon. During 
CI-MS, the background contained ions at almost every m/z 
value over the acquisition scan range, including m/z 
values of interest for SIR, although there were no 
chromatographic peaks eluting at the retention times of 
morphine or nalorphine. CI-SIR was conducted by 
monitoring the most abundant masses of the EDMS 
derivatives of morphine, nalorphine and buprenorphine. 
354.1889, 380.2045 and 536.3559. respectively. 
sensitivities down to the 20pg level were obtained easily 
wi thout background interference (Figure 3. I I 1.9) wi th the 
possibility of better detection after cleaning the lon 
source. There was no chromatographic interference with 
the morphine peak from blank blood extracts, making this 
extraction and derivatization procedure 
morphine analysis under CI-SIR-MS conditions. 
3.111.12 EXTRELUT EXTRACTION 
usable for 
The solvent extraction procedure which was the 
first stage of the developed method was later replaced by 
. extractl·on on a column containing 19 SOlld-phase 
Extrelut. The blood, internal standard and added buffer 
required about 5 
Extrelut and avoid 
minutes to absorb completely on the 
the risk of the aqueous phase eluting 
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Figure 3.111.9 SIR traces for morphine (A and C at 
200 and 20pg respectively) and buprenorphine (B and D at 1 
and 20pg respectively) EDMS derivatives obtained by EI (A 
and B) as well as CI (C and D) SIR for the masses 
457.2468. 464,2620, 354.1889 and 536.3559 respectively. 
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with the organic solvent. The final recoveries for 
morphine and nalorphine, which were measured by SIR, were 
96% and 98%, respectively, whl"le for b h O uprenorp lne the 
recovery was 94% with direct elution and 89% when a hexane 
wash was added. Blank blood extracts where a hexane wash 
was included did not show an interfering peak at the 
morphine retention time and in addition the base line and 
the cholesterol peak were significantly lower than the 
other blanks for which the hexane wash was omitted. 
3.111.13 DER1VAT1ZAT10N WITH HMDS AND DETMDS 
Solutions of HMDS or DETMDS were prepared in 
acetonitrile and an assessment was made of their ability 
to derivatize morphine, nalorphine and buprenorphine. A 
solution of 50% HMDS in acetonitrile gave complete 
derivatization of examined drugs after heating the sample 
for 15 min at 60 oe. 
and 
The products 
TMS-buprenorphine 
bis-TMS-morphine, bis-TMS-nalorphine 
gave good quality chromatographic 
peaks. Derivatization using HMDS alone was complete when 
compared with the mixture HMDS:DMCS:pyridine. A 
decomposition product from the buprenorphine derivative, 
corresponding to about 5% of the main peak, represented 
the dehydrated form of TMS-buprenorphine and appeared at 
RRT of 0.84 relative to TMS-buprenorphine o The siloxane 
peaks were significantly reduced compared to those formed 
with other TMS-donor reagents, but a significant degree of 
interference would still occur on monitoring the molecular 
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ion at m/z 429 in SIR, at the low levels of morphine 
usually encountered, because this is also a prominent ion 
in the s i loxanes . The cor res pond ing reagent DETMDS was 
expected to produce derivatives in a similar reaction to 
HMDS but because of their increased molecular weights, 
they would be less prone to background interference. 
DETMDS was not soluble in acetonitrile at room 
temperature and addition of 30% by volume of toluene to 
the acetonitrile regained the homogeneity of the mixture 
to ensure proper sampling for GC-MS. 
The chromatogram obtained was free from 
interference, as with HMDS, except for the early peaks of 
g rea serna t e ria 1 ( art e f act s fro m the s y nth e sis) . Morphine 
could be easily monitored at m/z 457 without 
interference. The glass injector liner was not 
contaminated as rapidly as with EDMS-I, and the occurrence 
of ghost peaks was negligible. 
The reagent concentration in the solvent was tested 
the range 5-50% by volume for the 
optimum 
over 
derivatization of morphine, nalorphine and buprenorphine. 
The results are summarised in Table 3.III.13. 
No significant differences were observed for morphine or 
nalorphine but the nature and quantity of buprenorphine 
products was affected. EDMS-buprenorphine peaked with 
reagent conta ining 40% by vo lume of DETMDS, which 
produced the least amount of the dehydrated product. 
also 
Working reagent was subsequently prepared with 40\ 
by volume of DETMDS in solvent. 
Routinely, SOpl were 
added to sample residues for derivatization. 
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Table 3.111.13: 
vo 1 ume ) in ACN 
derivatization 
Effect of 
on morphine, 
DETMDS concentration (% by 
na lorphine and buprenorphine 
Pea k are a s * 
VOL % 
DETMDS Morphine Nalorphine BU P-H6O ** Bup m/z 457 m/z 483 m/z 5 6 m/z 
5 6100 27088 1448 208 
20 63528 27840 1085 2590 
30 59920 28466 1397 4510 
40 64060 30400 1144 4824 
50 63206 31118 1120 4415 
* 
** 
Reactions were carried out at 70 0 C for 15 minutes 
BUP-H20 is the dehydrated product 
EDMS-buprenorphine 
3.111.14 RECOVERY AND REPRODUC1BIL1Y 
464 
of 
The extraction efficiency and reproducibility (as 
S. D. ) for morphine in blood were 91.6±4.9% and 
94.8±4.2% at 35 and 5 60ng Iml, respectively. For 
buprenorphine these were 82.8±5.2 and 87.1±4.2 at 0.5 
and 8ng/ml, respectively. For the internal standard 
(nalorphine) at 250ng/ml these were 97.2 ± 4.2. The 
results are shown in Table 3.111.14. The ratio of the two 
peaks monitored for morphine (m/z 457 and 442) was about 
3.5, which could be used to confirm the presence of 
morphine. The lower mass peak was used for quantitation 
if the morphine peak was overloaded at m/z 457. Good 
reproducibility of multiple injections of a single sample 
was best obtained by using a IJ.ll Hamilton syringe and 
keeping the needle in the injector port for 7 seconds at 
The reproducibility of the retention time was 
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Table 3.111.14 Extraction recoveries of morphine. 
buprenorphine and nalorphine from blood. 
Ext r act ion E f f i c i e n c y % 
Sample 
Number 
1 
2 
3 
4 
5 
Mean 
S.D** 
Morphine 
(ng/ml) 
35 560 
94.2 99.1 
98.3 88.8 
85.1 95.3 
89.5 97.4 
91.9 94.2 
91.8 94.9 
4.95 3.9 
C.V.(%)# 5.4 4.1 
* present at 250 ng/ml 
Buprenorphine 
(ng/ml) 
0.5 8 
80.2 84.5 
89.8 93.8 
81.4 84.4 
76.1 84.4 
86.2 88.9 
82.7 87.2 
5. 3 4.1 
6.4 4.7 
** S.D. = standard deviation. 
Nalorphine 
( I . S td . ) * 
95.4 
102.6 
97.3 
91.2 
98.8 
97.1 
4.2 
4.3 
# C.V. = coefficient of variation. percent. 
excellent. The sensitivity of the method for morphine and 
buprenorphine EDMS derivatives tested were 200pg and 1pg 
on-column. respectively, at a multiplier setting of 5Kv. 
Under these conditions the signal to noise ratio was more 
than 3:1 for buprenorphine (Figure 3 . I I I .9) . Lower 
detection limits could be obtained for morphine. In both 
cases the limiting factor was the chromatography, where 
the peaks started to broaden due to adsorption on the 
column of both drugs at low concentration. 
3.111.15 CALIBRATION CURVES 
The peak ratio of drug standard (morphine or 
buprenorphine) to the internal standard was plotted 
against its concentration. Curves for morphine and 
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buprenorphine concentrations ranging from 35 to 1140ng/ml 
and 0.5 to 16. 5ng/ml. respectively. were linear (Figure 
3 . I I I . 10) . The regression equations (Y = A + BX) and the 
correlation coefficients (r) were as follows:-
Morphine 
Buprenorphine 
A 
0.11 
0.01 
where Y is the peak area ratio. and. 
B 
0.0061 
0.045 
r 
0.99 
0.98 
X is the concentration of drug in the blood. 
3.111.16 EXTRACTION OF OTHER BASIC DRUGS 
Recoveries obtained by a single determination for 
basic drugs extracted from blood by the modified procedure 
are listed in Table 3.111.15. A GC-MS trace showing their 
separation is presented in Figure 3.111.11 and their mass 
spectra are shown in Figure 3.111.12. Fragments above 3% 
of the base peak in spectra of the above compounds and 
examples of other compounds examined in this study are 
listed in Appendix 1. Recoveries were more than 80% for 
all drugs tested. 
morphine. 
None of these drugs interfered with 
3.111.17 DRUG DERIVATIZATI0N WITH DETMDS 
The spectra of additional derivatized drug 
standards. where DETMDS in acetonitrile was added to each 
drug at 60 0 C for 15 minutes and luI was analysed by 
GC-MS. are shown in Figure 3. I I 1.13. Ion abundances and 
possible 
3.111.16. 
sites of derivatization are 
Derivatization was complete 
listed 
for 
in 
the 
Table 
drugs 
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tested except desmethyldiazepam, lorazepam and 
testosterone where the free drugs could be detected (up to 
41% for testosterone). 
3.111.18 COMPARISON OF EXTRACTION METHODS 
GC-MS chromatograms obtained for extracts by 
solvent extraction or by the modified procedure were 
comparable in respect of the clarity of base line and the 
presence of other extractable material. However, the 
recovery of morphine by solvent extraction was only 65%. 
The Extrelut eluate residue (before SCX clean-up) produced 
a GC-MS chromatogram with a high base line and large peaks 
of cholesterol and other unrelated materials. The 
recovery was more than 90%, similar to the fully modified 
procedure. 
3.111.19 ROUTINE APPLICATION 
The results of the analysis of autopsy samples 
using the modified procedure are listed in Table 3.111.17. 
including measurements of other drugs and alcohol. 
Full scan GCMS was performed to verify the presence 
of other drugs f or cases numbered 3. 5. 9 and 13. The 
findings are included in Table 3.111.17. 
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Table 3.111.15 Extraction efficiencies, retention indices (Rl) and significant ions in the mass spectra 
of selected drugs analysed as ethyldimethylsilyl ethers. 
Conc. 
)lg/ml 
Caffeine 1.90 
Dextromethorphan 1.02 
Methadone 0.76 
Amitriptyline 0.50 
M.wt 
194 
271 
309 
277 
Pentazocine 0.92 285 
Dipipanone 0.84349 
Codeine 0.70 299 
Morphine 0.40 285 
Nalorphine 0.50 311 
Dextromoramide 0.79 392 
pK 'I< 
a 
14 
8.3 
8.3 
9.4 
8.5 
8.5 
8.2 
8.0, 
8.9 
7.8 
N.A. 
Rl** Ext.Eff 
'0 
1803 94 
2180 89 
2187 93 
2242 88 
2434 87 
2528 93 
2616 95 
2772 95 
2878 96 
2927 85 
Derivative 
None 
None 
None 
None 
O-EDMS 
None 
O-EDMS 
bis(O-
EDMS) 
bis(O-
EDMS) 
None 
Significant lons(% base peak) 
194(100),109(51),55(28),67(23),89(21) 
271(100),59(87) ,150(71),270(70), 
214(44),171(35),212(26),213(26) 
72(100),75(23) ,117(23) ,87(16) ,59(10), 
129(9),131(8) 
58(100),202(3.2),203(2.6) 
303(100),70(81) ,69(66),110(49) ,258(48), 
259(47) ,260(40) ,200(30) 
112(100),113(12),110(6),59(6),297(6) 
385(100) ,178(72) ,210(54) ,57(46), 
59(44) ,243(17) ,229(37),71(29) 
457(100) ,250(96) ,210(72) ,59(92), 
87(74) ,146(62) ,229(36) ,228(34) 
483(100),87(85),442(75),484(51), 
454(50),338(48),236(45),274(42) 
100(100),265(50),128(44),56(15), 
208(14),98(12),266(14),55(10) 
* Values of pKa are from Ref[12]. M.wt is molecular weight. R1 is retention index. 
** Retention Index measured under conditions given in Section 3.11.25. 
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Figure 3.111.11 TIC trace of a spiked blood 
extract of the drugs presented in Table 3. I I 1.15. The 
drugs appeared at the following scan numbers: caffeine at 
264, dextromethorphan at 451, methadone at 455, amitripty-
line at 481, pentazocine at 574, dipipanone at 620, EDMS-
codeine at 660, morphine at 707, EDMS-nalorphine at 732 
and dextromoramide at 814. The oven temperature was 
programmed from 120 0 to 300 0 C at 8 0 C/min with a 
final isothermal period of 3 min and the injector oven 
temperature was at 300 0 C. 
The scan range was 50-600 with a scan rate of 
Isec/decade and interscan delay of Isec. 
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Figure 3.111.12 E1 mass spectra of the drugs 
presented in Table 3.111.15 as EDMS derivatives. 
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Figure 3.111.12 continued. 
+ m' 277 
+ 
m' 371 
+ 
m' 349 
+ m' 385 
100 - 123 - 4 7 BlS-E~~IHE 
90 
S0 0 EDM 0 70 60 
429 
50 2 0 
8 146 40 
30 CH 3 20 5 
10 EDM 
0 
400 450 + 457 m" 
100 4 3 
90 BIS-EOMS-HALORPHINE 
80 EDM 
70 4 2 
60 
:>J 50 E--t 
H 413 C/l 
C3H5 Z 30 !:iI 
E--t 20 
Z 10 EDM H 
~ 0 4513 + 
m" 483 
1 0 
DEXTROPIORAPllOE 
, iHrHs 
1 8 2 5 CH2CH"?"CsHs yO 
~~~~~~~~~~~~~3~~~~m/z ~ 
+ 
m" 392 
Figure 3.111.12 Continued. 
Table 3.111.16 
Desmethyldiazepam 
Etorphine 
Lorazepam 
Monoacetylmorphine 
Temazepam 
Cannabidiol 
Testesterone 
Oxazepam 
Lormetazepam 
Flupenthixol 
GC-MS data for selected drug EDMS derivatives. 
M.wt 
(free 
drug) 
270 
411 
320 
327 
300 
314 
288 
285 
384 
434 
Derivative 
N-EDMS 
O-EDMS 
O-EDMS 
O-EDMS 
O-EDMS 
O-EDMS 
O-EDMS 
O-EDMS 
O-EDMS 
O-EDMS 
N-EDMS 
O-EDMS 
O-EDMS 
d • • + erlvatlve m 
m/z '0 RI* 
355 86 2467 
497 21 
492 5 2760 
413 100 2709 
386 18 2718 
486 12 2473 
374 44 2830 
457 100 2596 
420 4 2788 
520 5 2960 
* Recorded using conditions described in section 3.11.25. 
Significant Ions (~ base peak) 
59(100),355(86) ,356(55),327(24), 
357(42),87(29),91(22),341(12) 
72(100),410(81),207(80),354(33), 
162(34),161(34),354(33),250(37) 
59(100),347{91),459{52),458{44),87(44) 
133(27),460(21),75(13) 
413(100),354(80),59{63),301(58), 
204(33),414{37),355(27),75{23) 
357(100),283(60},256(58},255(40), 
59(58),359(48},257(52}258(35) 
418(100),419(44} ,59(31),365(29),87(28), 
420(21),315(17) ,352(16) 
143(100) ,345{ 79} ,59(72), 75(70), 
374(44} ,270(39) ,91(31) ,115(32) 
457(100),358{76},359{64),429{50), 
460(41),87(5),133{33),355{30) 
391(100),393{76},317{44),392{30), 
291(25) ,394(21) ,59(21) ,289(20) 
229(100) ,98(40) ,230(30) ,97(27) ,125(15), 
221(13) ,59(18), 70(17). 
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Figure 3.111.13 E1 mass spectra of the drugs 
presented in Table 3.111.16 as EDMS derivatives. 
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Figure 3.III.13 continued. 
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Figure 3.111.13 continued. 
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Table 3.111.17: Results of routine application of the modified procedure: summary of post-mortem findings and 
causes of death where applicable. 
REF AGE opiates 
NO. )1g/ml 
1 
2 
3 
4 
5 
27 Morphine 
0.72 
25 Morphine 
0.19 
21 Morphine 
0.53 
19 
23 
Morphine 
2.0 
Morphine 
0.33 
B 1 0 0 d 
Alcohol Other Drugs 
mg/100ml )1g/ml 
151 
N.D 
216 
N.D 
6 
N.D 
temazepam 
5 
N.D 
N.D 
Temazepam 
0.78, 
phenobar-
bitone 
0.66 
CAUSE OF DEATH 
pulmonary oedema 
due to morphine 
intoxication. 
Temazepam 
and heroin 
overdose 
Heroin 
intoxication 
Morphine intox-
ication, broncho-
pneumonia, drug-
induced fibrosing 
alveolitis were 
contributing 
factors 
Inhalation of 
regurgitated 
vomitus due to 
morphine 
intoxication 
POST-MORTEM FINDINGS 
Oedematous lung, with 
petechial haemorrhages 
on the surface. 
REMARKS 
Heroin addict. Consumed 250mg heroin 
per day. Found lying in toilet, 
syringe & needle beside him. 
Lung oedema. Scattered Had defined needle tract with 
areas of haemorrhage. marked inflammatory processes, 
Occasional refractile several hours old. 
material. Moderate fatty 
liver changes with 
lymphocytic infiltrate 
of the portal tract. 
Little regurgitated 
material in the small 
bronchi. Fresh needle 
marks and punctures. 
Food fragments in the 
air passages,pneumonic 
consolidation. Marked 
oedema and enlarged 
lymph nodes below the 
carina. 
Portion of food was 
present in air pass-
ages. Enlarged lymph 
nodes in hilar region 
and porta hepatis 
and enlarged spleen. 
Syringe sticking out of arm was 
witnessed. Syringe positive for 
phenobarbitone, amitriptyline, 
methaqualone, codeine, morphine, 
diazepam and caffeine. 
Hodgkin's disease, nodular scleros-
ing type. Prescribed morphine sul-
phate 100mg twice daily. At time of 
death there were 6 tablets missing. 
Opiate abuser. Syringe was witnes-
sed sticking in groin region. 
Syringe positive for morphine, 
diamorphine, mono-acetylmorphine, 
temazepam, phenobarbitone,codeine, 
and acetylcodeine. 
t-' 
N 
co 
Table 3.111.17: 
REF AGE Opiates 
NO. J,1g/ml 
6. 24 bupren-
orphine 
0.65 
7 . 20 Morph-
ine 
0.73 
8. NA Bupren-
orphine 
negative 
9. NA Morphine 
1.7 
Bupren-
orphine 
5.1 
ng/ml 
10. NA Negative 
11. NA Bupren-
orphine 
1.4 
12. NA Morphine 
0.078 
13. NA Morphine 
positive 
continued 
B I 0 0 d 
Alcohol Other Drugs 
mg/100ml llg/ml 
CAUSE OF DEATH 
N.D N.D Drug overdose 
34 N.D Hanging 
N.D Diazepam 
0.49 
N.D Temazepam 4.8 
desmethyl-
diazepam 0.74 
diazepam 0.18 
mono acetyl-
morphine 
N.D Drowning 
N.D NA 
N.D Methadone 
Diazepam 
N.D Codeine Clinical case. 
N.D = not detected 
POST-MORTEM FINDINGS REMARKS 
Mild congestion in the Heroin addict. Temgesic(buprenor-
lungs phine)& 5 syringes found beside 
him. syringe wash positive for 
buprenorphine. 
Typical ligature marks Drug abuser. Found hanged and 
around his neck with suspended from tree. 
no internal damage. 
NA Data not available (NA) . 
NA Sample of 'urine' positive for ..... N 
cannabis & amphetamine by RIA ~ 
NA NA 
NA NA 
Two syringes were negative for 
morphine. 
Morphine peak was 3 times larger 
than codeine peak. Person 
admitted morphine intake. 
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3.IV DIS C U S S ION 
3. IV. 1 INTRODUCTION 
In forensic toxicology whole blood samples 
various states of decomposition are the most frequently 
supplied specimens for drug screening. Ever increasing 
demands for the analysis of such samples necessitate the 
handling of multiple samples simultaneously rather than on 
an individual case basis. The appearance of commercially 
available SPE sorbents has produced literature reports of 
efficient and reproducible methods for the recovery of 
morphine from biological fluids other than blood. Also, 
ten samples or more can be prepared at the same time, 
providing a partial solution for the analysis of these 
samples. The extracts are often sufficiently clean for 
analysis by HPLC but further purification is required for 
other methods of analysis such as GC or GC-MS. 
SPE with cationic exchange sorbents, for example, 
benzenesulphonylpropyl bonded silica, has not previously 
been applied to the extraction of drugs from autopsy 
samples. I n t he pre sen t stu d Y , a co mm e r cia 11 y a va i 1 a b 1 e 
phase of this type (Bond-Elut SCX from Analytichem) was 
assessed for the extraction of basic drugs from blood, 
taking morphine and buprenorphine as prototypes. The 
basic properties of most drugs in common use allow them to 
be isolated from endogenous matrices by ion exchange 
chromatography [112]. 
3 . IV. 2 
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SPE EVALUATION 
Before applying biological material to the 
Bond-Elut cartridges, the method parameters affecting 
sample application, retention, sorbent washing and elution 
were optimized using an aqueous morphine standard with a 
concentration range similar to that encountered in 
biological 
contexts. 
samples wi thin 
Tritium-labelled 
the clinical 
morphine was 
or forensic 
added to the 
morphine 
behaviour 
standard 
of the 
in small amounts 
two substances 
as 
ln 
a tracer and the 
the experimental 
procedure was assumed to be identical [140]. The 
radioactivity could be easily detected by liquid 
scintillation counting, which allowed very small amounts 
of radioactivity to be measured with accuracy. The 
detection of the tracer provided information about the 
behaviour of unlabelled morphine in a fast and sensitive 
manner for preliminary assessment of the method under 
development. 
solvation of the sorbent with methanol and water 
was sufficient to condition the phase and ionise the sex 
functional group, which has a cationic exchange activity 
once it is charged. Both the sorbent and the isolate 
should be charged for a strong interaction to occur and to 
provide adequate retention of the solute [116]. The 
aqueous methanolic morphine standard 
reta ined on the sorbent, evidenced 
radioactivity on washing with methanol. 
was completely 
by no loss of 
Adsorbed species are conventionally eluted from a 
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cation exchange sorbent by five methods [116]. Following 
the normal practice for SPE methods, elution is carried 
out with the minimal amount of solvent, to maintain as 
high a concentration of the analyte as possible in the 
eluent. 
(a) 
pK 
a 
A buffer with a pH which 1S 2 units lower than the 
of the sorbent neurtralizes the charge of the 
sorbent. However, sulphonic acid is a strong acid (pK
a 
0.69) and this approach is unavailable in the present 
instance as the sorbent is destroyed by eluents with a pH 
below about pH 2. 
(b) A buffer with a pH which is 2 units higher than the 
pK
a 
of the cationic solute (morphine pKa values are 8 
and 9.9 for amino and phenol groups, respectively) will 
neutralize the charge on the isolate. 
(c) A high ionic strength buffer (>O.lM) can be 
used. The high concentration of cations in the buffer 
will compete with the cationic analyte for sites on the 
sorbent, promoting elution of the isolate. 
(d) An eluent containing competitive cations or bases, 
for which the sorbent has an extremely high affinity, will 
displace the analyte. 
(e) Combinations of the above four techniques can be 
used. 
In the present study, an alternative procedure was 
tried using the derivatizing reagent mixture of first 
HMDS:DMcs:pyridine (2:1:3 v/v/v) , after the sorbent had 
been dehydrated by passing acetone. HMDS as a TMS donor 
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should react with the active sites of the sorbent to form 
the TMS ester and further derivatize the morphine for 
subsequent gas phase analysis. This type of approach has 
been used in the analysis of organophosphorus pesticide 
metabolites following their adsorption on an anion 
exchanger. by on-column reaction with a diazoalkyl reagent 
[141]. However. only 76% of the radio label was 
recovered. The application of a warm solution to 
facilitate the reaction did not improve the recovery in 
the eluate while increasing the volume to lml increased 
the recovery to 92%. The recovery was improved after the 
addition of acetonitrile to the washing and elution 
solution to disrupt the non-polar interaction between the 
sorbent and morphine. It must be recalled that the SCX 
sorbent has a high potentiality for non-polar interaction 
due to the presence of the propylbenzene substituents on 
the surface [116] and. especially after reaction with the 
silylating reagent. the morphine molecule has a large 
non-polar skeleton. using larger volumes of the 
derivatizing mixture is not practicable as the eluate 
would have to be concentrated and such solvents are not 
easily volatilized. 
Triethylamine (TEA). diethylamine (DEA) and ammonia 
fall into category (d) above: they are volatile, give 
, I' n water or methanol and can break the basic solutIons 
interaction between the sorbent and morphine. One 
millilitre of 5-10% v/v solution of any of these bases in 
MeOH/ACN recovered more than 99% of the radioactivity and 
could be evaporated quickly. 
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3 . IV. 3 . DIFFICULTIES IN RADIOACTIVITY COUNTING 
The efficiency of liquid scintillation counting is 
usually dependent on many factors such as the presence and 
concentration of quenching substances, the nature of the 
sample and the variable conditions under which the 
analysis is conducted, particularly where several media 
containing different solvents were used, giving extracts 
which also varied in colour in each extraction procedure. 
These factors were difficult to control or compensate for, 
albeit efforts were made to include a blank sample in 
parallel with every analysis. The counting efficiency was 
estimated by comparing the counts per minute of the 
quenched blank sample with the count obtained before the 
blank was added. The actual count is corrected with the 
quench correction factor obtained under the same 
conditions. This method works as an internal standard 
method and is valid for colour quenching as well as for 
chemical and dilution quenching [140]. However, the 
figures obtained by radioactivity counting were considered 
as an approximate resul t for each experiment conducted. 
The final results of the extraction procedure were 
subsequently obtained by GC-MS analysis. 
3 . IV. 4 APPLICATION OF BLOOD TO BOND-ELUT COLUMNS 
Solid phase extraction cartridges contain silica 
particles of average diameter 40um, held in place by a 
porous fit. Particulate samples, e.g. homogenates, cannot 
readily be applied and viscous samples such as whole blood 
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must usually be pretreated before application to the 
cartridge. In autopsy samples, the problem is further 
complicated by the nature of the blood, which may be 
partially clotted and/or haemolysed. In most cases even 
Hb-stained plasma cannot be prepared. In this study, 
three different approaches were tried haemolysis plus 
deproteination, solvent extraction and Extrelut 
extraction. Haemolysis and protein precipitation was 
disappointing, both in terms of morphine recovery and the 
suitability of the extract for application to the 
cartridge: the first was due to binding of the drug to 
the protein pellet, from which no successful procedure was 
found to dislodge it, and the second was due to the 
presence of protein microparticulates which failed to 
settle even with centrifugation. Ultracentrifugation was 
cons idered too comp lex f or a rou tine procedure. However, 
direct application of blood on bonded silica after 20-30 
minutes of ultrasonication has been described for morphine 
[142] and anti-inflammatory drugs [143]. The eluates were 
analysed by HPLC. The authors did not mention similar 
problems. 
Extrelut extraction provided an easy solution for 
direct blood application. Blood buffered with low 
molarity buffer (O.lM/L ammonia in water) was applied to a 
column packed with Extrelut, after which the eluate was 
passed directly through the Bond-Elut SCX cartidge for 
purification. 
capability of 
The diatomaceous material has the 
absorbing the aqueous media and will act as 
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a filter for the blood material. The Extrelut was eluted 
with ethyl acetate:isopropanol 9:1 (v/v) which has an 
excellent extraction efficiency for morphine in biological 
matrices [91,92]. This combination produced a polar 
eluting solvent which also eluted undesirable endogenous 
material from the blood. These extracts, when analysed on 
GC-MS, produced huge peaks of cholesterol, high base lines 
and interferences with the morphine peak due to the 
endogenous material (Figure 3. IV .1A). The addition of a 
non-polar solvent (hexane) wash prior to the elution step 
with the eluting solvent, removed some of the non-polar 
lipids while polar drugs such as morphine and 
buprenorphine, which have poor solubility in hexane were 
not affected significantly. The chromatogram of the fully 
modified procedure extract (Figure 3.IV.1B) had a low base 
line, lower peaks of cholesterol and no peaks interfering 
with morphine. 
In comparison with solvent extraction. the modified 
method has a high extraction efficiency, saves both time 
and solvents and avoids multiple extraction 
and 
centrifugation procedures. The purity of the extracts and 
the chromatograms were similar. 
3 . IV . 5 . DERIVATIZATION OF MORPHINE 
The polarity of morphine due to the presence of two 
I d t o losses during GC by adsorption to hydroxyl groups ea s 
the active surfaces on the system. The GC column is 
normally coated with non-polar to moderately-polar phases 
1 ae. B S 1 , 11 ,G2 
90 
se 
70 
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Figure 3 . IV. 1 GC-MS traces for 
extracts of morphine (M) monitored by 
1.00 
3466 
rn/z 457 
1.ee 
3182 
TIME 
rn/z 457 
TIIV'E 
spiked 
SIR to 
blood 
m/z 
457.2468. The samples were prepared according to the 
developed method without (A) and with (B) hexane washing 
step. The retention time of morphine (as the EDMS 
derivative) was 11 mln 29 sec and 11 min 38 sec 
respectively in the two GC runs. 
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such as dimethyl silicone or methylphenyl silicone, for 
example SE-30 or OV-17, which are widely employed for 
general drug screening. Morphine has to be derivatized at 
these hydroxyl groups to obtain a good quality 
chromatographic peak, In terms of peak shape and absence 
of tailing. From the literature review, silylation using 
the common TMS donor reagents reproducibly gives one 
derivatization product which In turn results In better 
sensitivity 
Acetylation of 
and reliability 
morphine produced 
for quantification. 
similar results, but 
acylation with higher molecular weight groups such as 
pentafluoropropionyl or heptafluorobutyryl each produced 
two products [101] which were unstable and had to be 
purified from the excess reagent. 
During the present work, trimethylsilylation of 
morphine produced results similar to those described in 
the literature when the sample was injected on the gas 
chromatograph in the reagent. The reaction was 
essentially complete on dissolution for morphine whereas 
sample heating was required for buprenorphine. Silyl 
ethers are sensitive to moisture [144]. Removal of the 
excess reagent under a stream of dry nitrogen resulted in 
loss of the derivative, presumably by hydrolysis. This 
could be explained by exposure to atmospheric water and by 
the instability of the phenolic silyl ether when removed 
from the reagent [144]. 
The molecular ion of bis-TMS-morphine (m/z 429) was 
the most intense peak in the mass spectrum (excluding the 
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trimethylsilyl ion at m/z 73). However, monitoring of 
this mass in SIR suffered from interference from siloxane 
peaks and column bleed from the stationary phase, both of 
which increase when the sample l' •• d s 1n J ecte on-co 1 umn in 
the reaction mixture. The net result of this interference 
was to produce confusing results and unreliable detection 
when morphine was present in samples at low levels (less 
than Ing on-column). 
On the other hand, the MTBS products of morphine 
were stable on exposure to moisture, and the derivatized 
morphine could be purified from the excess reagent. 
Bis-MTBs-morphine had a good chromatographic peak with the 
most abundant mass m/z 456 obtained by loss of a tertiary 
butyl group (57 a.m.u) from the molecular ion (m/z 513), 
Table 3.IV.1, which could be monitored without significant 
interference from the background ions which were mostly 
odd number masses. For this reason efforts were made to 
obtain complete derivatization of morphine as the 
bis-MTBS-morphine product, to increase the sensitivity and 
reproducibility of the assay, which are not expected to be 
acceptable when more than one product is formed. 
The correct choice of solvent can influence the 
rate of a reaction, where the chief requirement of any 
solvent is that it should dissolve both reagent and sample 
without reacting with either [144]. The three solvents 
tested for the reaction were polar and should have 
promoted a faster reaction. However, none of them 
succeeded as a solvent to obta in complete reaction. The 
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Table 3. IV.1. Fragmentation pattern of morphine and buprenorphine 
silyl ethers. 
Substance Parent Ion Mass Loss Composition Product 
of fragment ion m/z 
1. Bis-EDMS-morphine 457 (Mt) 15 • CH3 442 (Electron Impact) 
457 (Mt) · 29 C2H5 428 
457 (Mt) 57 , C2H5N 414 
+ 
· 400 (M' - 51) 15 C H3 385 
+ • 457 (M' ) 87 C4H11Si 370 
+ • 370 (M' - 87) 15 CH3 355 
+ 
· 457 (M' ) 104 C4H12OSi 353 
+ • 353 (M'- 104) 29 C2H5 324 
+ 
· 457 (M' ) 156 C8H16OSi 301 
(Mt) • 457 207 C8H2302Si2 250 
(Mt) · 2. Bis-EDMSi-morphine 458 15 CH3 442 (Chemical Ionization) 
+ 500 (M' + 43) C3H7 500 
+ 
· 514 (M' + 57) C4H9 514 
+ 
· 457 (M' ) 29 C2H5 428 
458 (M + H)+ 104 C4H12OSi 354 
· 354 57 C3H7N 297 
354 87 C4H11Si 267 
(Mt) · 3. Bis-MTBS-morphine 513 15 CH3 498 
(Mt) · 513 57 C4H9 456 
+ · 456 (M' - 57) 15 CH3 440 
+ · 456 (M' - 57) 43 C2H5N 413 
+ • 513 (M' ) 114 C6H15 Si 399 
+ · 513 (M' ) 131 C6H15 SiO 382 
----_. ----
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Table 3.IV.1. continuation 1. 
Substance Parent Ion Mass Loss 
Composition Product 
of fragment ion m/z 
4. Bis-EDMS-buprenorphine 553 (M;) 
. 
15 CH 3 538 
553 (Mt) 18 H2O 535 
538 + (M' - 15) 18 H2O 520 
535 (Mt - 18) · 15 CH3 520 
535 (M;) 32 CH30H 521 
521 + · (M· - 32) 15 CH3 506 
(M~) • 553 57 C4H9 496 
496 + (M· - 57) 32 CH30H 464 
496 + (M' - 57) 18 H2O 478 
+ 0 553 (M' ) 101 C6H13O 452 
+ 0 452 (M' ) 15 CH3 438 
452 (Mt_ 101) 29 • C2H5 422 
(Mt) • 5 . EDMS-buprenorphine 553 15 CH3 538 
(Electron Impact) 
553 (Mt) 18 H2O 535 
538 (M: - 15) 18 H2O 520 
(M~ 0 535 - 18) 15 CH3 520 
553 (Mt) 32 CH30H 521 
521 + (M' - 32) 15 CH3 506 
(M~) 0 553 57 C4H9 496 
496 + (Mo - 57) 32 CH30H 464 
496 + (M' - 57) 18 H2O 
478 
553 + (M' ) 101 
0 
C6H13O 
452 
+ . 452 (MO_ 101) 15 CH3 438 
(Mt-
. 
452 101) 29 C2H5 
422 
- -_. -- - . ~.---
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Table 3.IV.1. continuation 2. 
substance Parent Ion Mass Loss Composition Product 
of fragment ion m/z 
6. EDMS-buprenorphine 554 (M + H)! 18 H2O 536 (Chemical Ionization) 
596 {M + 43)t C3H7 596 
7. EDMS-buprenorphine 535 + • (M' ) 15 CH 3 520 (dehydrated form) 
(M"t) • 535 29 C2H5 506 
(M"t) • 535 41 C3H5 494 
(Mt) • 535 57 C4H9 478 
535 (Mt) 71 · C5H11 464 
(Mt) · 535 87 C4H11Si 448 
535 (M"t) 103 C4H11SiO 432 
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yield of bis-product produced was higher in DMF than 
pyridine. Acetoni trile produced mainly the mono product 
which could be explained by poor solubility of the reagent 
in the solvent, similar to the results obtained when the 
reagent was used without any solvent. Lower mole 
fractions of reagent in the derivatisation mixture down to 
10% by volume, promoted the formation of the 
bis-derivative. 
Increasing the temperature and time of the reaction 
(to 100oC) to increase the rate of the reaction and to 
enable complete derivatisation of the hindered hydroxyl 
group failed to do so, and although the total yield 
increased, the ratio of products could not be improved. 
The addition of a Lewis acid catalyst such as boron 
trifluoride etherate or a base such as aluminium oxide had 
no value. 
The failure of the reaction to go to completion can 
be explained by at least three possibilities: firstly, 
the mono-derivative has a bulky tertiary-butylsilyl group 
which could cause steric hindrance to the other hydroxyl 
group and inhibit its silylation; secondly, a structural 
rearrangement, such as polymerization of the molecule, 
could occur at the free hydroxyl group of 
mono-MTBs-morphine; and thirdly, the reaction could reach 
a thermodynamic equilibrium at a certain point where it 
can not proceed further, rather than because it 1S rate 
(kinetically) limited. 
The experiments which were conducted to investigate 
the above possibilities 
that these products 
bis-MTBS-morphine. The 
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(GC-MS and NMR analysis) confirmed 
were mono-MTBS-morphine and 
mass spectral analysis of the 
mono-MTBS-morphine corresponds to derivatization of the 
hydroxyl group at C-3, similar to mono-PFP and 
mono-HFB-morphine [101,145]. The major fragments obtained 
for 3-MTBS-morphine in this study are illustrated in 
Figure 3. IV. 2. The routes of fragmentation were similar 
to those described for the morphine EI mass spectrum 
[146]. 
The 
localizing 
be assumed 
ultraviolet spectra were not helpful in 
the site of derivatization, although it might 
that if the derivatization occurred on the 
phenolic hydroxyl 
bathochromic shift 
group it should prevent the I red I or 
to a longer wavelength in an alkaline 
The maximum UV absorption of free solution [147]. 
morphine in aqueous acid is 285nm and in aqueous alkali it 
is 298nm [12]. Free morphine and its two MTBS-products 
showed absorption around 300nm in alkaline solution which 
could be explained by the presence of free morphine due to 
partial hydrolysis, although GC-MS analysis showed no 
significant hydrolysis of products after solvent back 
extraction of the alkaline solution. However, free 
morphine if present could have been lost by absorption to 
the GC column and therefore not detected. This was not 
further investigated. 
Derivatization of mono-MTBS-morphine and codeine 
(where the hydroxyl group at C-3 is replaced by methoxy 
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Figure 3.IV.2 Major fragments obtained for 
3-MTBS-morphine during EI mass spectrometry. modified 
from Reference [146]. ?? is a tentative pathway. 
• 
CH 
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group), with MTBSTFA produced bis-MTBS-morphine and 
6 - MT B S - cod e in e , res p e c t i vel y . I n bot h cas e s abo u t 10% 0 f 
the products were underivatized. However, 6-MAM was 
completely der iva t ized by MTBSTFA a t the C-3 pos it ion. 
These reaction studies, where codeine and mono-MTBS-
morphine derivatization did not reach completion at C-6 
position while 6-monoacetYI morphine was easily 
derivatized at C-3 position, indicate that the 
incompleteness 
thermodynamic 
of the 
equilibrium 
derivatization 
state and is 
1S due to a 
not a kinetic 
limitation. In conclusion, although the products are 
stable, the presence of more than one product was not 
favourable for a good analytical method and a new reagent 
(EDMS-I) was assessed. 
3. IV. 6 . ETHYLDIMETHYLSILYL-IMADAZOLE DERIVATIZATION 
Derivatization with EDMS-I has not been reported 
for morphine and buprenorphine. It has an extra methylene 
group compared to the TMS group. Trimethylsilyl-imidazole 
has strong silyl donor ability [144]. The reactions and 
the products obtained with EDMS-I were similar to those 
from TMS-I. The product of morphine derivatization was 
bis-3,6-EDMS-morphine and the molecular ion (m/z 457) was 
the most abundant ion in the mass spectrum. It could be 
monitored in SIR without interference from the background 
siloxane ions. Derivatization of buprenorphine occurred 
only at the phenolic hydroxyl group, as the other group 
was sterically hindered. The most abundant ion at 
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mass 464 occurred by the loss of a neutral group 
(methanol) plus the tertiary butyl group (57 a.m.u.) from 
the molecular ion (m/z 553). This fragmentation reaction 
(Table 4.1V.1) did not occur in the degradation product of 
EDMS-buprenorphine, where the loss of a water molecule 
from the side chain produced a double bond (Figure 
3.111.6) between C-7,1 which resulted in stronger bonding 
of the methoxy and tertiary butyl groups with less 
possibility of cleavage. The mass spectrum of the 
de g r a d at ion pro d u c t ( F i gu r e 3 . I I I . 6 ) i s qui ted iff ere n t 
from buprenorphine the high mass ions are intense and 
therefore ideal for SIR. If it could be formed in 100% 
yield it would be useful. The dehydration of buprenorphine 
was due to a high injector temperature; a temperature of 
300 0 C did not compromise the results, produced better 
chromatography and resul ted in a higher detector response 
compared wi th lower temperatures. This product can be 
eliminated by mild acid hydrolysis and ring formation 
between the side chain and methoxy group after losing 
methanol [107,109]. Also, more recent analysis carried 
out on a new capillary column (Chrompack cp-sil 5) showed 
a much smaller dehydration product peak, suggesting that 
the by-product observed was at least partially due to the 
presence of active sites on the column surface. 
Due to the liability of the above silyl derivatives 
to hydrolyse on exposure to air after removal of excess 
reagent by evaporation (as discussed earlier), samples 
were injected in the reaction mixture. Acetonitrile was 
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employed as a solvent for the reaction instead of 
pyridine, which is usually used for silylation, because 
pyridine tailed badly on the chromatogram and could 
interfere with the analysis of early eluting drugs if the 
method were to be extended to a general drug screen. 
Although the quantity of EDMS-I in the solvent (30%, v/v) 
was suffient for derivatization of both morphine and 
buprenorphine (40%, v/v) was employed to cover possible 
presence of extractable material in the blood which might 
consume the reagent. The products were found to be stable 
when kept in the reaction mixture for periods of up to 2 
months, although background interference from siloxane 
material increased during this time. The presence of 
increasing siloxane material could be due to deterioration 
of the reagent at room temperature and to possible 
evaporation of the solvent, care being taken to avoid 
condensation of moisture in the storage vials. 
3.IV.7. DERIVATIZATION OF BLOOD EXTRACT 
Trimethylsilylation reagents can be placed in the 
following approximate order of silyl donor ability 
[144,148]: 
TMSI > BSTFA > BSA > MSTFA > 
TMSDEA > MSTA > TMCS (with base) > HMDS 
TMSDMA > 
Samples analysed by GC-MS were injected directly in 
the reaction mixture, as evaporation of excess reagent 
(EDMS-I) in a stream of nitrogen was not practicable, due 
to low volality of the reagent (BP 105°C/10mmHg) [149]. 
When this was tried, 
hydrolysed similar to 
this reagent into the 
following reasons: 
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it was found that EDMS-morphine was 
the TMS ether. The injection of 
GC-column was troublesome for the 
firstly, there was a detrimental 
effect on the column due to head of the column 
contamination; secondly, there was a rapid accumulation 
of solid debris in the glass injector liner from the 
reagent 
required 
injector 
observed, 
itself and from co-extracted material which 
frequent cleaning and 
liner; thirdly, morphine 
which required two blank 
silanization of the 
'ghost' peaks were 
injections of reagent 
mixture to clear the system and the occurrence of these 
peaks could be explained by rederivatization of the debris 
in the injector port; fourthly, the derivatization of 
extractable lipids such as cholesterol required 
prolongation of the final isothermal time at the upper 
temperature in the GC oven programme. 
Purification of the silylated product on a column 
of hydroxyalkoxypropyl Sephadex (Lipidex-5000) was aimed 
at getting rid of excess reagent. This gel material has 
hydroxyl groups to react wi th the excess reagent and has 
been used by previous workers for purification of steroid 
TMS derivatives from excess TMS-I reagent [150]. In the 
experiment performed only free morphine and 
(internal standard) were found in the eluate. 
nalorphine 
This CQuld 
be explained if, the EDMS derivatives of both drugs were 
hydrolysed on drying or on removing them from the reagent 
mixture. In the quoted method [150], HMDS was included in 
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the eluting solvent (hexane:pyridine:HMDS:dimethoxypropane 
97:1:2:10 v/v/v/v) as a weak TMS donor [144] which could 
protect the derivatized molecule from hydrolysis. 
This purification procedure would be too complex 
for a routine extraction and analytical method and was not 
further continued. 
Extract derivatization was conducted using DETMDS 
instead of the analogous EDMS-I. The reaction conditions 
were similar in terms of reaction temperature and time as 
well as the stability of the product. However, the 
chromatograms obtained 
relatively free from the 
where DETMDS 
siloxane peak 
was used 
materia 1. 
were 
Also, 
there was no contamination of the injector port and no 
significant 
chromatogram. 
3 . IV. B . 
carryover of the sample to 
HIGH RESOLUTION MASS SPECTROMETRY 
the next 
High resolution mass spectrometry for quantitative 
analysis was discussed earlier [Chapter 2]. It was 
assessed in the present work as a method for EDMS-morphine 
analysis without interferences at the mass monitored, 
where by increasing the resolution of the mass 
spectrometer the 
mass and another 
cross-channel contribution between one 
ln SIR is reduced and the background 
interference from other components is reduced 
accordingly. At 10,000 resolution, the interfering peaks 
could still be seen at low levels, which is explained by 
the fact that instrument can still register the signal 
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from a closely adjacent mass if the sides of the adjacent 
peak fall within the window used to monitor the target 
peak [151]. even if the accura te mass ion is not shared 
with the background spectrum. 
3 . IV. 9 . CHEMICAL IONIZATION MASS SPECTROMETRY 
As discussed in Chapter 2. CI is a soft ionization 
technique causing a low degree of fragmentation. The 
protonated molecular ion obtained by this method of 
ionization has greater relative abundance than the 
molecular ion obtained by E I. On this assumption 
EDMs-morphine coud be monitored at its protonated ion 
(m/z 458) and the interfering background ions. if 
resulting from fragmentation of a higher molecular weight 
molecule. should decrease or disappear. Analysis of blood 
samples and blanks by isobutane CI SIR showed that no 
interfering peak was present at the retention time of 
morphine. 
Chemical ionization SIR also had excellent 
sensitivity. where detection down to the 20pg level was 
easily obtained by monitoring the most abundant ions of 
the morphine. nalorphine and buprenorphine EDMS 
derivatives. 
In conclusion. CI-SIR can be used as a sensitive 
method for the above drug without interferences. Another 
potential benefit of CI is the use of negative ion CI for 
morphine and related drugs by derivatizing them with an 
electron-capturing moiety such as the hept~luorbenzYl 
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groups. Higher sensitivity expected for such 
derivatives under negative 
is 
Ion CI and background 
interferences would be lower. However, this approach was 
not studied during the present work. 
3. IV. 10 ESTABLISHMENT OF THE PROCEDURE 
The fully developed extraction procedure produced 
excellent recovery for morphine and buprenorphine as well 
as a clean extract free from interferences. The 
calibration curves for these two drugs were linear over 
the range likely to be encountered In routine 
application. Reliable quantitation was obtained due to 
the excellent reproducibility of the method at high and 
low levels for these drugs. 
The SIR mode of scanning where only one or two ions 
are scanned at one time and an analysis free from 
interferences have improved the detection limit as 
described earlier to levels better than quoted in the 
literature (Tables 3.1.2 and 3.1.3). The extraction 
efficiency of this method was also good for other basic 
drugs which are commonly encountered in forensic 
toxicology. By careful selection of retention time 
windows and the most intense ions, an SIR-based drug 
screening procedure could be developed to include a wide 
range of drugs which can be extracted using the developed 
extraction procedure. 
The derivatisation reagent DETMDS produced good 
silylating ability for most of the examined compounds on 
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both nonhindered hydroxyl and amino groups. Drugs which 
were not complete ly s i lyla ted us ing DETMDS can be 
completely silylated using EDMS-I if the EDMS derivative 
is required. However. DETMDS would be sui table for the 
purpose of general drug screening in routine applications. 
3.IV.ll.2 ROUTINE APPLICATION 
The levels of morphine in blood in cases where 
morphine or heroin was abused or 
time. were higher than O.19ug/ml 
taken over a prolonged 
(Table 3.111.17). These 
values were in accordance with the reported minimum lethal 
level of O.2ug/g morphine in tissue [72]. 
Rapid death was observed in cases numbered 1. 3 and 
5 in Table 3. I I 1.17 in which the deceased was wi tnessed 
just less than one hour before injecting heroin. In these 
cases. other agents such as alcohol or additional drugs 
contributed to the rapidity of death since even such high 
levels have been observed in heroin-associated fatalities 
whose deaths were due to other causes. However. the 
pathological findings and the circumstances of death are 
required for an accurate interpretation of the cause of 
death. 
In case number 13. the morphine level was three 
times higher than that of codeine. which could reflect 
morphine intake. rather than codeine. if the urine sample 
was collected within the first 24 hours after dosing with 
morphine [4]. 
not known. 
morphine. 
Although the exact time of drug intake was 
however. the person had admi tted taking 
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The buprenorphine concentration (0.65ng/ml) ln 
blood in case number 6 . was a low level. Levels of 
2-50 ng Iml were reported within the first 3 hours of 
buprenorphine injection at a dose of 6)lg I kg [64]. The 
cause of death in case No.6 was attributed to drug 
overdose due to the buprenorphine finding and the 
circumstances of death, although the length of time which 
had elapsed between intake and death was not known. The 
level of free buprenorphine in the urine in case No. 9 
(5.1ng/ml) is not helpful on its own for interpretation. 
However, similar values (3.7 and 14.4ng/ml) were found 
after 72 hours in two patients receiving 4mg buprenorphine 
daily [109]. 
The finding of buprenorphine in the above cases and 
in the syringes of drug abusers supported previous reports 
of an increase in buprenorphine abuse [68]. 
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CHAPTER F 0 U R 
4.1 ANALYSIS OF SOLVENTS 
4.1.1 INTRODUCTION AND LITERATURE REVIEW 
The importance of volatile solvent analysis 1n 
biological media in the field of forensic toxicology 
emerges in two major aspects. The first is the monitoring 
of volatile substance abuse (VSA) either in clinical 
practice or as part of a post-mortem investigation where 
VSA is suspected. The second is occupational monitoring 
where solvents are used during routine daily practice. A 
volatile substance is one which is capable of readily 
changing from a solid or liquid form to vapour; that is. 
one having a high vapour pressure and low boiling 
point [152]. Many solvents exhibit appreciable volatility 
under the conditions of use and consequently the persons 
who use them will be exposed to their vapours. The 
present study was concerned with the second of these 
categories. in particular the monitoring of occupational 
exposure to solvents in painters. 
4.1.2 VOLATILE SUBSTANCE ABUSE 
VSA is a term used to mean the deliberate 
inhalation of vapours given off by certain solvents and 
propellants solely for the purpose of intoxication. Other 
synonymous terms are glue sniffing. solvent sniffing and 
solvent abuse [153-157]. The epidemiology of VSA, 
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problems associated with it, clinical presentation and 
methods of abuse, have been extensively described in the 
literature [158-164], to mention a few. The abused 
solvents are available mostly in household products 
[163,165,166] and include xylene toluene, chlorinated 
hydrocarbons, white spirit, petrol, etc. 
Solvent abusers experience short-term effects which 
are mostly reversible. The clinical picture starts with 
an excitatory phase of delirium followed by signs of CNS 
depression 
euphoria, 
[165]. 
mental 
Early on, 
confusion, 
there is a feeling of 
ataxia and dysarthria. 
Bizarre impulsive behaviour leads to trauma during this 
period which is a frequent source of morbidity and 
mortality [155,159]. Continuous inhalation may lead to 
coma, convulsion and cardiorespiratory arrest [163,164], 
and long term effects such as ataxia, encephalopathy and 
epilepsy have been reported [163,164,167,168]. possible 
autopsy findings have also been reported [159,169]. 
4. I . 3 OCCUPATIONAL MONITORING OF VOLATILE SOLVENTS 
In contrast to VSA, workers are exposed to low 
levels of volatile compounds over a prolonged time and 
exposed to possible irreversible long-term hazards during 
their work practice. The hazards and toxicity of both 
aromatic and aliphatic solvents have been frequently 
reviewed [170-174]. Painters are one example of such 
workers; they are exposed to a wide range of solvents 
present in the various types of paint or paint removal 
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material. The main route of exposure is through the lungs 
with possible additional solvent absorption through the 
skin. Several factors influence the quantity of solvents 
entering the body, such as air concentration of solvents 
and duration of exposure in the workplace [175-178], which 
are, in turn, affected by the working material, working 
conditions, safety precautions and working methods. Other 
factors include pulmonary ventilation [179-182], 
solubility of 
coefficient) 
the solvent 
[183,184], 
in blood and 
the phys ique 
tissue (partition 
of the worker, 
metabolism and presence of drugs or alcohol in 
blood [185-187]. 
4.1.4 METHODS OF OCCUPATIONAL MONITORING 
Occupational monitoring of exposure to volatile 
solvents can be conducted by one of the following 
procedures: 
(a) Atmospheric air monitoring [188-194] 
A threshold limit value (TLV) is one of the main 
regulatory controls of solvent in the workplace. A TLV is 
defined by the American Conference of Governmental 
Industrial Hygienists (ACGIH) as the maximum airborne 
concentration of a substance that represents conditions 
under which it is believed that nearly all workers may be 
exposed daily without adverse effects [172]. Three 
categories of TLV are described -
(i) Time Weighted Average (TWA). A value for a normal 
8 hour work day and 40 hour work week. 
( i i) 
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Short-Term Exposure Limit (STEL). A value for a 
short time. 
(iii) Ceiling (TLC-C) . A value that should not be 
exceeded even briefly. 
(b) Biological Monitoring 
In this type of monitoring a marker is traced ln 
either breath, urine or blood. The pharmacokinetics, 
metabolism and physical properties of the solvent of 
interest should be considered before selecting a 
biological medium. So a properly designed biological 
monitoring method should provide a better indication of 
the absorbed dose and a better estimate of the risk than 
air monitoring. An ideal biological monitoring protocol 
for a solvent or a mixture of solvents can correlate 
exposure with effect. detect 
damage occurs, is specific 
exposure [195]. 
The literature is not 
changes before significant 
and occurs shortly after 
scarce in the 
single biological markers or compilations 
reporting of 
of related 
data [196-198]. 
follows: 
Body fluids used in the past are as 
(i) Breath Analysis 
The technical and theoretical aspects of breath 
analysis have recently been reviewed [199]. Breath is an 
easily-obtained specimen for monitoring substances with 
sufficient volaltility [155.178]. Proper alveolar samples 
are collected in a plastic bag. glass tube [181.200], tube 
packed with adsorptive material [189] or by cryogenic 
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trapping. These samples are then analysed by GC or 
GC-MS. Direct analysis by exhaling into an infra-red 
detector [201]. gas chromatograph [201] or mass 
spectrometer [202.203] has been used. 
( i i ) urine Analysis 
urine analysis is used for detection of the 
volatiles [188.204] or their metabolites, for example 
benzoic acid [205] and its glycine conjugate hippuric 
acid(HA) for toluene monitoring [206.297]. methylhippuric 
acids (MHA) for xylenes [178.207.208] and mandelic acid 
for styrene monitoring [186]. Limitations are present on 
the use of some of these metabolites as markers for 
monitoring. For example. HA can be present as a normal 
dietary metabolite [206.209] and the wide range of normal 
levels present in urine will decrease the significance of 
toluene monitoring at low levels of exposure to toluene. 
However. previous studies have shown that HA in the 
majority of urine samples collected at the end of the work 
shift was correlated to exposure even when the toluene 
concentration in the air did not remain constant during 
the working day [180.209-211]. Another factor leading to 
a limitation is the metabolic formation of HA and MHA 
which are affected by the availability of glycine ln the 
rate limiting step [212]. Glycine can be consumed by the 
presence of high concentrations of toluene or xylene in 
blood or the presence of drugs such as salicylates [213]. 
Adding to these is a considerable variation of excretion 
of metabolites among individuals. as with mandelic acid 
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[181] where its excretion pattern is ~so modified in the 
presence of alcohol [185.186.209]. 
(iii) Blood Analysis 
The blood level of a solvent usually shows the best 
correlation with the atmospheric concentration. the amount 
absorbed (regardless of exposure route). the degree of 
retention and severity of the effect [195.214]. The 
literature is rich in references to monitoring different 
types of solvents in blood and correlation with other 
biological media and atmospheric exposure [178-181.188. 
209.212.215]. Blood biochemical and haematological 
parameters have also been studied for the purpose of 
monitoring [176.210.216-220] but due to the wide range of 
normal values for these parameters encountered in control 
groups. the correlation with the exposed group was rarely 
significant for the early detection of effects before 
occurrence of pathological changes. 
4. I .5 OCCUPATIONAL HAZARDS OF SOLVENTS IN PAINT 
Painters are usually exposed to a wide range of 
solvents present in the different types of paints. The 
degree of exposure is influenced by several factors as 
discussed in Section 4. 1.3. Concern over 
emerged health hazards to painters has 
literature. especially after the appearance 
which are symptoms related to the work 
described as "neuroasthenic syndrome" 
the long-term 
through the 
of clinical 
collectively 
[221.222] or 
"painter's syndrome" [221.223]. The symptoms are related 
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to memory loss such as poor short-term memory and an array 
of neuropsychological deficits, as well as symptoms 
related to personality changes which include depression, 
anxiety. pre-occupation with somatic concerns, hostile 
feelings and fatigue. These symptoms were found 
significantly higher than ln other groups of workers 
[221,224] as well as by experimental exposure of volunteer 
workers to various solvents used in paint material 
[190,222.225]. where the solvents were within the TLV 
levels in most of the studies. Other reported hazards are 
peripheral neuropathy due to exposure to hexane [226], 
elevation of morbidity due to diseases of the respiratory 
and genito-urinary systems [227]. glumerulonephritis 
[228]. severe morbidity due to elevation of 
carboxyhaemoglobin to levels that stress the 
cardiovascular system on exposure to methylene chloride 
[229.230]. encephalopathy and presenile dementia [221,231] 
as well as elevation of mortality due to malignant 
neoplasms [232]. 
At present. the neuroasthenic syndrome in a patient 
who has been exposed to solvents for at least 10 years, is 
recognized as a work-related risk when other diseases have 
been excluded reasonably well [222] and the resultant 
chronic toxic encephalopathy is accepted as an 
occupational disease entitling workers to compensation in 
Finland, Sweden, Norway and Denmark [231]. 
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4. I . 6 ANALYTICAL PROCEDURES FOR VOLATILES ANALYSIS 
Analysis of volatile solvents from biological 
samples can be done by one of the following procedures:-
(a) Solvent Extraction 
A low boiling point solvent is used to extract the 
volatiles from biological [233-236] or non-biological 
rna t e ria I [19 1 , 2 15 ] . The limitations of such a method are 
the dilution of the volatile analytes, loss of the more 
• 
volatile analytes during the concentration step, the 
masking of early eluting peaks by the solvent and adverse 
effects on the detection limit due to solvent impurities, 
which may also cause chromatographic interference. 
(b) Direct Aqueous Injection 
A biological fluid such as blood [237] is injected 
directly into the GC. This method is routinely used for 
blood alcohol analysis and can be suitable for VSA 
samples, but might not have sufficient sensitivity for 
occupational monitoring. 
(c) Head space Techniques 
The techniques and applications of head space 
ana lys is have been recent ly reviewed [209,238-242]. Two 
types of head space technique are commonly used for 
volatile enrichment followed by GC or GC-MS analysis. 
(i) Static Head Space Analysis 
The biological material, which is placed In a 
closed vessel, comes to equilibrium with its vapour at a 
controlled temperature. The sample in equilibrium within 
the closed system is normally a solution of the volatile 
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component of interest (i) in a liquid solvent. In an 
'ideal
' solution. the partial vapour pressure of the 
volatile component pi can be expressed by Raoult I sLaw 
as [241]:-
pi = Poi x Xi 
............ Equation 4.1 
where Poi is the vapour pressure of pure component i and 
xi is the mole fraction of component i in the solution. 
In most cases, however. molecular interactions exist in 
solution which leads to the expression:-
pi = Poi x Xi x Ai Equation 4.2 
where Ai is the activity coefficient of component i . The 
activity coefficient Ai depends on the nature of the 
component i and other components in the mixture. the mole 
fractions of all the components. the temperature and to a 
small extent on the pressure. For the dilute solutions 
used in trace analysis. the vapour pressure of the solute 
tends to vary linearly with its concentration. hence. the 
activity coefficient becomes a constant. 
Fi = ci x pi Equation 4.3 
where Fi is the chromatographic peak area and Ci 1S a 
constant which depens on the detector being used. Such 
behaviour is known as Henry's Law. Combining Equations 
4.2 and 4.3 the following relation is produced:-
Fi = ci x Poi x xi x Ai . . . . . . . . . . . . Equation 4.4 
or xi = Fil (Ci x Poi x Ai) . . . . . . . . . . . . Equation 4.5 
where 1 I (Ci x Poi x Ai) is a constant called the 
calibration factor which has to be determined 
experimentally. A volume of the head space 1S sampled for 
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chromatography. This technqiue is employed extensively 
for VSA samples [154.155.230.242-245] as well as 
biological monitoring [189.212.216] where relatively high 
levels of volatiles are encountered. 
(ii) Dynamic Head Space Analysis 
The sample is exposed to a continuous flow of gas, 
often passed through it as a stream of fine bubbles. As 
in static head space analysis. volatile substances 
partition into the gas. but because this is constantly 
being replaced. equilibrium is not achieved and the sample 
is purged or I stripped I of volatiles. The stripped 
volatiles are collected in a suitable trap which may be a 
cold trap. a solid adsorbent or a solid support coated 
wi th a liquid stationary phase. This technique has been 
extensively used for the analysis of volatiles and the 
metabolite profile in blood [246-248]' urine [249.250] and 
milk [251] as well as volatiles in water [192.252-254]' 
sediments [248] and other media [239.255] to name a few. 
In the present study dynamic head space analysis 
was evaluated for the measurement of volatile solvents 
present in painters and to 
pilot project for a future 
would include environmental 
assess solvent uptake as a 
comprehensive study. This 
and biological monitoring 
accompanied by clinical evaluation for the assessment of 
the hazards of paint solvents to these workers. 
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4. I I E X PER I MEN TAL 
4.11.1 MATERIALS AND REAGENTS 
N-alkanes, Cs to C14 (Analar grade) and diethyl 
ether (Aristar grade) were individually purchased from 
BDH. Other solvents were glass-distilled grade. Tenax-GC 
(35-60 mesh) was purchased from Altech (Lancashire, U.K.). 
4.11.2 INSTRUMENTATION 
Gas chromatography used a pye-Unicam model 204 gas 
chromatograph fitted with a glass capillary column 
(Chrompak cp-Sil 5, 25m x 0.5mm I.D. with a O.BJ,lm film 
thickness) and a flame ionization detector. GC-MS was 
carried out using the mass spectrometers described in 
Chapter 3.11. The scan parameters In the two mass 
spectrometers in full scanning mode were as follows:-
16F 70-250S 
Scan range 
(exponential down scan) 250-20 200-35 
scan rate 1.0 sec/decade 1.0 sec/decade 
Interscan delay 1.0 sec 0.3 sec 
4.11.3 CHROMATOGRAPHIC PARAMETERS 
The volatiles of interest which are present in 
paint are aliphatic hydrocarbons in the range Cs to 
A solvent extraction procedure was assessed for 
these hydrocarbons, but before that, several factors which 
influence chromatography were examined, including the 
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inJ·ection technique, analytl· 1 1 ca co umn and GC operating 
conditions including the carrier gas flow rate. 
4.11.3.1 INJECTION MODE 
Two modes were assessed 
(i) Direct injection mode on an SGE splitless injector. 
(ii) GroB split/splitless mode in which the split 
valve was closed for 1 min following injection. 
In both modes a helium pressure of 12 p.s.i. was 
applied at the head of the column to give a constant 
carrier gas linear velocity of 26.3cm/sec. The oven 
temperature was programmed from 40-1S0°C at 12°C/min. 
The injector and detector temperatures were 200°C and 
220°C, respectively. Nitrogen make-up gas flow rate was 
30ml/min. A standard mixture of Cs to C12 n-alkanes 
in diethyl ether was 
concentrations of about 
varying from O.5-10J.ll were 
prepared 
20J.lg/ml. 
tested for 
with individual 
Aliquots injected 
their ability to 
produce reasonable chromatographic peaks and base lines. 
The base line in both cases was not acceptable, so a 
packed pre-column was added before the capillary column. 
Other solvents such as n-pentane, acetone, methanol and 
petroleum spirit were similarly examined. 
4.11.3.2 PREPARATION OF PACKED COLUMNS 
Two empty glass columns (l.S and 3m x 4mm I.D.) 
were thoroughly cleaned with detergent and rinsed with 
water followed by acetone, then were filled with ethanolic 
potassium hydroxide (0.2% w/v) overnight to clean the 
inner surface of the columns. That layer was removed with 
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methanol and the columns were silylated with DMCS in 
toluene (10% v/v) followed by rinsing with methanol 
(lS0ml) and acetone (SOml) and were dr ied under a stream 
of nitrogen. Each column was packed with 3% SE-30 on Gas 
Chrom Q (80-100 mesh) and was conditioned from 40-300 0 C 
at 2°/min and kept at 300°C for 16 hours under a flow 
of the carrier gas of 30ml/min. The top of the 1.8m 
packed column was connected to the injector and the other 
end was connected Vla a I / 4 x 1/16 x 1/16 II T-piece 
to the capillary column and to an on/off vent valve. The 
flow through this valve was controlled by a needle valve 
and was set at 40ml/min. The flow rate in the capillary 
column was Sml/min. Aliquots (S-10~1) of standard mixture 
were injected while the initial oven temperature and time 
were changed to optimize chromatography and response after 
closing the venting valve. The solvent void time for 
diethyl ether and the retention time of octane were 
determined by connecting the packed column to the detector 
directly at the same carrier gas flow rate and at an oven 
temperature of at 40°C. 
The 1.8m packed column was replaced by the 3m 
column to offer better resolution of the early eluting 
peaks from the end of the solvent front. 
were conducted as above. 
Similar tests 
The following parameters were then selected: the 
venting valve was closed at 3 min with helium flow rate at 
40ml/min through the packed column and the column oven 
temperature was programmed from to at 
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12°/min, following an initial isothermal period of 3 mln. 
The reproducibility of retention time and response 
(peak height) were determined by repeated injection of 
10ul of the standard mixture, at a detector attentuation 
of 1 x 10 2 . 
4.11.4 BLOOD EXTRACTION 
A stock standard solution was prepared by adding 
100ul of each of the C8-C 12 n-alkanes to 
methanol/acetone (1/1 v/v) in a SOml volumetric flask. A 
blood sample was prepared by adding 100)11 of the stock 
solution to 25ml of whole blood to give a concentration of 
about 8)1g/ml of each. The blood sample (lml) was 
extracted with 3ml of diethyl ether, acetone or 
dichloromethane, by vortex mixing for 30 secs In a ISml 
screw-capped test tube. Another blood sample was 
extracted using diethyl ether as above, but the blood was 
saturated first with freshly crushed rock of ammonium 
carbonate. Then the mixture was centrifuged at 3000 rpm 
and an aliquot of the solvent (2ml) was collected into a 
Sml tapered receiving vessel which was graduated in O.lml 
units. The solvent volume was reduced to O.lml under a 
stream of nitrogen at room temperature. 
An aliquot of the residue (10)11) was injected into 
the GC as described in Section 4.11.3.2. Extraction 
efficiency was determined as in shown Equation 3-2, by 
comparing the peak height of the sample with that of 
similar standards prepared in diethyl ether. A solvent of 
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a similar volume was reduced as in the extraction 
procedure and was run on the GC to look for any 
interferences from each of the extracting solvents or from 
the blank blood. The reproducibility of the extraction 
was determined using ten replicate samples at 
concentration of 8pg/ml. These samples were prepared 
using Aristar grade diethyl ether as an extraction solvent 
and compared with similar standards on the GC. The above 
blood standard (8pg/ml) was diluted serially in blood down 
to 15ng/ml and Iml of each was extracted, as described 
above, to determine the detection limit and to construct a 
calibration curve. 
4.11.5 ANALYSIS BY GC-MS 
I. Two-Column Arrangement 
Analysis by GC-MS was aimed at improving the 
sensitivity of detection. The same column arrangement was 
reconstructed on the VG-16F mass spectrometer. The end of 
the capillary column was connected to the capillary 
interface and the vent at the end of the packed column was 
temporarily connected to the packed column interface (jet 
separator) to the mass spectrometer where the helium flow 
rate was 30ml/min. The GC oven was operated from 40°C 
( 3 mins isothermal) to 180°C at 12°/min. The 
retention times of the solvent and n-octane were 
determined then the connection to the packed column 
interface was replaced by an on/off valve with needle flow 
rate controller similar to the GC set-up. However, 
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reasonable peaks could not be obtained with this 
arrangement under the condtions described so analysis was 
conducted on the packed column alone and, later, by the 
desorption and trap method followed by capiliary column 
analysis. 
II. Analysis on the Packed Column 
The prepared packed column (3% SE-30, 3m) was 
connected via the packed column interface containing a jet 
separator and dump valve. The helium flow rate was set at 
30ml/min. Separation of the standard mixure was conducted 
with an oven temperature programmed from 80°C (1 mln 
isothermal) to 180°C at 12°/min. The reproducibility 
of response was determined by repeated injection (5pl) of 
a standard mixture containing 2J.lg/ml of each of the C8 
to C12 n-alkanes in diethyl ether. 
The detection limit 
was determined by serially diluting the above standard and 
applying 5ul of each standard solution. Analysis was by 
SIR of mass 57 for hydrocarbons and 68 for limonene 
(I.Std.). The channel dwell time was 100msec and the 
interchannel delay was 30msec. 
III. Desorption and Trap Analysis 
111.1 Preparation of Tenax-Column: Straight stainless 
steel columns (23cm x 4mm I.D) were cleaned with 
detergent, rinsed with water followed by acetone and dried 
in an oven at 100°C for 3 hours. Each column was packed 
with Tenax-GC (0.5g) and conditioned from 50°C-280°C 
at 5 o /min and kept for 2 hours at 280°C under a helium 
flow rate of 30ml/min. 
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A Tenax-GC column was placed in a desorption oven 
(Figure 4. I 1.1) at 250°C, composed of a steel tube 
(22cm x 7. 5mm I .D), insulated with glass tape and wound 
with a heating cord (Electrothermal Ltd.) which was 
controlled by a variable transformer. The carrier gas 
(He) flow rate was set at 20ml/min and passed to a cold 
trap (25cm x O.5mm I.D stainless steel tubing) in a 6 port 
valve (Valco Ltd.). The collected volatiles in the cold 
trap (cooled under liquid nitrogen) were then transferred 
to the GC column (CP-Sil-5 CB WCOT fused silica column, 
25m x O.32)lm I. D and 1.2 )1, film thickness), by 
electrically heating the sample loop which raised the 
temperature to approximately 10QOC in 15 sec. 
111.2 Testing the Desorption System 
The optimum flow rate of the carrier gas through 
the Tenax column and cold trap was determined by injecting 
on to the hot column 1)11 of a standard containing a 
mixture of n-alkanes at a concentration of 
32)lg /ml. The column was desorbed for 15 min, and then 
hydrocarbons collected in the cold trap were transferred 
to the GC column, which was operated from 40°C to 
lS00C at So/min with the helium flow rate at 3ml/min. 
The reproducibility of the system was determined by 
repeated injections of the above standard at a flow rate 
of 20ml/min and a desorption time of 15 min. 
111.3 Solvent Extracts 
An aliquot of diethyl ether (10}1l-1ml) , 
representing a blood extract, was tested for applicability 
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Figure 4. I 1.1 Schematic diagram of the desorption 
and inlet system used to transfer volatiles from the 
Tenax-GC column to the analytical GC column via a cold 
trap held in a 6-port valve. Electrical contacts [or 
heating of the cold trap were at the points indicated as + 
and -
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on the Tenax-GC column. The ether layer was first eluted 
ctt room temperature and later the Tenax column-was heated 
and the hydrocarbons were collected in the cold trap. 
Large volumes of ether were difficult to evaporate within 
a reasonable time. Eliminating the dilution effect of 
solvent extraction and improving sensitivity did not 
succeed using such a system. Dynamic head space analysis 
was evaluated to substitute the solvent extraction method. 
4.11.6 DYNAMIC READ SPACE (DRS) ANALYSIS 
I. Preparation of Standard Solutions 
internal standard of limonene was A 
prepared 
distilled 
working 
at a concentration of 32)Jg/ml in reboiled 
solution in water by dilution of a stock 
solvent, and a working standard solution of each n-alkanes 
from C
s 
to C12 was prepared in blood at a 
concentration of 32ng/ml. The elution flasks were cleaned 
with detergent after use followed by soaking in chromic 
acid overnight to get rid of organic material then washing 
in detergent and rinsing with distilled water. All 
glassware and 
until needed 
pipettes were kept ln an oven at 100°C 
to reduce the surface condensation of 
volatiles from the laboratory environment. 
II. Extraction Method 
The apparatus used for DRS extraction was 
previously described [256,257]: a schema tic diagram is 
presented in Figure 4. I 1.2. The extraction procedure was 
conducted as follows: the elution flask and condenser 
Charcoal 
Liquid 
N 
trap 
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Figure 4.11.2 Schematic diagram of the apparatus 
used to strip solvents from blood and collect them in a 
Tenax-GC column. 
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were purged with helium at a flow rate of 100ml/min at 
in the water bath for 5 min before use. The helium 
supply was cleaned before use with a charcoal trap 
(Chrompack U.K.). A conditioned Tenax-GC column was then 
connected to the condenser outlet using a Swaglock 
coupling wi th Vespel ferrules. A sample of whole blood 
(lml) was then transferred to the elution flask and 10JIl 
of the internal standard solution was added and mixed with 
the blood. The flask was then connected to the condenser 
with the aid of retaining springs. Helium elution was 
then started for a few seconds to allow the foam formation 
in the sample to reach the middle of the flask, then the 
flask was lowered into the hot water bath to allow the 
blood to coagulate. Elution was then resumed at a flow 
rate of 40ml/min. The helium was collected quantitatively 
in 
the 
the gas 
end of 
burette. The Tenax-GC column was 
the elution and sealed with two 
blanking pieces fitted with Vespel ferrules. 
removed at 
Swagelock 
The sea led 
traps were kept at room temperature until analysis. Each 
sample was analysed as described in Section 4.11.5.111. 
I I I . Source of Contamination in the Analysis 
Large 
hydrocarbons 
extraction 
interefering peaks of aromatic and 
appeared in the blank samples 
aliphatic 
of both 
and desorption system. The source of 
contamination was investigated by collecting volatiles 
from about 800ml of helium at each of the possible sources. 
111.1 Desorption System: the carrier gas to both the 
analytical column and desorption system were tested by 
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collecting volatiles from the helium in the cold trap 
under liquid ni trogen for each individually. A charcoal 
trap (Chrompack U.K. Ltd.) was placed in the common supply 
stream to try and eliminate the contamination and all 
access ible tubing was replaced by new tubing which was 
cleaned by flaming it under a flow of nitrogen at 
lOOml/min. connections were made wi th the shortest 
possible lengths of tubing. 
Later, the contamination was eliminated from the 
supply line by incorporating another cold trap immediately 
before the inlet system. 
111.2 Extraction System: The background impurities in 
helium were collected in a clean Tenax-GC column from the 
following points: 
i. Apparatus blank sample collected with the usual 
extraction procedure. 
i i . At the exit of the charcoal trap. 
iii. Before entrance to the charcoal trap. 
iv. From the helium cylinder at the regulator exit. 
The new tubing and charcoal trap did not eliminate 
the contamination. A cold trap of Sm x l/SI1 copper 
tubing was made and later was substituted by another trap 
made from a 10m x O.5mm I.D stainless steel coiled tube 
which was placed under liquid nitrogen at the time of 
extraction. 
V Determination of Stripping Volume I . 
The volume of helium which was required to produce 
efficient extraction of n-alkanes from blood 
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was determined by extracting lml of blood containing 
32ng/ml of each hydrocarbon and 32ng of limonene (I.Std) 
as described above, with helium volumes of 400, 600, 800, 
1000 or 1200ml. The extraction efficiency was estimated 
by comparing the peak areas (as in Equation 3-2) of each 
of the hydrocarbons with those obtained with a similar 
non-extracted standard in diethyl ether where 1~1 was 
applied directly to the desorption system. The 
reproducibility of the extraction was measured by repeated 
extraction of the above blood sample using an elution 
volume of BOOml. 
4.11.7 ANALYSIS OF PAINT MATERIAL 
An aliquot (lg) of paint used by the painters under 
study was placed in a 6ml hypovial which was then closed 
with a rubber cap and an aluminium crlmp seal. It was 
placed 1n a heating block at 40°C for 20 minutes and 
10pl of the head space was taken by a warm glass gas-tight 
syringe and applied to the Tenax-GC column. This was 
desorbed and analysed as described above. 
4.II.B ANALYSIS OF BLOOD FROM PAINTERS 
Blood samples (3ml each) were collected from 7 
painters on two occasions. The first collection was at 
the beginning of the working day on Monday and the second 
was at the end of the working day on Friday. The samples 
were 
kept 
received in a lithium-heparin plastic tube and were 
at 4°C until analysis. The analysis was conducted 
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as described earlier by DHS extraction with an elution 
volume of 800ml. The analysis by GC-MS on the VG-70-250S 
instrument was by the full scanning mode. Reboiled 
distilled water from a sampling vial and a blank apparatus 
extraction were analysed at the same time. 
Quantitation was peformed by measuring the peak 
areas in reconstructed ion chromatograms of the following 
masses: m/z 68 for 
limonene (I.Std), 91 for toluene and xylenes, and 105 for 
higher alkyl benzenes. The ratio of each response to the 
I. Std was taken. The ratios of the two groups of samples 
were compared by Student 1sT-test. Quantitation of the 
amount of hydrocarbon present in the blood sample was 
carried out for those substances whose ratios showed 
significant differences between groups by comparing with 
standards prepared in blood. 
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4.111 RES U L T S 
4.111.1 INJECTION MODE 
The direct injection mode on the capillary column 
produced a base line which remained high, even with a 
small injection volume (O.5pl), and the solvent peak 
obscured early-eluting peaks. This was more prominent in 
subsequent samples following repeated applications. The 
hydrocarbons were dissolved in other solvents, such as 
n-pentane, acetone, methanol and petroleum spirit, to try 
and reduce this problem but there was no improvement. 
However, the peaks were of good quality and the resolution 
was good. 
The GroB split/splitless mode of injection 
permitted large volumes of solvent to be introduced while 
still bringing the baseline back to the origin after the 
solvent front, but the peaks were relatively small 
especially the octane and nonane peaks, indicating both 
inefficient solute transfer to the column and negative 
sample bias with respect to more volatile components. 
4.111.2 PACKED AND CAPILLARY COLUMNS 
It took more than 5 min for the baseline to return 
to the origin after injecting 5).11 of diethyl ether at a 
carrler gas flow rate of 40ml/min and oven temperature of 
400C. While both packed columns offered retention of 
applied 
slightly 
hydrocarbons, the 
bigger margin of 
longer column permitted a 
separation between the solvent 
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front and the octane peak although in both columns this 
peak appeared on the tail of the solvent peak. The 
venting valve at the end of the packed column was closed 
after 3 min whi Ie the oven was at 40°C, allowing 
reasonable clearance of the solvent front. However the 
tail of the solvent front used to reappear after closure 
of the vent valve, especially with larger volumes of 
solvent injection (10)11 ) and the early-eluting peak 
(octane) eluted on the solvent peak tail (Figure 4.1II.l). 
The reproducibility of retention time and response 
are listed in Table 3.111.1. 
Table 3.111.1: 
standards. 
Reproducibility of analysis of n-alkane 
Rt(min) c.v. (%) c.v. (%) of RRt. Analyte (Rt) response 
Octane 3.7 12.1 14 0.50 
Nonane 4.9 11.2 14 0.67 
Decane 6.7 7.4 13 0.92 
Undecane 8.0 1.3 12 1.10 
Dodecane 9.9 1.2 11 1.35 
Limonene 7.3 5.2 14 1.0 
Tetradecane 12.1 3. 6 S 1.65 
C.V. (%) is the coefficient of variation. RRt 1S the 
relative retention time. 
4.111.3 BLOOD EXTRACTION 
The extraction efficiency of CS-C 12 alkanes and 
the internal standard from a blood sample using 
dichloromethane or acetone ranged from 35-62% and the 
diethyl ether extraction efficiency was 60-70%. In 
general, higher efficiencies were obtained for the higher 
hydrocarbons. Diethyl ether extraction where ammonium 
l·ncluded produced efficiency better than SO\ carbonate was 
-1 81 -
~ Time (min) 
Figure 4. I I 1.1 GC trace of n - alkane hydrocarbon s 
CS - C12 where 1 0UL of solvent containing the s tandard s 
were applied at the inlet of the two - column arrange me nt 
and the vent valve at the end of the pack e d c olumn wa s 
clos ed after 3min. The oven temperatur e wa s p r ogr amme d 
from 400 to lS Oo C at 120/min aft e r a 3m i n i s o t h ermal 
period at 40°C. 
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for the hydrocarbons examined (Table 4.111.2). The small 
interfering peaks early in the chromatogram, which were 
most prominent in the diethyl ether blank, became 
negligible, when Aristar grade solvent was used instead of 
Analar grade. Two small unidentified peaks, present in 
extracts of blank blood, eluted after nonane and decane, 
respectively, without interference. 
Table 4.111.2: Extraction efficiency of n-alkanes 
from Iml of blood by 3ml of diethyl ether. 
Octane Nonane Decane Undecane Dodecane Limonene 
Ext.Eff 70 91 88 81 83 81 
C.V. (%) 18 17 12 11 11 14 
The GC detection limit for the extracted blood was 
approximately 125ng/ml for each hydrocarbon with peak-to--
noise ratios of 3: 1. The calibration curve (for nonane) 
was linear over the range 125ng to 8ug/ml with the 
regression equation: 
Y = 1.78 x 10- 4 + 0.73X Equation 4.5 
where Y is the response ratio and X is the concentration. 
The correlation coefficient (r) was 0.98 
4.111.4 ANALYSIS BY GC-MS 
4.111.4.1 Two-Column Arrangement 
The solvent front started to elute from the packed 
column (3mm) after 28 secs and octane at 1:48 minutes, so 
the vent valve was closed at 1:30 minutes without loss of 
the early eluting peak, but after closure of the vent 
valve, residual solvent led to a rise in the base line due 
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to loss of the split ratio. Peak separation was good but 
peaks had a broad shape due to band broadening in the 
pre-column. Attempts to increase the flow rate to sharpen 
the peak were limited by the adverse effect on the vacuum 
pressure in the mass spectrometer. However. sharp peaks 
could not be obtained through the capillary interface by 
this arrangement. 
4.111.4.2 Packed Column Analysis 
The solvent front ln the packed column was 
eliminated by the jet separator valve in the packed column 
interface. which was opened after 1:5 minutes from the 
start. There was still a prominent solvent peak tail at 
this time and the first peak (octane) eluted on it. The 
peaks were well separated and had a reasonable peak shape 
for a packed column. The repeated application of 5)11 of 
2pg Iml standard solution in diethyl ether showed 
reproduc i ble res ponse where the coef f ic ien t of var ia t ion 
ranged from 3.7-9% (Table 4.111.3) and that of retention 
time varied from 6-11%. 
Table 4.111.3: The reproducibility of response and 
retention time in the analysis of n-alkanes by GC-MS with 
a 3m packed column. 
Coefficient of variation (%) 
Octane Nonane Decane Undecane Dodecane Limonene 
Height 3.7 7 6 5.8 3 6 
RT(min) 11.8 9 . 5 8.2 7.3 6.5 8.6 
Ratio(r) 3 5 3 3 6 1 
Ratio: Peak height of standard over the peak height of 
I.Std. 
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Although the solution had a similar concentration of each 
hydrocarbon, the chromatogram showed the phenomenon of 
increasing peak size with increasing molecular weight, due 
to a corresponding increase in the efficiency of the 
separator. 
The detection limit obtained by SIR for a 
standard solution 1n diethyl ether (5).11) was 15ng/ml 
(75pg on-column). Application of a larger sample volume 
to improve detection led to an increase in the solvent 
tail which in turn led to the octane and part of the 
nonane peak being obscured. 
4.111.4.3 Analysis by Desorption and Trap Method 
The flow rate of helium, which was optimum for 
eluting the hydrocarbons from the Tenax-GC while enabling 
them to be collected efficiently in the cold trap, was 20 
ml/min for 
sUfficient 
effectively. 
variation) 
15 minutes. A lower flow rate was not 
to elute decane, undecane and dodecane 
The reproducibility (coefficient of 
under these conditions for six replicate 
applications of 1).11 standard solution containing 32ng of 
each hydrocarbon and internal standard ranged from 
4.5-7.5%. Higher flow rates produced poor reproducibility 
and inefficient trapping. Application of a larger volume 
of ether (10)11) on the Tenax-GC required 10 minutes to 
clear the solvent from the column, which was not 
reproducible since it led to blocking of the cold trap by 
freezing of the residue of diethyl ether. So a larger 
sample volume required a longer time and caused more 
frequent blockage of the cold trap. 
4.111.5 
4.111.5.1 
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DYNAMIC HEAD SPACE ANALYSIS 
Source of Contamination in the Analysis 
Severe contamination by aliphatic and aromatic 
hydrocarbons was found in both extraction and desorption 
systems. Examples of the aromatic materials were benzene, 
toluene, xylenes (0. m and Q-xylene) benzonitrile and 
alkylbenzenes (C 2 -C 4 substrated benzenes); other 
contaminants included straight and branched alkanes, 
dichloromethane. ether, chloroform and acetone. All 
appeared within the normal temperature programme run of 
the column. 
The source of contamination was from almost all 
parts of the two systems. Charcoal traps were found to be 
useless with this huge source of contamination. Cleaning 
the carrier gas by passing it through a narrow diameter 
s tee I tub e ( 0 . 5 mm I. D.) i mm e r sed i n I i qui d nit r 0 g en was 
SUfficient as a temporary solution at the time of 
analysis. although later in the study this trap started to 
be inefficient in the extraction system even though the 
tubing was kept in a closed circuit without exposure to 
the atmosphere. 
4.111.5.2 Helium Stripping Volume 
The volume of helium which stripped more than 90% 
blood sample was 800ml of the hydrocarbons in the 
(Figure 4.111.2). Cooling the condenser led to decreased 
recoveries. especially for the higher hydrocarbons. None 
of the hydrocarbon broke through the Tenax column within 
the range of helium volumes examined. The amount of water 
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Figure 4.111.2 Recoveries of n-alkane hydrocarbons 
(CS-C12) and limonene (I.Std) from blood using 
different helium stripping volumes. 
vapour enter ing 
did not have 
especially if 
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the Tenax-GC 
a detrimental 
the trap was 
column 
effect 
flushed 
was very little and 
on the procedure, 
with helium for 5 
minutes before heating to desorb the volatiles. The 
reproducibility (coefficient of variation) of the 
procedure (extraction and desorption) determined by five 
replicate samples ranged from 5 
materials. 
4.111.6 PAINT CONSTITUENTS 
11% for different 
Both aliphatic 
the paint 
and aromatic hydrocarbons were 
present in material, these constituents are 
presented in figure 4.111.3 and listed in Table 4.111.4. 
4.111.7 ANALYSIS OF PAINTERS' BLOOD 
The chromatograms obtained 
showed numerous 
hydrocarbons. At 
present to a 
peaks 
the 
lesser 
of both 
same time 
extent 
for the blood samples 
aromatic and aliphatic 
these constituents were 
in the blank samples. 
Table 4.111.5 presents the ratio of the most prominent 
peaks to the internal standard (peak areas) for each blood 
sample in the two groups and for the blank vial sample. 
The ratios for the blank were least for C9 -C 11 
n-alkanes and ethyldimethylbenzene and less than any of 
the ratios for the first blood collection. The ratios of 
these C
9 
to C12 hydrocarbons, trimethylbenzene 
and ethyldimethylbenzene showed higher values 
isomers 
In the 
second group for each individual case, but only nonane and 
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ethyldimethylbenzene showed a probably significant 
increase by student's t-test (unpaired), when the means of 
each group were compared. For the others, the 
significance was not proven. Toluene, 
heptane did not follow any special 
significance test (Paired t-test) [258] 
xylenes, hexane and 
pattern. Another 
was carried out on 
the ratios observed for each person taken at the beginning 
and at the end of the week (Table 4.111.5). This test 
showed a significant difference for 
substances: nonane, undecane, dodecane, 
and ethyldimethylbenzene, where the 
significance was P~ 5%. 
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Figure 4.111.3 GC-MS analysis of a paint headspace sample. Condition were described 
in Section 4.11.5.111.2 The identity of thQ major peaks is presented in Table 4.111.4. 
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Table 4.111.4 consti tuents of the paint material used 
by the painters under study. 
RETENTION INDEX 
A. ALIPHATIC 
500 
550 
560 
600 
630 
658 
667 
677 
681 
695 
700 
722 
745 
758 
764 
783 
800 
846 
858 
900 
916 
927 
932 
938 
951 
960 
971 
983 
990 
1000 
1023 
1050 
1077 
1100 
1109 
1130 
1144 
1200 
1224 
1230 
COM P 0 U N D SCAN NUMBER 
HYDROCARBONS 
n-pentane 
methylpentane 
2-butanone 
n-hexane 
methylpentane 
cyclohexane 
2,4-dimethylpentane 
3-ethylpentane 
1,2-dimethylcyclopentane 
4,4-dimethyl-2-pentane 
n-heptane 
1,2,3-trimethylcyclopentane 
2-methylheptane 
3-methylheptane 
methylcycloheptane 
l-methyl-2-ethylcyclopentane 
n-octane 
2,4-dimethylheptane 
2,5,5-trimethYl-l-hexane 
71 
178 
318 
n-nonane 490 
3-methyloctane 
3-ethyl-3-heptane 
4-ethylheptane 
3-ethylheptane 
1_methyl-3-isopropylcycloheptane 
isopropylcyclohexane 
isobutylcyclopentane 
3-methylnonane 
4-methylnonane 
n-decane 670 
pentylcyclohexane 
5-methyl-2-decene 
4-methyl decane 711 
n-undecane 845 
2,3,7-trimethyl-4-octane 
butylcycloheptane 
2,4,6-trimethyloctane 
n-dodecane 
4_methyl-1-undecene 
4_methylpentylcyclohexane 
B. AROMATIC HYDROCARBONS 
635 
732 
875 
890 
920 
benzene 
toluene 
Q-xylene 
m-xylene 
o-xylene 
._--------------------------_._-- ---
250 
397 
414 
450 
Table 4.111.4 
RETENTION INDEX 
985 
988 
1010 
1058 
1082 
1140 
1152 
1158 
1270 
1281 
1290 
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continued 
COM P 0 U N D SCAN NUMBER 
trimethylbenzene 
trimethylbenzene 
1,2-diethylbenzene 
sec-butyl benzene 
sec-butyl benzene 
4-ethyl-l,3-dimethylbenzene 
4-ethyl-l,2-dimethylbenzene 
4-ethyl-2,3-dimethylbenzene 
1,3-diethyl-5-methylbenzene 
4-phenybutan-l-ol 
2-methyl-l-butenyl-benzene 
589 
634 
685 
735 
Table 4.111.5: Results of analysis of paired blood samples from painters. 
n- n-
hexane heptane 
Case: 
1.87 
1. 37 
Case: 
---
0.65 
1.2 
Case: 
2.51 
ll.l 
1 
2 
3 
0.23 
0.46 
0.38 
0.27 
0.19 
0.35 
Case: 4 
0.78 0.63 
0.75 0.12 
Case: 5 
3.8 0.53 
1.16 0.33 
Case: 6 
2.7 0.91 
1.6 1.56 
Case: 
---
ll.3 
5.0 
Blank 
---
1.6 
7 
0.32 
3.4 
0.22 
n-
octane 
1.0 
0.92 
0.35 
1.1 
0.67 
2.4 
0.56 
0.5 
2.2 
1.2 
0.86 
1.1 
0.3 
2.1 
0.14 
P value x 100~ ** 
tl-
nonane 
0.11 
0.44 
0.06 
0.51 
0.07 
0.24 
0.18 
0.34 
0.14 
0.5 
0.32 
1.0 
0.2 
1.4 
0.03 
1.3 
RAT I 0 
n- n-und-
decane ecane 
1.6 
1.7 
1.2 
2.6 
1.2 
4.0 
1.3 
1.5 
2.9 
2.6 
2.0 
2.6 
2.5 
1.9 
0.3 
21 
0.4 
0.6 
0.26 
0.7 
0.3 
0.5 
0.6 
0.8 
0.5 
1.1 
0.7 
1.5 
0.6 
0.4 
0.1 
4.ll 
o FAN A L Y T E T 0 I. S T D * 
C - C - C- C-
n-dod- m- n- 0- 3 3 3 4 
- toluene - L- -
ecane xylene xylene xylene benzene benzene benzene benzene 
1.3 
0.9 
1.0 
0.2 
0.7 
2.3 
0.4 
0.9 
1.9 
1.4 
1.0 
1.5 
1.6 
0.9 
0.5 
99 
1.0 
1.5 
0.9 
1.2 
0.2 
2.1 
6.1 
0.6 
1.8 
1.5 
4.0 
5.4 
2.3 
0.5 
1.7 
1.3 
1.5 
0.9 
1.7 
1.5 
3.6 
1.7 
0.9 
2.5 
4.0 
4.0 
4.1 
3.9 
7.9 
3.2 
1.9 
2.6 
1.6 
3.1 
2.6 
4.6 
2.3 
1.8 
3.2 
6.5 
6.2 
5.6 
6.7 
9.9 
6.4 
0.5 
1.0 
0.4 
1.1 
0.7 
1.2 
1.0 
0.7 
0.9 
1.9 
2.6 
2.4 
1.6 
4.5 
1.1 
0.2 
0.8 
0.2 
0.9 
0.3 
0.6 
0.7 
0.7 
0.6 
1.3 
1.6 
2.0 
0.9 
1.9 
0.2 
1.6 
0.2 
0.5 
0.2 
0.7 
0.3 
0.5 
0.3 
0.8 
0.6 
0.7 
1.6 
1.9 
0.9 
2.1 
0.3 
1.9 
0.9 
2.3 
0.9 
2.2 
1.0 
1.7 
1.0 
1.9 
1.8 
3.7 
3.8 
4.0 
3.3 
5.9 
1.4 
5.3 
0.27 
1.1 
0.41 
0.96 
0.37 
0.42 
0.54 
1.1 
0.67 
1.86 
0.91 
1. 85 
1.6 
2.0 
0.23 
4.7 
* Results aloe given for paired samples in each case. Upper lines represent results for samples Laken <It Ute 
beginning of lhe week, and lower line these taken at the end of the week. 
** P is the probability value. 
I-' 
1.0 
N 
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4. IV DIS C U S S ION 
4. IV. 1 INTRODUCTION 
The volatile analytes which represent an exposure 
hazard to painters and which were of interest to this 
project have molecular weights in the range 100-200. They 
are therefore in a critical position which is dissimilar 
to the one occupied by low molecular weight volatiles 
which can easily be analysed by simple headspace methods 
[155,225,243,245,259,260] or direct analysis of a solution 
by GC [237]. 
At the same time they require special attention 
during a solvent extraction procedure because at the end 
of the extraction the solvent cannot be evaporated to 
complete dryness, otherwise all the analyte will be lost. 
'I'he volume can only be reduced to a reasonable Slze, to 
minimize the dilution of the analyte, which might result 
in a procedure with insufficient sensitivity. 
4. IV. 2 OPTIMIZATION OF CHROMATOGRAPHIC PARAMETERS 
In GC 
factors have 
chromatography 
analysis of this type 
to be controlled 
characterized by 
of extract, several 
to produce good 
sharp, narrow and 
reproducible peaks. These will yield improved resolution 
which benefits qualitative and quantitative analysis. 
These factors include: 
1. Analytical Column 
2. Injection Mode 
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3. Detection Method 
4. Operating conditions, including flow rate of 
the carrier gas and temperature of the 
injector, column oven and detector ovens as 
discussed in Chapter 2. 
Capillary columns in general have very good 
chromatographic efficiency. A non-polar phase such as 
CP-SIL 5 (a chemically-bonded dimethylsilicone) is a 
suitable choice for non-polar hydrocarbons. especially 
with a film thickness of O.8-1.2p, which is preferable for 
the range of hydrocarbons of interest and provides better 
separation of low boiling point compounds and increased 
sample capacity. 
Although sharp peaks were obtained for higher 
hydrocarbons in the direct injection (splitless) mode, 
this was not suitable for the present procedure since the 
solvent peak tail obscured octane and nonane which led to 
irreproducibility in quantification, especially at low 
concentrations. 
The GroB split/splitless mode of injection 
produced sharp peaks without the solvent peak obscuring 
early eluting peaks. However, this mode is not suitable 
either since the low molecular weight hydrocarbons were 
lost after the split was opened, similar to the solvent, 
resulting in reduced peak height. In both modes of 
injection 
analyte at 
described 
the head 
above, 
of the 
the solvent should 
column. However, 
focus the 
the early 
peaks were broad in the direct injection mode because the 
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I solvent effect I was not operating, while in the other 
mode part of the analytes were lost with the solvent. 
A packed pre-column was also evaluated. The aim of 
connecting the packed column, containing a stationary 
phase (SE-30) which was similar to the capillary column 
phase, was to permit 
provide retent ion of 
This technique was 
inexpensive home-made 
multi-dimentional GC 
application of larger samples and 
analyte while eluting the solvent. 
tried during this study with an 
system similar to 
and column swi tching 
that 
which 
used in 
are now 
commercially available. warming of the column oven helped 
eliminate the bulk of the solvent within a reasonable 
time. Where the n-alkane solution was applied in 10pl of 
diethyl ether and the split valve was left open for 3 min, 
the shape of the early eluting peaks was not adversely 
affected. However, this technique affected the 
reproducibility of the retention times of both octane and 
nonane (Table 4.111.1). 
To improve on this would require very reproducible 
timing of injection and closing the vent which would best 
be obtained by automation. The relatively high 
coefficient of variation of the response (8-14%) is not a 
hindrance to using such a system since the response can be 
corrected with the presence of an internal standard 
(1 imonene) which has simi lar behaviour. Tetradecane was 
tested as an internal standard but was found to be 
impractical due to its low volatility and also because it 
was later found to be present in the background. 
4. IV. 3 
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SOLVENT EXTRACTION 
In 
test 
selecting a suitable solvent for extraction of 
the hydrocarbons the following criteria were 
desirable. The chosen solvent needed to be a very 
volatile, high grade solvent with very low concentrations 
of volatile impurities as well as being a good solvent for 
the analytes. N-alkanes C9 to C12 are relatively 
soluble in the selected solvent, diethyl ether 
(Table 4.IV.6), which provided good solubility and 
extracted the hydrocarbon effectively from blood samples. 
The addition of ammonium carbonate to the blood sample 
produced higher extraction efficiency which can be 
explained by the salt saturating the aqueous phase and 
therefore increasing the ether/water partition coefficient 
[261]. 
Solvent extraction was performed ln non-silanized 
glass tubes. If silanized tubes were used, the extraction 
efficiency was lower due to n6n-polar interactions between 
the silanized glass and the hydrocarbons. This problem 
was encountered when such glass tubes from the general 
laboratory store were used inadvertently. Silanization 
was removed by washing the glass in 5M sodium hydroxide 
solution. 
The high coefficient of variation for both octane 
and nonane(18%) is due to their high volatility relative 
to the other hydrocarbons (Table 4.IV.6) causing variable 
losses during the solvent volume reduction. Further 
solvent reduction at room temperature would result in 
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Table 4.IV.6: Physical properties of to 
aliphatic and aromatic hydrocarbons. 
Compound 
octane 
nonane 
decane 
undecane 
dodecane 
toluene 
Q.-xylene 
m-xylene 
-p-xylene 
r,2,3-trimethyl-
benzene 
1,2,4-trimethyl-
benzene 
1,3.5-trimethyl 
benzene 
methylethyl-
benzene 
1,2-diethyl-
benzene 
1,3-diethyl-
benzene 
1.4-diethyl-
benzene 
propyl benzene 
butylbenzene 
125 
150 
174 
195 
216 
110 
144 
139 
138 
176 
169 
164 
161 
183 
181 
183 
159 
183 
Density 
3 g/cm 
0.70 
0.71 
0.73 
0.74 
0.74 
0.88 
0.86 
0.86 
0.86 
0.89 
0.87 
0.86 
0.86 
0.88 
0.86 
0.86 
0.86 
0.86 
M.P Solubility 
m. wt. CO w/al/eth 
-56 
-53 
-24 
-25 
-9 
-94 
-25 
-47 
13 
-25 
-43 
-44 
-95 
-31 
-83 
-42 
-99 
-88 
114 
128 
142 
156 
170 
92 
106 
106 
106 
120 
120 
120 
134 
134 
134 
134 
120 
134 
i/v/s 
i/v/s 
i/v/s 
i/v/s 
i/v/s 
i/v/s 
i/v/s 
i/v/s 
i/v/s 
i/v/s 
i/s/s 
i/v/s 
i/v/s 
i/v/s 
i/v/s 
i/v/s 
i/v/s 
i/v/s 
TLV 
(TWA. 
ppm) 
500 
200 
100 
100 
100 
100 
100 
* Solubility in water/alcohol/ether: v = very soluble; 
s = soluble; i = insoluble [263,264]. 
** TLV (TWA) is time weighted average TLV 
further losses and even lower reproducibility. Similar 
ext r act ion pro c e d u res, us in g Q.- pen tan e a san ext r act i n g 
solvent for petroleum fuel in blood have been described 
[244,262] where the coefficient of variation ranged from 
5-24%. This procedure might still be used for routine 
application with inclusion of an internal standard to 
correct for losses. The sensitivity of the method that 
was obtained by GC analysis using flame 
ionisation 
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detection was not acceptable for occupational monitoring 
where lower levels might be present. Slight improvements 
could be made by recovering all the diethyl ether extract 
by freezing the centrifuged mixture. when the solvent 
could be recovered by decanting it without risking 
contamination from blood components. 
4. IV. 4 ANALYSIS BY GC-MS 
Analysis of the extract by GC-MS was aimed towards 
enhancing 
two-column 
the sensitivity of 
arrangement could 
the procedure. The 
not be duplicated 
successfully on the mass spectrometer where the source 
pressure requirements limited the higher carrier gas flow 
ra tes through to produce good chroma tography. simi lar to 
that obtained by GC analysis. Packed column GC-MS 
provided good chromatography: the bulk of the solvent and 
the excess of the carrier gas were eliminated by the jet 
separator. Analysis by SIR improved the sensitivity down 
to 15ng/ml and there was no interference in the peaks of 
interest. The reproducibility of such procedures was very 
good especially with an internal standard to correct for 
variation. However. the retention times of octane and 
nonane showed a higher variation relative to the others 
caused by slight variation in the opening time of the 
separator valve. as discussed in Chapter 2. The 
disadvantages of applying larger volumes of sample extract 
were the masking of early eluting peaks. which would limit 
the detection of small quantitites of analyte passing into 
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the source, and the danger of exceeding the limits on the 
source pressure that can be tolerated by the mass 
spectrometer. 
4. IV. 5 DESORPTION AND TRAP 
The aim of using a trap column packed with Tenax-GC 
was to permit a large volume of extract to be applied 
where by passing the carrier gas the diethyl ether would 
elute at room temperature as it is highly volatile, and 
the less volatile analytes would be retained. The 
analytes were then transferred by desorption at high 
temperature and a relatively high flow rate to be 
collected in a cold trap, followed by transfer of the 
analytes to the capillary column. Care was taken with the 
geometry and plumbing of the cold trap in order that the 
analyte would be concentrated as a sufficiently narrow 
band in the inlet section of the column. 
Tenax-GC is an organic polymer material and was 
selected due to its catalytic inertness, toleration of 
high temperatures (300 0 ) wi thout deterioration [192] and 
excellent retention characteristics for volatiles which 
can be reversibly desorbed [192,239,251,265]. In this 
assay the limi ting factor for the flow rate during the 
desorption stage was the narrow diameter of the cold trap 
which resulted in a high linear velocity through the trap 
and inefficient trapping at high flow rates. This had to 
be weighed against the desorption time, so that all 
analytes would be sufficiently desorbed and trapped within 
a reasonable time. An assay of this type showed excellent 
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reproducibility. However. the final limiting factor for 
its application was the impracticality of applying larger 
volumes of extract (to improve sensitivity and reduce the 
coefficient of variation observed by reducing the diethyl 
ether extract) which required long periods to purge the 
solvent and resulted in blockage of the cold trap by the 
diethyl ether, if insufficient time was allowed for the 
solvent to be eluted. 
4. IV. 6 DYNAMIC HEAD SPACE 
Dynamic head space elution methods have been 
extensively applied for extraction of volatiles from 
flu ids and b i 0 log i c a I rna t ric e s ( see Sec t ion 4. I . 5) whe r e 
it proved to be reliable. Effective stripping of a blood 
sample elutes the volatiles into a Tenax-GC column as in 
the above procedure, after which the volatiles are totally 
transferred to the analytical column. Also. they are 
transferred in a narrow band, without the presence of a 
solvent front which usually masks early eluting peaks. 
Hence the sensititivy will be greatly improved. To ensure 
high reliability and sensitivity. the extraction and 
analytical systems should be freed from contamination as 
much as possible. 
4.IV.6.1 Sources of contamination 
The contaminating materials which were present in 
the tubing and regulators of both systems included 
aromatic hydrocarbons such as benzene. toluene. Q. m and 
o-xylene. alkylbenzenes and aliphatic hydrocarbons (both 
unsaturated and saturated) in the range 
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Most of these materials are present in paint and possibly 
in blood obtained from painters. The origin of these 
materials is thought to be from atmospheric organic 
pollutants which might originate inside the laboratory, 
especially xylenes, toluene, acetonitrile, dichloromethane 
and other solvents, or which might be released in the 
vicinity of the laboratory and circulated through the 
laboratory suite via the ventilation system, for example, 
car exhaust, or from general building work in progress in 
the Department, including painter work, during the period 
of study [191,193,266,267]. These contaminants entered 
the extraction system while the tubing was opened and 
exposed to the atmosphere. Although parts of the 
apparatus were exchanged with shorter lengths of clean 
tubing, the contaminating peaks were still present. This 
necessitated either changing all tubing and regulators and 
re-starting with a clean cylinder, or else, as a temporary 
solution inserting a cold trap just before the helium 
supply point to the manifold supplying the inlet systems. 
Attempts to use adsorbent traps containing activated 
charcoal failed as these were soon overloaded and became 
themselves a source of contamination. Cold traps using 
wide-bore tubing did not trap the contaminants very 
efficiently, but a long piece of tubing (10m x 0.5mm i.d.) 
provided a good trap. However, after repeated cooling and 
bringing up to room temperature while it was not in use, 
it later started to fail and to allow contaminant peaks to 
break through once more. 
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4. IV. 6 . 2 
The 
Helium Stripping Volume 
extraction procedure was similar to that 
described for volatiles in blood samples from fire 
fatality cases [246,247,256]. Cooling of the condenser 
with cold water was discontinued, which led to higher 
recoveries for the higher hydrocarbons (C10 to C12 ). 
When blood samples were being extracted, water vapour did 
not hinder the completion of the procedure but larger 
quantities of water collected in the Tenax column when 
aqueous samples were extracted. If the water was not 
sufficiently purged with helium at ambient temperature 
before thermal desorption, it frequently led to blockage 
of the capillary tubing of the cold trap. Similar results 
occurred when collecting air pollutants during humid 
weather on Tenax material [193]. Water can be selectively 
eluted from the Tenax-GC column due to the retention 
characteristics of the latter, such that hydroxylated 
compounds including water, lower aliphatic alcohols and 
aliphatic carboxylic acids are eluted before other 
non-polar and/or lower boiling compounds [239]. 
A stripping volume of helium of 800ml plus heating 
of the sample to 97°C with foam formation, provided 
efficient recovery for hydrocarbons. 
Heating of the sample to this temperature reduced the 
volume of helium required for C10 to C12 , 
which have 
higher boiling points and require more than 1.5L of helium 
to strip them from water at ambient temperature [252]. 
None of the added hydrocarbons broke through the Tenax-GC 
column with this volume, which 1S in agreement with 
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previous workers [252] and shows the retentive ability of 
the Tenax-GC material. 
The efficiency of the extraction, reproducibility 
of the analytical procedure and its sensitivity should 
make it applicable to the analysis of blood samples for 
occupational hygiene monitoring of paint volatiles or 
others which share the same characteristics. 
4. IV. 7 ANALYSIS OF BLOOD FOR SOLVENTS 
The aim of this part of the project was to develop 
a reliable and sensitive procedure for detection and 
quantitation of solvent in painters' venous blood. This 
procedure will be used for a future comprehensive study of 
a painter work force including physical and psychological 
examination, environmental monitoring and estimation of 
solvents in blood during the study period. During the 
development of the analytical procedure, factors which can 
influence solvent intake by the body, such as age. weight, 
smoking history, the state of health and atmospheric 
solvent levels were not evaluated. Also, an appropriate 
control group was not established. However, two groups of 
samples, at the beginning and end of a working week, were 
included to estimate the uptake. The work exposure and 
physical effort during this week could be described as 
moderate, where the painting was indoors, ventilation was 
natural and there were no protective devices. 
Identified volatile peaks in chromatograms from 
both groups of blood samples were materials similar to 
those in a paint sample and to those present in the method 
- 204 -
blank. Because of the small numbers in each group and the 
background interference, significant differences could not 
be shown between the two groups when their means were 
compared (unpaired T-test). However, the differences in 
the two values for each individual (paired T-test) were 
significant for nonane, undecane and alkylbenzenes, but an 
accurate estimation of their levels in blood could not be 
obtained due to the interference. An estimation of nonane 
and n-undecane levels in blood for the first group was 
10 ± 6ng/ml and 18 ± 6ng/ml, respectively, and the 
second group was 41 ± 27ng/ml and 31 ± 15ng/ml, 
respectively. The levels in the first group were slightly 
higher than the background interferences. Alkylbenzenes 
were not estimated partly due to the unavailability of 
standards. However, these values give an indication of an 
uptake of aromatic and aliphatic hydrocarbon during the 
course of the working week. 
In a previous experimental study on volunteers, 
the half life of white spirit was estimated to be between 
46-48 hours [183] which could mean that the low levels of 
solvent in the first group were due to incomplete 
clearance of these solvents from the body_ However, the 
modified method described provides sufficient sensitivity 
for the estimation of solvents in blood in future 
studies. In view of the problems encountered it will be 
necessary to clean or replace the extraction system, 
ensure that samples are collected in clean glass vials and 
to perform the analysis in an isolated place away from 
solvents and contamination. 
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C HAP T E R F I V E 
5.1 LIQUID CHROMATOGRAPHY MASS SPECTROMETRY 
5. I . 1 INTRODUCTION AND LITERATURE REVIEW 
Mass spectrometry, GC 
techniques in the field of 
establishment of dynamically 
invaluable technique in this 
recent years, fruitful efforts 
and HPLC are fundamental 
forensic toxicology. The 
coupled GC-MS provided an 
and other fields. During 
have been appl ied to the 
coupling of HPLC and mass spectrometry (LC-MS), with the 
aim of providing a technique with the same status as 
GC-MS. Successful LC-MS coupling would have the following 
potential benefits: 
I. HPLC has advantages over GC in that compounds are 
not exposed to excessive heat, so heat-labile compounds 
can be safely analysed. 
II. Less sample cleaning IS required. 
III. Can be applied in analysis of polar compounds since 
derivatization is not usually necesssary in HPLC. 
IV. LC-MS will compensate for the lack of versatility 
of conventional HPLC detectors. 
V. LC-MS will complement the important role played by 
GC-MS. 
5. I .2 METHODS OF INTERFACING LC AND MS 
Direct on-line combination of LC and MS was 
previously considered as an unapproachable ideal due to 
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the apparent incompatibility of the two techniques. Mass 
spectrometry requires high vacuum and ionization of 
molecular species in the gas phase, while HPLC is intended 
for the analysis of relatively non-volatile compounds in 
liquid media. An ideal LC-MS interface should have the 
following criteria:-
I.. No significant compromises in the various operating 
conditions of both systems. 
II. A high transport efficiency, that is, most or all 
of the analyte leaving the LC column should enter 
the mass spectrometer. 
I I I . Should keep the integrity of a chromatographic 
profile. 
IV. The performance of the interface should remain the 
same for the transmission of volatile, non-volatile 
and thermally labile compounds and they should not 
be chemically modified by the interface in an 
uncontrolled manner. 
Several LC-MS interfaces have been developed 
successfully. However, none have satisfied the above 
criteria as successfully as a good GC-MS interface. They 
were recently reviewed in the literature [268-273] and a 
brief description of these methods will be presented. At 
present, the mos t commonly accepted LC-MS inter f aces can 
be divided into two main categories, mechanical transfer 
interfaces and aerosol-based interfaces. 
5.1.2.1 MECHANICAL TRANSFER INTERFACES 
This category includes the moving belt 
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interface [278-286] and, earlier, the moving wire 
interface [287]. The concept is that liquid from the 
column effluent passes either by direct deposition or 
spray deposition [277], onto a moving polymer belt which 
passes through successive vacuum locks, pumped 
mechanically, prior to entering the mass spectrometer 
ionization source. Solvent vapour 1S removed 1n these 
evacuated areas, in conjunction with thermal irradiation 
to enhance the rate of solvent evaporation. The analyte 
is then removed from the belt in the ion source region by 
a flash vaporization process and the vaporized molecules 
may be ionized by electron impact or chemical ionization 
processes. Al ternatively the sample on the bel t surface 
is bombarded with the fast atoms for FAB ionization. The 
solvent capacity of the belt system is 1-1.5ml/min for 
volatile, non-polar solvents and 0.4-1ml for solvents 
having intermediate volatility, while that of the wire 
system was much lower. The disadvantages of the moving 
belt interface include a restriction on solvents in 
reversed phase systems, thermally labile compounds may be 
decomposed in vaporization from the belt interface, 
non-volatile ionic species must be derivatized for their 
ready removal from the belt and finally the possibility of 
cross contamination if the analyte is not completely 
removed from the circulating belt. The response of the 
system is in the region of l-lOng of analyte. The moving 
belt interface has been recently reviewed by Arpino [288]. 
5 . I . 2 . 2 
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AEROSOL BASED INTERFACES 
Several types of aerosol generation interface have 
been developed. A properly designed system has the 
following advantages over the moving belt interface: 
I. Minimal sample cross-contamination. 
II. Minimal peak broadening. 
III. Solvent removal by rapid evaporation of the solvent 
from the aerosol droplet surface is faster than that in 
the moving belt interface. 
IV. It has a simpler mechanical design. 
5.1.2.2.1 DIRECT LIQUID INTRODUCTION(DLI) 
In thi s interf ace [289-293], the eff I uent from HPLC 
is split and only part of the stream which can be 
tolerated by the mass spectrometer pumping system is 
introduced, or else the entire effluent of microbore HPLC 
with a low flow rate (1-10)ll/min) is introduced directly 
to the mass spectrometer [294-301]. Splitting of the 
effluent is the main disadvantage of this interface as the 
transport efficiency is reduced. Also, solvent does not 
significantly evaporate from the aerosol droplets which 
produces CI spectra where the solvent molecules act as 
reagent gas. 
5.1.2.2.2 ATMOSPHERIC PRESSURE IONIZATION(API) 
Three types of LC-MS interfaces will be summarized: 
I. Heated Pneumatic Nebulizer 
This is a probe-type interface [271,302]. It takes 
full advantage of the large solvent vapour throughput 
tolerated by an API source and provides routine operation 
- 209 -
with an HPLC flow rate up to 2ml/min, including reversed 
phase systems. The effluent from HPLC passes through the 
central microbore tube (Figure 5. I .1) of the probe while 
the nebulizer gas and make-up gas are introduced coaxially 
into the heated nebulization region (150°C). The 
nebulized droplets are desolvated and produce a dry vapour 
of solvent and analyte molecule by the combined effects of 
the heat and gas flow. Ionization of these molecules is 
initiated by a corona discharge producing CI of the 
analyte by the solvent ions. These ions are focussed 
through a dry nitrogen curtain gas and then pass through a 
micro-orifice into the analyser which is in a high vacuum 
region. 
II Electrospray 
In this interface [271.303] a fine mist of charged 
droplets is produced by injection of the sample into 
nitrogen gas at atmospheric pressure through a metal 
capillary tube (Figure 5. 1.2) at a potential of several 
kilovolts relative to the surrounding chamber walls. 
Dispersion of the mist results from repulsion forces on 
the charged surface of the droplets which overcome its 
surface tension. Then the emitted ions pass into the high 
vacuum of the mass spectrometer to the analyser. 
HPLC flow rates for operation are in the 
5-10pl/min and CI spectra are produced. 
III Monodisperse Aerosol Generation (MAGIC) 
Optimum 
range of 
In this interface [270,304] a nebulizing gas is 
directed orthogonal to the flow of HPLC effluent and very 
Li uid Heat 
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Figure 5.1.1 (Above) Schematic diagram of pneumatic 
nebulizer LC-MS interfase with an atmospheric pressure 
ionization (API) source. 
Figure 5.1.2 (Below) Schematic diagram of 
electrospray LC-MS interfase. 
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uniformly-sized droplets are generated. A dispersion gas 
is used to prevent clustering of the drops as they are 
passed through a desolvation region on their way to the 
mass spectrometer ion source (atmospheric pressure) 
(Figure 5. 1.3) . The aerosol beam enters the high vacuum 
region of the mass spectrometer via an aerosol beam 
separator. Optimal operation occurs at flow rates of 
0.1-0.5ml/min and both EI an CI spectra can be obtained. 
5.1.2.2.3 THERMOSPRAY 
I. Introduction 
The thermospray (TSP) system, developed by Vestal 
[305], has achieved widespread use recent ly due to the 
simplicity of its operation where solvent removal and 
ionization of the sample occur in one process. In this 
system (Figure 5.1.4) eluent from HPLC is pumped through a 
capillary tube which is heated by passing a current 
through it. The eluent emerges from the capillary in a 
form of an expanding jet of vapours and droplets. The 
aerosol jet subsequently enters the thermospray chamber. 
Ions 
cone 
formed are sampled via the orifice in the 
assisted by the lateral expansion of the 
sampling 
jet that 
occurs as it traverses the ion source. The excess of 
solvent is 
interface 
removed directly via 
permits up to 2ml/min 
the pumping line. 
of polar solvent 
A TSP 
to be 
introduced to the mass spectrometer. One restriction is 
that the solvent should contain at least 20% by volume of 
an aqueous solution of ammonium acetate for ionization to 
be possible [306]. 
Gas alignment 
Dispersion 
gas Desolvation 
chamber 
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Figure 5.1.4 Schematic diagram of Thermospray (TSP) 
LC-MS interfase. 
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II. Ion Generation in Thermospray 
1. Thermospray Ionization 
Two distinct stages are involved ln TSP mass 
spectra [307,308]. The first stage is the formation of 
the primary gaseous ions out of the microdroplets produced 
by the vaporizer. The mechanism of their formation is 
believed to be as follows. Complete varporization of the 
liquid at the rate at which it is supplied to the 
vaporizer produces a superheated mist carried in a 
supersonic jet of vapour. The droplets of the mist are 
charged positively or negatively according to random 
statistical fluctuations in the distribution of these 
charges in the droplets [304,309]. Molecular ions 
clustered with a few solvent molecules evaporate from the 
superheated droplets assisted by the high local electrical 
fields generated by the charge on the droplet. 
In the second stage, new product ions are produced 
in a gas-phase ion/molecule reaction by removing the 
primary TSP ions [304,309,310]. This gas-phase 
ion/molecule reaction was found to have a strong influence 
on the relative ion intensities in TSP mass spectra in the 
presence of ammonium acetate [307], and the gaseous 
molecules were protonated by transfer from the ammonium 
ion [311]. The mass spectra have characteristics similar 
to those produced by ammonia CI, and exhibit both [MH]+ 
and [MNH
4
] + pseudo-mo lecu lar ions. The former 1 s 
produced at the expense of the latter and their formation 
is dependent on the proton affinity of the sample molecule 
with respect to ammonia. 
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2. Plasmaspray(PSP) Ionization 
Ions in PSP are achieved by initiating a glow 
discharge inside the ion source using the thermospray 
probe tip as an electrode (Figure 5.1.5). The probe is 
maintained as a cathode at a voltage of approximately 
-600V with respect to the source block (anode) and is 
operated with a discharge current of O.SmA [312]. All 
analytes and solvents entering the ion source must pass 
through the ca thode dark space which sur rounds the probe 
tip. This region of the discharge is especially rich in 
energetic ions, neutrals and metastable species [313] 
which are primarily responsibile for the PSP ionization. 
In this mode there is no restriction on the mobile phase 
constituents for ionization to be possible and it is an 
energetic process in which more fragmentation of the 
molecule appears than in TSP. 
3. Thermospray with Filament-on Ionization 
This uses an external source of ionization such as 
a conventional electron filament, and is therefore called 
called IIfilament-on ll TSP [314-316]. It eliminates the 
need for the presence of water and buffer in the mobile 
phase, which are required for true TSP ionization, hence 
normal phase and gradient elution HPLC eluents can be 
applied directly to the mass spectrometer without 
post-column addition [317] of the buffer. This method 
also increases the possibility of molecular fragmentation. 
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5 . I .3 
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APPLICATIONS OF LC-MS 
as 
Although none of the developed LC-MS interfaces 
universal as the established GC-MS interface. 
and limitations of 
are 
an 
each understanding of the benefits 
interface has permitted users 
their specific capabilities. 
to take full advantage of 
practical applications of 
The literature contains many 
LC-MS (Table 5.1.1). These 
applications include a large set of substance classes that 
are difficult to investigate using conventional GC-MS. 
such as very polar and thermally labile compounds as well 
as those with high molecular weight and low volatility. 
especially with the availability of different ionization 
methods which could be used in these interfaces [308.348]. 
Specific examples include the separation of therapeutic 
agents and their metabolites. such as glucuronide 
conjugates. from biological fluids [319.321.323.326]. 
other thermally labile biologically-active compounds from 
their media [297.334.340.344] and metabolites of 
explosives from biological fluids [340]. Mos t of the 
reviewed methods using LC-MS interfaces provide 
qualitative and quantitative procedures for specific 
analytes with very good sensitivity. In general terms. 
the sensitivity of the detection has been determined to be 
compound-dependent and difficult to predict. especially in 
TSP-MS. However. impressive full scan data can be 
acquired at 10-100 ppt (parts per trillion) under TSP 
conditions [316]. The more recently developed PSP should 
provide higher sensitivity and stability compared to TSP 
[312] . 
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Table 5. 1.1 References to LC-MS applications using Thermospray 
(TSP) Moving Belt (MBl) and Direct Liquid Introduction (DLl) interfaces 
for different types of analyte. 
Number T S P M B I D L I 
1 Therapeutic Agents 
Antibiotic 318 
Antiviral 319 
Amphetamines 314 282 
Diuretic 320 
Analgesic 321,322 
Others 299,323-327 274,275,281 289,291,294 
2 steroids and their 327,328 329 302 
Conjugates 
3. Pesticides and 317,330-333 274,279,292, 300,335-337 
Herbicides 295,334 
4. Environmental Hazards - 316,318,339 
Dyes, Explosives, 340 
polynuclear Aromatic 
Hydrocarbons 383 
5. Fatty Acids 315,341,342 293 
6. Plant and Fungal 334,343,344 297 
Products 
7 . Organic Acids 284,345 
8. Enzymes and Peptides 346,347 
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In this study both TSP and PSP were assessed as an 
LC-MS interface for detection of the commonly encountered 
drugs in forensic toxicology. These drugs have 
established HPLC methods. positive results by HPLC could 
then be confirmed and the nature of the unidentified peaks 
could be established using LC-MS, similar to the situation 
of using GC and GC-MS. Initially conditions were assessed 
which determine TSP and PSP sensitivity, such as operating 
temperature of the source and probe in TSP, as well as the 
applied voltage and mobile phase constituents. 
5.11 
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EXPERIMENTAL 
5.11.1.1 MATERIALS AND REAGENTS 
Methanol (MeOH) and acetonitrile (ACN) were HPLC 
(glass distilled) grade solvents. Water was purified in a 
MIKI water purification system (Millipore, U.K.). 
Ammonium acetate was Aristar grade obtained from BDH, U.K. 
5.11.1.2 INSTRUMENTATION 
An LKB model 2150 HPLC pump was used for solvent 
delivery. It was connected to a VG Thermospray/Plasmaspray 
probe by a switching valve, either directly via stainless 
steel tubing (25cm x O.lmm I.D) which by-passed the HPLC 
column (subsequently referred to as "loop only 
injection"), or via an HPLC column (25cm x 4.6mm I.D) 
packed with Hypersil ODS, Sum spherical silica, obtained 
from HPLC Technology, U.K. An in-line low-dispersion 
filter with a 2pm frit (Hewlett Packard, U.K.) was placed 
at the inlet of the TSP probe. Mobile phases were 
degassed with helium before use using a 2pm solvent 
fil ter. Samples were introduced by a 25).11 SGE syringe via 
a Rheodyne injection valve (Model 71255) fitted with a 
20).11 sample loop. The LC-M5 interface was a VG 
Thermospray/Plasmaspray model. The stainless steel 
capillary tubing of the probe ( 0 . 1 mm I. D 0 r O. 25 mm I. D) 
tube was silver-soldered to the probe frame. The probe 
was isolated from the HPLC tubing by a deactivated fused 
silica tube (1m x O.lmm I.D) which acted as a filter at 
the same time (Figure 5. 11.1). The interface wa!: 
Feedthrough and 
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Figure 5.11.1 Thermospray/Plasmaspray probe assembly. 
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connected to the model VG 70-250S mass spectrometer with 
minor modifications, by replacing the EI/CI source with a 
special TSP source and attaching a line to remove excess 
solvents connected to a high-temperature rotary vacuum 
pump. 
5.11.2 SAMPLE PREPARATION 
Stock drug standard solutions were prepared in MeOH 
at approximately 10)lg/ml each. Polyethylene glycol (PEG) 
stock solution was prepared by dissolving approximately 2g 
of PEG 200, 400, 600, 800, 1000 and 1200 ln MeOH/O. 1M 
ammonium acetate buffer in water (1:1, v/v) in a 100ml 
volumetric flask giving a final concentration of 2% w/v 
for each PEG. 
5 . I I . 3 CALIBRATION OF THE MASS SPECTROMETER 
The mass spectrometer was initially tuned on the 
ammonium acetate ions at m/z 78 or 59 in the positive or 
negative modes, respectively, at the start of each period 
of work. The peak intensity was maximized by adjusting 
the temperature of the probe in the range 200-220°C for 
TSP or 270-300°C for PSP ionization. The flow rate of 
mobile phase, containing O.lM ammonium acetate buffer:MeOH 
(1:1, v/v) was set to Iml/min. The source temperature was 
set at the multiplier at 2.5KV and the 
accelerating voltage at 6KV. The source pressure was 
monitored by a Pirani gauge, normally showing 5 x 10- 4 
mbar, and an Edwards digital pressure meter. Mass 
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calibration of the spectrometer was carried out using PEG 
as a reference as described below. 
5.11.3.1 FULL SCAN MODE 
The stock solution of PEG was diluted 100 times in 
mobile phase and filtered over Millex-HV4, 0.45pm filter 
before use. An aliquot of 20)11 (containing 4}lg of each 
PEG) was introduced to the mass spectrometer via loop only 
injection. The acquisition range was from 600-70 at 1 
sec/decade, with an interscan delay of 0.3 sec. 
5.11.3.2 
A 
w/v) was 
probe. 
SELECTIVE ION RECORDING MODE 
fresh solution of PEG in mobile phase 
introduced continuously via the by-pass 
(0.005% 
to the 
Tuning of the mass spectrometer was done on a 
reference mass from PEG nearest to the selected masses for 
SIR. During 
nearest upper 
calibration, the 
and lower masses 
computer selected the 
from PEG, which bracketed 
the masses chosen for the analyte, as references for 
calibration. 
5.11.4 OPTIMIZATION OF RESPONSE 
The following parameters influencing the response 
of the mass spectrometer when operated with the TSP/PSP 
LC-MS interface were studied: 
1. 
2 . 
3 . 
4 . 
5.11.4.1 
Probe temperature. 
Source temperature. 
Probe discharge voltage in PSP. 
Mobile phase composition. 
PROBE TEMPERATURE 
The effect of probe temperature in both TSP and PSP 
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modes on sensitivity and on the fragmentation patterns of 
the analyte molecules were evaluated ln the following 
experiments: 
I. A standard solution of amitriptyline (2mg/100ml) in 
mobile phase (O.lM ammonium acetate:MeOH, 1:1, v/v) was 
introduced to the mass spectrometer via the column by-pass 
and probe at lml/min. The plasmaspray emission ln the 
positive ion mode (PSP+), was set at a current of o. SmA, 
the source temperature at 270°C and the multiplier 
voltage at 
and 
4KV. The 
raised 
probe temperature was 
to 340°C in lOCO 
started at 
steps and 
approximately 50 scans were recorded at each temperature. 
The scans obtained at each temperature were averaged and 
the spectra were compared for the intensity of the 
fragments obtained such as m/z 78 and the molecular ion of 
amitriptyline as well as for the sensitivity of detection 
based on the reconstructed TIC and mass chromatograms for 
ions in the mass spectra of the buffer and analyte. 
II. The same experiment as above was repeated using TSP 
in the positive ion mode [TSP(+)] while the multiplier 
voltage was set at SKV. 
III. A standard solution of amylobarbitone 
(1.3smg/l00ml) was prepared as above, and the above 
experiments (1 and 2) were repeated for both PSP and TSP 
using the negative mode of ionization (PSP(-) and TSP(-), 
respectively). 
IV. A mobile phase of O.lM ammonium acetate:MeOH 
(1:1, v/v) was introduced as above. The effect of the 
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probe temperature ln PSP(+) at settings of 2400, 2700, 
300° and 330°C was assessed with respect to 
sensitivity and fragmentation of the following drugs: 
cannabidiol, doxepin, propranolol, buprenorphine, 
flupenthixol, indomethacin, morphine and triazolam. An 
aliquot of 20pl containing 200ng of sample was introduced 
for each drug individually at each temperature. The peak 
shape, background noise in the chromatogram and 
sensitivity were recorded. 
5.11.4.2 SOURCE TEMPERATURE 
The effect of source temperature on mass spectral 
peak shape and fragmentation was assessed by repeating 
experiment number 4 above. The probe was set at 300°C 
and the following source temperatures were tested: 
PLASMASPRAY DISCHARGE VOLTAGE 5.11.4.3 
The effect of the PSP discharge voltage on 
sensitivity of detection and on the fragmentation patterns 
of analyte molecules was assessed by repeating the above 
experiment. The source temperature was set at 270° and 
the voltage at the probe tip was increased ln steps. 
Morphine and triazolam were used as test compounds at each 
PSP discharge setting. 
5.11.4.4 MOBILE PHASE CONSTITUENTS 
The mobile phase constituents used for liquid 
chromatography were studied to assess their effect on 
sensitivity using the PSP 
buprenorphine at 10)lg/ml as a 
following conditions: flow 
LC-MS interface, with 
model compound under the 
rate lml/min, multiplier 
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voltage 3KV, source temperature and probe 
temperature 270-280°. 
The following mobile phases were assessed: 
1. Individual constituents: water, MeOH and ACN. 
ii. Ammonium acetate buffer in water: 0.01-0.3M. 
iii. 0.15M buffer:MeOH (1:1, v/v). 
iVa 0.15M buffer:ACN (1:1, v/v). 
v. 0.15M buffer:MeOH:ACN (2:1:1, v/v:v). 
Five replicate samples of 20pl of buprenorphine 
were introduced in each mobile phase. The sensitivity 
was assessed by comparing the peak areas of m/z 450 
for buprenorphine. The peak shape, 
background interference, fragmentation pattern and HPLC 
pump pressure were observed. 
5.11.5 REPRODUCIBILITY OF RESPONSE 
The reproducibility of response ln the mass 
spectrometer using the LC-MS interface in the PSP(+) mode 
was tested by repeated introduction of buprenorphine and 
doxepin (20pl aliquots containing 200ng of each drug) 
under the conditions described in Section 5.11.4.4. Both 
peak heights and areas were compared. 
5.11.6 SENSITIVITY 
The sensitivity was tested in both full scan and 
SIR modes using buprenorphine as a model compound, under 
the following conditions: flow rate lml/min, mobile phase 
O.lM ammonium acetate:MeOH (1:1. v/v), multiplier voltage 
5KV, source temperature 
240-250°C, scan range in 
scan rate 1 sec/decade 
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270°C, and probe temperature 
full scanning mode was 150-600, 
and interscan delay 0.3 sec. 
Acquisition in SIR was on a single ion, mass 450, the 
dwell time BOmsec and interchannel delay 20msec. The 
detection limit was determined by introducing an aliquot 
of buprenorphine solution containing 0.3-160ng via a 20pl 
sample loop and the direct connection (column by-pass) 
route, under both modes of acquisition. 
5.11.7 DRUGS AMENABLE TO LC-MS 
Several drugs representing different groups of 
compounds which are commonly encountered ln forensic 
toxicology were studied. 
phase at concentrations 
20pl of each drug was 
Each drug was prepared in mobile 
of approximately 10pg/ml where 
individually introduced via the 
direct connection. The mass spectra of these drugs in 
full scan PSP(+) mode (as in section 5.11.6) were obtained 
to assess the usefulness in the forensic field of the 
LC-MS interface and the information which might be 
obtained from their fragmentation patterns. 
5.II.B HPLC-MS 
The applicability of the TSP/PSP LC-MS interface 
for on-line connection and introduction of the HPLC 
effluent was assessed using the following three models of 
separation: 
1. Mixture of basic drugs. 
2 . 
3 . 
S.II.B.l 
Mixture of 
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sedative/hypnotic 
anticonvulsants. 
Mixture of opiates. 
BASIC DRUG MIXTURE 
drugs and 
This was a mixture of basic drugs composed of 
oxazepam. diazepam. pentazocine. codeine. caffeine. 
dextromoramide. dextromethorphan. amitriptyline. 
pethidine. dipipanone and methadone. each at a 
concentration of approximately 10~g/ml. Separation was 
performed on the ODS-column with a mobile phase based on a 
mixture of ammonium acetate buffer. MeOH and ACN. The 
ratios (v/v) of the mobile phase constitutents and the 
concentration of the buffer. without pH adjustment. were 
varied to obtain optimum chromatography and flow rate 
within the capabilities of both HPLC column and vacuum 
system. 
The following mobile phases were tested (ratios 
are v/v): 
1. Methanol:water (BO:20). 
2 . Methanol:0.05M buffer (BO:20) 
3 . Methanol:0.1M buffer (BO:20). 
4. Methanol:0.1M buffer(90:10). 
5 . Methanol:ACN:0.2M buffer (80:10:10). 
6 . Methanol:ACN:0.2M buffer (65:20:15). 
7. Methanol:ACN:0.2M buffer (50:30:20). 
The interface and source temperatures were both set 
at 270°C and the mass spectrometer was operated in the 
PSP(+) full scanning mode with a mass range of 150-600. 
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The multiplier vo 1 tage was 
chromatograms was performed 
current (LTIC) chromatograms 
at 
using 
4KV. Comparison 
1 imi ted tota 1 
and reconstructed 
of 
lon 
ion 
chromatograms of the protonated molecular ions [M + H]+ 
of the analytes. 
5.11.8.2 HYPNOTIC AND ANTICONVULSANT DRUGS 
Similar experiments to those detailed above were 
performed for a mixture of hypnotic/sedative and 
anticonvulsant drugs, composed of primadone, pheno-
barbi tone, bu tobarbi tone, amylobarbi tone, gl u tethimide, 
phenytoin, methaqualone, carbamazepine and 
quinalbarbitone. The mobile phase O.lM buffer :ACN:MeOH, 
(110:50:50, v/v/v) was a modification of a system 
described in the literature for such drugs [349], obtained 
by substituting ammonium acetate buffer for phosphate 
buffer. The pH was adjusted to pHS with acetic acid. The 
flow rate was 1ml/min and other parameters were as 
described in the previous section. Acquisition was 
performed in full scan mode and both PSP(+) and PSP(-) 
mode spectra were obtained. 
5.11.8.3 SEPARATION OF OPIATES 
A mixture of morphine, morphine-3-glucuronide 
(M3G), nalorphine and buprenorphine, at a concentration of 
10pg/ml each was made as a model for this type of 
separation. Experiments were performed as in the previous 
two sections, based on a similar mobile phase with the 
addition of diethylamine to obtain the optimum 
chromatogram and a suitable 
pressures in the HPLC pump and 
flow rate with reasonable 
ion source. Initially the 
- 230 -
effect of probe temperature on the M3G fragmentation 
assessed in the PSP(+) mode via the by-pass inlet 
temperatures between 120-300°. The chromatography 
then performed while the probe temperature 
120-200° to locate M3G and the other drugs. 
5.11.9 CLEANING THE PROBE AND SOURCE 
was 
was 
for 
was 
at 
The probe was cleaned at the end of each working 
day by passing water via the column by-pass connection at 
150-200° for 15-30 minutes using the TSP mode while the 
mass spectrometer was on the standby position. A 
partially blocked probe was cleared as described in the 
literature [350]. The probe was removed from the mass 
spectrometer and citric acid solution (O.lM in distilled 
water) was passed through at a flow rate of O.l-lml/min 
according to the extent of blockage. The vaporizer 
temperature was slowly increased from 100-150° to permit 
as high a flow rate as possible to be used within the 
pressure 
dropped 
SObar at 
limit of the 
to the original 
a flow rate of 
O.lmm I.D. at 200°C. 
washing with distilled 
polished under a flow 
system. until the back 
level at that setting 
lml/min of water in a 
pressure 
typically 
probe of 
This procedure was followed by 
water. The probe tip was also 
of water. A completely blocked 
probe was replaced by a new one. 
The metal sampling cone and the inside of the 
source block were polished with fine grade emery paper. 
followed by ultrasonication for 3 minutes 1n acetone. 
followed by air drying before installation. 
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5.111 RES U L T S 
5.111.1 CALIBRATION OF THE MASS SPECTROMETER 
Calibration tables for the mass spectrometer, which 
were stored 
calibration 
period of 
in 
files, 
the computer 
were found 
data 
to be 
system 
usable 
in several 
over a long 
time for the full s canning mode, whi Ie a new 
calibration was needed each day when analyses were 
performed 
via the 
by SIR. Although the introduct ion of PEG was 
was thoroughly 
rinsed 
direct 
wi th the 
connection and 
mobile phase, 
the system 
it used to interfere with 
subsequent analyses and required the source temperature to 
be raised to 300°C for %-1 hour after the process of 
calibration to eliminate high molecular weight PEG 
condensed on the source block. 
mass, 
ions 
During full scan acquisition starting 
solvent ions at low mass were the major 
and no well-defined peaks could be seen 
chromatogram for analytes at low concentration. 
from low 
background 
in the TIC 
Examples 
of these masses ions originating from the mobile phase 
constituents are listed in Table 5.111.1. These ions were 
used for ini tial tuning of the mass spectrometer. The 
problem of high noise levels was avoided by stopping the 
down scan at a high mass such as 150, or by generation of 
a limited total ion current (LTIC) chromatogram for masses 
above 200, for example. 
Table 5.111.1 
plasmaspray. 
1. positive 
M a s s e 
Ions 
s 
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Major solvent ions generated by 
o r i g i n 
19.37.55.73 [(H20)n + H]+.n = 1-4 
33.65.97 [( CH30H)n + H]+.n = 1-3 
42.83 [(CH3CN)n + H]+.n = 1-2 
77.78 [Acetate + H]+ 
95 [Acetate + NH4I + 
100 [(CH3CN) 2 + NH4]+ 
2 . Negative Ions 
M a s s e s o r i g i n 
59 [CH3COO]-
119 [(CH3COO)2 + H]-
5.111.2 EFFECTS OF PROBE TEMPERATURE 
During the experiments which were conducted to 
study the influence of variation of the operating 
temperature of the TSP/PSP probe of the LC-MS interface. 
the probe temperature showed a profound effect on the mass 
spectral peak shape and intensity. In general. the peaks 
obtained at the optimum temperature for an analyte were 
more stable and smoother in the PSP mode than those 
obtained in the TSP mode of operation. and the background 
noise level was much lower in the former. Only positive 
ions were produced in significant amounts in the 
continuous analyte introduction experiment with 
amitriptyline. while both positive and negative ions were 
produced from amylobarbitone. The sensitivity for the 
latter was 10 times higher in the negative ion mode. The 
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chromatogram obtained using PSP(-) was free from 
background noise from the mobile phase constituents. which 
had a high intensity level in the positive ion mode. The 
mass spectra of amylobarbitone and amitriptyline are shown 
in Figure 5.111.1. These two drugs did not show any 
differences In the fragmentation patterns as a result of 
changing the probe temperature. which significantly 
influenced the sensitivity in both TSP and PSP modes. 
The ami triptyline experiment was conducted by 
continuous introduction of amitriptyline solution as a 
concentration of 2mg/l00ml in the mobile phase via the 
by-pass connection while the probe temperature was raised 
from 180°C to 300°C In 10° steps and approximately 
50 scans were acquired at each temperature. In PSP(+) 
mode the protonated molecular ion (m/z 278). which was the 
most intense analyte ion. showed the maXImum intensitiy 
between 220-230° and a gradual loss of intensity outside 
this range down to 210° and up to 260°C. followed by a 
sharp drop after 260°C. The protonated molecular ion of 
ammo n i u mac eta t e ( m / z 7 8 ) did no t foIl ow t he s a me pat t ern 
as the analyte: its highest response occurred where the 
intensity of m/z 278 for amitriptyline dropped (above 
2600C) followed by a gradual drop with further increases 
of temperature (Figure 5.1II.2a). 
During TSP operation. the maximum response for m/z 
278 was over a narrow range 190-200°C with a sharp drop 
at higher and lower temperatures. The response to m/z 78 
corresponded to that of m/z 278 with a wider range over 
5.III.2b). However. at lower 
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Figure 5.111.1 Plasmaspray-generated mass spectra 
of amitriptyline and amylobarbitone obtained in positive 
(a and b) and negative (c) ionization modes. The mobile 
phase was methanol:ammonium acetate buffer (O.lM), 1:1, 
v/v and the TSP/PSP probe temperature was 220 oC. 
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Figure 5.111.2 Effect of probe temperature on ionization of 
amitriptyline in methanol/ammonium acetate buffer (O.lM 1:1, v/v) by (a) 
PSP (+) LC-MS and (b) TSP(+} LC-MS. Amitriptyline was introduced 
continuously at 2mg/100ml in the mobile phase while the probe temperature 
was increased in steps of 10 Co. The traces show: A the total ion 
current chromatogram, Band C: mass chromatograms for the quasi-
. ·ine and ammonium acetate at m/z 278 and m/z 
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temperatures the response was erratic, resulting ln a 
chromatogram full of spikes and noise. 
The amylobarbi tone exper iment was conducted in a 
similar way to the amitriptyline experiment and both 
PSP(+) and PSP(-) were evaluated. The quasi-molecular 
ions (m/z 227 and m/z 225, respectively) and the buffer 
ions (78 and 119, respectively) followed the same pattern, 
where they maximized at 200-210°C, followed by a gradual 
drop as the temperature was increased to 250°C 
(Figure 5.111.3). The latter was followed by a marked 
drop in response. The response using TSP mode was erratic 
and unstable. For this reason, examination of the effect 
of probe temperature on ionisation of amylobarbitone was 
not continued in that mode. 
Following these tests, eight drugs were introduced 
separately (200ng each) via the by-pass connection at four 
different probe temperatures (240°, 270°, 300° and 
330°C). Table 5.111.2 presents the peak areas from 
reconstructed ion chromatograms of the most intense ion 
for each drug obtained at the four different probe 
temperatures evaluated. It shows that the tested 
compounds did not share the same probe temperature for 
optimum sensitivity. However, very high temperatures 
(300°C or higher) dropped the sensitivity for all drugs, 
although they were detected to a varying degree over the 
wide range of temperature. The behaviour of ammonium 
acetate, 
m/z 78, 
represented by the intensity of the ion at 
was similar to tha t described earlier. Ion 
:>i 
E-I 
50 
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Figure 5. 111.3 Effect of probe temperature on ionization of 
amylobarbi tone in methanol/ammonium acetate buffer (0.1M 1: 1, v/v) by 
(a) PSP(+) LC-MS and (b) PSP(-) LC-MS. Amylobarbitone was introduced 
continuously at 1.3 mg/lOOml in the mobile phase while the probe 
temperature was increased in steps of 10 Co. The traces show: A 
the total ion current chromatograms, Band C: mass chromatogram for 
the quas i-molecular ions of amylobarbi tone and anmlOn i Um acetate. 
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intensities tended to increase at lower probe temperatures 
with a simultaneous increase in the irregularity of the 
base line (Figure 5.111.4). 
The mass spectra of these drugs are presented in 
Figure 5.111.5, and Table 5.111.3 summarises their major 
fragment ions. 
Table 5.111.2 
sensitivity of 
PSP(+) LC-MS. 
Effect of probe temperature on the 
detection of eight representative drugs by 
COM P 0 U N D 
Cannabidiol 
Doxepin 
Propranolol 
Buprenorphine 
Flupenthixol 
Indomethacin 
Morphine 
Triazolam 
Ion 
Used 
m/z 
315 
280 
260 
450 
435 
220 
286 
343 
Pea k Are a 
at probe temperature co of 
240 
28167 
5732 
47136 
176 
10958 
7853 
26487 
5402 
270 
13728 
29597 
20135 
2095 
28338 
3455 
3734 
300 
7079 
19249 
18036 
1594 
3456 
1387 
8148 
2344 
330 
4853 
15002 
11739 
530 
2639 
360 
6435 
1146 
The source temperature was 270°C 
was composed of O.lM ammonium 
(1:1, v/v) 
and the mobile phase 
acetate buffer:MeOH 
Table 5.111.3 
spectra of eight 
LC-MS. 
COMPOUND 
Cannabidiol 
Doxepin 
Propranolol 
Buprenorphine 
Flupenthixol 
Indomethacin 
Morphine 
Triazolam 
Summary of major 
representa t i ve drugs 
ions in 
obtained 
the mass 
by PSP(+) 
Base peak and other M.Wt prominent ions (m/z) 
314 315,316 
279 280,281 
259 260,261 
467 450,468,396 
434 435,436,437,407,405,393 
358 220,162,176,174,190,204,358,312 
285 286,268 
343 343,245,309,275,311,236 
1001 A 
8 1134 50 
:>-t 
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Figure 5.111.4 Effect of probe temperature on sen-
sitivity of detection of 8 representative drugs by PSP(+) 
LC-MS. An aliquot (200ng) of each drug in Table 5.11.2 
was injected via the column by-pass inlet at each of the 
tempera tures (300 0 , 330 0 , 270 0 and 240 0 C represen-
ted by a, b, c and d respectively). The traces show the 
partial ion chromatogram (sum of masses 200-600) and a 
mass chromatogram for m/z 78, from the ammonium acetate 
buffer. The mobile phase was methanol:ammonium acetate 
buffer (O.lM), 1:1 v/v. 
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Figure 5.111.5 Mass spectra of representative 
drugs obtained in PSP(+) LC-MS mode. The mobile phase was 
methanol:ammonium acetate buffer (O.lM), 1:1 v/v, and the 
TSP/PSP probe temperature was 270 o C. 
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The most significant changes in fragmentation patterns 
resulting from different probe temperatures were noticed 
for indomethacin and buprenorphine where their protonated 
molecular Ions tended to disappear at high temperatures 
while, in addition, the intensities of the fragment ions 
tended to vary as shown in Figure 5.111.6. 
5.111.3 EFFECTS OF SOURCE TEMPERATURE 
The mass spectrometer source block temperature was 
increased stepwise between 240-320°C during the 
operation of the LC--MS interface. At each source 
temperature mass spectra were recorded for 8 model drugs 
and these were examined and evaluated for the response, 
fragmentation pattern and peak shape of reconstructed ion 
chromatograms. The effect of source temperature on 
sensitivity did not follow a specific pattern. Peak areas 
from computer--reconstructed ion chromatograms of the most 
intense ion of each of the examined drugs are presented in 
Table 5.111.4. The results show that the best sensitivity 
was obtained at a source temperature of 270°C, which was 
almost general for the test compounds. There were no 
noticeable changes in the fragmentation patterns at the 
four different temperatures examined. Also, an obvious 
effect was noticed on the "peak" shape where there was 
less tailing with higher source temperatures, although the 
peaks were similar to those obtained in flow injection 
analysis and were not 
However, a temperature of 
sensitivity and peak shape. 
actual chromatography 
270°C was reasonable 
peaks. 
for both 
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Figure 5. I I 1.6 Effect of probe temperature on the 
mass spectra of buprenorphine and triazolam obtained in 
PSP(+) LC-MS mode. The mobile phase was MeOH: ammonium 
acetate buffer (O.lM), 1:1 v/v, and the TSP/PSP probe 
temperature was at 300 0 ,330 0 ,270 0 and 240 0 C 
represented by A,B,C and D respectively. 
Table 5.111.4 
sensitivity of 
PSP(+) LC-MS. 
Effect 
detection 
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of 
of 
source temperature 
8 representative 
on 
drugs 
the 
by 
COM P 0 U N D 
Peak area of the ion used (m/z) at 
source temperature °C 
Cannabindiol 
Doxepin 
Propranolol 
Buprenorphine 
Flupenthixol 
Indomethacin 
Morphine 
Triazolam 
240 
11449 
2816 
18720 
1899 
3949 
2107 
10427 
2075 
270 
12232 
27179 
25143 
1353 
4587 
2958 
10291 
2697 
300 
7472 
18894 
17275 
1573 
3398 
1355 
8132 
2174 
320 
10573 
14118 
28381 
1206 
4146 
2724 
10952 
2451 
Probe temperature was 300°C and mobile phase was O.lM 
ammonium acetate buffer:MeOH (1:1, v/v) 
5.111.4 DISCHARGE VOLTAGE IN PSP MODE 
In the normal PSP operation, a discharge voltage of 
350V is generated at the probe tip. The PSP module has an 
analogue control which allows the discharge voltage to be 
increased in 6 increments, up to 600V. Such an Increase 
showed higher sensitivity in response (Figure 5.111.7) 
with no apparent change in the fragmentation pattern of 
morphine or triazolam. However, the increase in 
sensitivity was obtained at the expense of ion beam 
stability where the TIC chromatogram was full of spikes in 
the background and on the sample chromatographic peaks, 
resulting in irreproducible response and a decrease in 
signal to noise ratio (Figure 5.111.7). 
5.111.5 EFFECTS OF MOBILE PHASE CONSTITUENTS 
The aim of this experiment was to assess the effect 
of changing the mobile phase composition on both TSP and 
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F'igure 5.111.7 Effect of PSP discharge voltage on 
sensitivity of detection of morphine and triazolam. The 
traces show the intensities of the total ion current (A) 
and partial ion current above mass 200 (B) as a function 
of PSP discharge voltage from 350 to 600V, where 200ng of 
morphine (M) and triazolam (T) were introduced separately 
at each setting via the column by-pass inlet. The mobile 
phase was methanol:ammonium acetate buffer (O.lM), 1:1 
v/v, and the TSP/PSP probe temperature was 270°C. 
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PSP modes, but due to the difficulties occurring in the 
TSP mode such as mass spectral peak instability and poor 
response, the experiment was conducted on PSP mode only. 
The results of using different mobile phases based 
on ammonium acetate buffer, MeOH and ACN on the 
sensitivity of detection of buprenorphine in PSP(+) mode 
are listed in Table 5.I11.5. 
Table 5.I11.5: Effect of different mobile phase 
constituents on mass spectral peak profile and on response 
and reproducibility of LC-MS of buprenorphine. 
Mobile # Average C.V% Peak * Pump Pressure 
Phase Peak Area Stability 'Bar' 
Methanol 2200 9.5 Poor 55 
Water 2941 3.1 Poor 95 
O.OlM Buffer** 8822 24 Unstable 93 
0.05M Buffer 13300 17 Good 92 
0.10M Buffer 15004 17 Better 92 
0.15M Buffer 21381 4 Best 92 
0.20M Buffer 20823 15 Good 92 
0.30M Buffer 21792 14 Good 94 
0.15M Buffer:MeOH 21000 12 Good 125 
( 1 : 1, v/v) 
0.15M Buffer:ACN 86936 14 Best 78 
(1/1, v/v) 
0.15M Buffer:ACN: 56741 10 Good 95 
MeOH (1:1:1, v/v:v) 
Acetonitrile 6711 20 Unstable 45 
** Buffer:Ammonium acetate, 
C.V%: coefficient of variation for 5 replicate injections. 
* Peak profile of ion at m/z 450. 
# Based on area under peak in computer-reconstructed ion 
chromatograms for [MH-H20]+ 
They show a significant influence on sensitivity in 
general. The increase in sensitivity of detection was for 
both buprenorphine and mobile phase constituents, but the 
sensitivity for buprenorphine has far exceeded that of the 
other mobile phase constituents. Buprenorphine peaks 
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started to become visible in the TIC chromatogram when ACN 
was included in the mobile phase. As the buffer 
concentration increased the protonated molecular ion of 
ammonium acetate (m/z 78) started to reach full-scale 
intensity on the detector and meaningful measurements 
could not be taken to compare its response with that of 
the analyte. 
However. increasing the strength of the buffer was 
accompanied by increased sens i t i vi ty (Figure 5. I I I. 8) up 
to a buffer concentration of 0.15M. At the same time, the 
reproducibili ty of response based on peak area improved. 
Higher buffer concentrations gave a full-scale response in 
the TIC chromatogram and worsened the reproducibility. 
although there was no significant change in the 
sensitivity. Methanol increased the back pressure on the 
HPLC pump while ACN reduced the back pressure. The major 
ion obtained for buprenorphine [(MH-H2 0)+ at m/z 450] 
was obtained in all mobile phases. However. the 
improvement of sensitivity obtained at higher ammonium 
acetate concentrations permitted other ions to be detected 
as well. such as m/z 396 representing the loss of the 
N-alkyl group. 
5.111.6 REPRODUCIBILITY OF RESPONSE 
The work described in previous sections showed 
that the peak area reproducibility varied according to 
the operating conditions. In this experiment the 
reproducibility was tested after fixing all variables such 
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Figure 5.111.8 Ammonium acetate 
ion in the mobile phase versus the 
response to 5 replicate injections of 
phine introduced in each mobile phase 
interfase. 
buffer concentrat-
mass spectrometer 
200ng of buprenor-
via the PSP LC-MS 
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as probe temperature. mobile phase composition. source 
temperature and flow rate. The coefficients of variation 
for seven replicate injections of buprenorphine (200ng 
each) were 7 and 18% for peak area and height. 
respectively. and were 9 and 17%. respectively. for 
fourteen replicate injections of doxepin (200ng each) 
(Figure 5.111.9). 
5.111.7 SENSITIVITY 
The lowest amount of buprenorphine introduced to 
the mass spectrometer via the by-pass connection and the 
PSP LC-MS interface was 1.2ng. where a full scan spectrum 
was acquired. Only the base peak was observed a t lower 
concentrations. However. this experiment was conducted 
after prolonged use of the interfac~. when both the source 
block and the probe were dirty. leading to loss of 
sensitivity and instability of the lon beam. Because of 
this, the detection limit could only be demonstrated down 
to O.3ng by SIR and the experiment could not proceed 
further. 
5.111.8 DRUGS AMENABLE TO LC-MS 
Several drugs representative of those which are 
commonly observed in forensic toxicology were introduced 
separately to the mass spectrometer at 200ng each via the 
TSP/PSP LC-MS interface to evaluate their spectra using 
the PSP(+) mode of ionization. The mobile phase was 
MeOH:ammonium acetate buffer (O.lM). 1: 1 v/v. at a flow 
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Figure 5.111.9 Reconstructed partial ion chromato-
grams (above mass 200) showing the response reproducibil-
ity on the TSP/PSP LC-MS interface for two model drugs. 
buprenorphine (above) and doxepin (below) where several 
aliquots of 200ng of each were introduced via the column 
by-pass inlet. The LC-MS interphase was operated on 
PSP(+) mode and the mobile phase was methanol:ammonium 
acetate buffer (O.lM). 1:1 v/v. and the TSP/PSP probe 
temperature was 230 oC. 
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rate of lml/min and probe temperature of 270°C. The 
most abundant ions obtained for these compounds are listed 
in Table 5. I I 1.6 and examples of their mass spectra are 
shown in Figure 5.111.10. 
Table 5.111.6 Drugs, their molecular weights (M.Wt) 
and ions obtained by PSP(+) LC-MS. 
COM P 0 U N D 
B-Hydroxyethyl 
Theophylline 
Caffeine 
Carbamazepine 
Chlordiazepoxide 
Clobazam 
Clonazepam 
Codeine 
Dextromethorphan 
Dextromoramide 
Diamorphine 
Diazepam 
Dipipanone 
Flurazepam 
Lorazepam 
Lysergide (LSD) 
Methadone 
Morphine 
Morphine-3-
glucuronide 
Nalorphine 
Naproxen 
Oxazepam 
Pentazocine 
Pethidine 
Temazepam 
Theophylline 
Verapamil 
M.WT 
224 
194 
236 
299 
300 
300 
299 
271 
392 
369 
284 
349 
387 
321 
323 
309 
285 
461 
311 
230 
286 
285 
247 
300 
180 
454 
Base Peak and Other Ions (m/z) 
225,226 
195 
237,238 
284,300,273,237,294 
301,303,318,267 
301,181,303,318,267,222,237 
300,282,317 
272 
393 
370,328,310,286,268 
285,287,286 
350 
388,390 
303,305,307,271,321,163,253 
324,325 
310,311 
286,286,303 
286,462,303,268,194,444,227 
312,313,314,294,272 
231,248,185,232,233 
269,271,287,268 
286,287 
248 
301,303,267,286,237 
181 
456,212,291,305,196 
These spectra provided molecular weight information on the 
majority of the compounds examined, especially for those 
where little or no fragmentation occurred and where scant 
structural information could be obtained. The base peaks 
of most of these compounds were the protonated molecular 
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lons [MH] +: only for lorazepam was this ion less than 
2% of the base peak. Other important characteristic ions 
were [MH-H2 0] for nalorphine, codeine and clonazepam as 
well as oxazepam and lorazepam where this ion was also the 
base peak. Chlordiazepoxide yielded a base peak ion which 
corresponded to loss of oxygen from the protonated parent 
molecule. 
5.111.9 
5.111.9.1 
HPLC-MS 
BASIC DRUGS 
Development trials were carried out to optimize a 
mobile phase based on aqueous ammonium acetate buffer and 
an organic modifier of MeOH and/or ACN for the separation 
of a mixture of basic drugs. The results obtained are 
listed in Table 5.111.7 and an example of a separation is 
shown in Figure 
constituted from 
5. I I 1.11, for which the mobile phase was 
MeOH:ACN:O.2M ammonium acetate buffer 
65:20:15, (v/v:v) . The following points were observed 
during this experiment: 
I. The HPLC column added an extra back pressure on top 
of that generated by the flow resistance in the probe and 
the back pressure caused by the column was slightly lower 
with organic solvents than with water, and a flow rate of 
1-1.2ml/min could be obtained. An upper pressure limit of 
200 bar was used to prevent damage to the HPLC column. 
I I . The inc Ius ion of ammonium aceta te buf fer produced 
better chromatography as well as a better response. 
However, drugs such as amitr i pt yline, methadone, 
Table 5. Ill. 7 Effect of different mobile phase constituents on capacity factor, chromatographic peak shape 
and response during PSP(+) LC-MS of basic drugs. 
Flow Pump Cap a c MOB I L E 
P HAS E 
v/v/v 
Rate Pressure 1 2 
(ml/min) (Bar) 
MeOH waler 
30:20 
MeOH:0.05 
buffer 
80:20 
MeOH:0.1M 
buffer 80:20 
MeOH:O.IM 
buffer 90:10 
MeOH:ACN:0.2M 
buffer 
80:10:10 
1 
1 
1 
1.2 
1 
175 1.1 3.6 
174 1.0 3.4 
175 0.9 2.0 
180 0.4 0.5 
171 0.4 9.6 
i t y F act 0 r 
3 4 5 
3.6 nil nil 
3.7 4.7 4.9 
3.3 3.5 4.2 
1.0 1.6 2.6 
1.1 2.1 2.6 
( k' ) o f D rug N 0: '/( REM ARK S 
6 7 8 9 10 11 
nil nil nil nil nil nil Intensity is very 
low except for 
caffeine 
7.2 10.8 diff diff diff diff Slightly improved 
response and 
separation 
6.9 
3.1 
3.0 
9.4 14.4 diff diff diff Improved response 
and better peak 
shape 
3.3 
3.3 
6.1 diff diff diff ¥urther improvement 
of response and 
6.0 diff 8.4 
and peak shape 
6.3 Better response and 
peak shape, the 
last 4 peaks have 
severe tailing 
MeOH:ACN:0.2M 1 165 0.8 2.0 2.6 3.6 5.3 9.0 11.38 diff diff diff diff Betler separation, 
buffer 65:20:15 slight peak tailing 
MeOH:ACN.0.2M 1 158 0.3 0.8 1.4 1.8 2.1 3.1 3.7 5.5 diff 8.4 6.6 Betler response,bul 
buffer 50:20:20 poorer separation 
MeOH:ACN:0.2M 1 
buffer 50:30:20 
155 0.3 0.8 0.8 0.8 1.1 2.2 3.8 4.7 diff 9.:3 7.9 Poor separalion 
diff -= diffused, nil -= nol observed, *1 = caffeine, 2 = oxazepam, 3 = pentazocine, 4 = diazepam,S.:: codeine, 
6 = pethidine, 7 = dextromoramide, 8 = methadone, 9 = amitriptyline, 10 = dextromethorphan, 11 ..:: dipipanonc. 
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Figure 5. 111.11 Computer reconstructed total ion current chromatogram obtained by HPLC-MS of a 
nlixture of basic drugs (200ng of each drug on column). The LC-MS interfase was operated in PSP(~' ion mode, 
the mobile phase was mcthanol:acetonitrile:ammonium acetate buffer (0.2M), 65:20:15 v/v/v, pH 7.6, the flow 
rate was O. 9ml/mi n, The chromatography was performed on an ODS-Hypers i 1 25cm X 4. 6mm 10 column and the 
TSP/PSP probe temperature was 270oc. 
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dipipanone and dextromethorphan eluted either as severely 
tailing or diffused peaks. 
III. The pH of the mobile phases ranged from pH 7.4-7.7 
due to the ammonium acetate buffer. 
5.111.9.2 HYPNOTIC AND ANTICONVULSANT DRUGS 
Both positive and negative plasmaspray ionization 
modes were tried. The sensitivity to barbiturate drugs in 
PSP(+) LC-MS was very poor, so optimization of the mobile 
phase was based on PSP (-) mode, where only drugs which 
generate 
separation 
negative ions 
was obtained 
were monitored. A 
using a mobile 
reasonable 
phase of 
MeOH:ACN:O.1M ammonium acetate buffer 5:5:11 (v/v:v), 
adjusted to pH 5.5 with acetic acid (Figure 5.111.12). 
The flow rate could not be increased above lml/min within 
the pressure limit of the column due to the viscosity of 
the mobile phase. 
Mass spectral fragment ions of the drugs examined 
via the TSP/PSP LC-MS interface in both positive and 
negative ion mode are listed in Table 5.111.8. The 
chromatogram obtained in negative ion LC-MS showed that 
the response for barbiturate drugs was very high but was 
poor for non-barbiturate drugs such as methaqualone, 
glutethimide and carbamazepine. However, the 
chromatograms obtained in the negative ion mode for 
barbiturates had less background noise and less 
interference than those in the positive ion mode, which 
would result in better detection. 
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400 1200 1400 1600 Scan no. 
Figure 5. I I 1.12 Computer reconstructed total ion 
current chromatogram obtained by HPLC-MS of a mixture of 
phenobarbitone (a), butobarbitone (b), phenytoin (c), 
amylobarbitone (d) and quinalbarbitone (e) (200ng of each 
drug. on column). The LC-MS interfase was operated in 
PSP(-) ion mode, the mobile phase was methanol :acetonitr-
ile:ammonium acetate buffer (0.2M), 5:5:11 v/v/v, 
adjusted to pH 5.5 with acetic acid; the flow rate was 
1ml/ min. The chromatography was performed on an 
ODS-Hypersil 25cm X 4.6mm ID column and the TSP/PSP probe 
temperature was 230 oC. 
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Table 5.111.8 Prominent ions in the PSP(+) and PSP(-) 
LC-MS spectra of sedative and anticonvulsant drugs. 
COM P 0 U N D M.Wt Base Peak and other ions 
positive Mode Negative Mode 
Phenobarbitone 232 233,114,207,234 
178,188,219 
231,156,203,232 
Amylobarbitone 
Carbamazepine 
Quinalbarbitone 
Phenytoin 
Methaqualone 
Glutethimide 
N D: not detected. 
226 
236 
238 
252 
250 
217 
227,158,184 
237,194,238,180 
239,240.241 
169,170 
253,182,254,183 
251,168,252 
218,219,168,154 
5 . I I I . 9 . 3 SEPARATION OF OPIATES 
225,197,155 
193,194,207 
197,237,167 
251,252,197 
N D 
N D 
I. Effect of Probe Temperature on Morphine-3-
glucuronide (M3G) 
The effect of variation of the probe temperature 
between 120-300°C on the sensitivity and fragmentation 
pattern of M3G was clearly demonstrated. In this 
instance, the samples were introduced Vla the column 
by-pass inlet. Although the highest response measured on 
the TIC chromatogram was obtained at a probe temperature 
of only fragment ions corresponding to free 
morphine in the form of and were 
observed. At lower probe temperatures, the protonated 
molecular ion of M3G started to appear with an intensity 
of 10% and 20% of the base peak (m/z 286) at probe 
temperatures of 200° and 150°C, respectively. Other 
ions present were those of morphine, and m/z 444, 
representing loss of H20 from the parent molecule and 
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m/z 194, the ammonium adduct of the glucuronide fragment 
(Figure 5. I I 1.13) . However, the appearance of the 
protonated M3G molecule corresponded to an overall loss of 
sensitivity. 
II. Mobile Phase With Acidic Buffer 
In this experiment the PSP probe was operated at 
temperatures of lBO-200°C in order to locate morphine 
and M3G. The mobile phases examined were similar to those 
described in section 5.111.9.1 but the pH of the mobile 
phases ranged from pH 3.4-4.5, adjusted by the addition of 
acetic acid. The following remarks can be made on the 
results: 
1. Mobile phases containing only water and MeOH 
were insufficient to elute the analyte and give a 
good response within a reasonable time. 
2 . Mobile phases based on ammonium acetate 
buffer with acetic acid adjustment of the pH had 
improved the response and the presence of organic 
solvents in the range of 20-30% (v/v) in such 
mobile phases provided reasonable separation of 
morphine, M3G 
obtained using 
and nalorphine. 
a mobile phase of 
A separation 
MeOH:ACN:0.05M 
buffer at pH 4.0 with a flow rate of O.Bml/min is 
shown in Figure 5. I I 1.14, which could be used for 
identification and quantification, but which still 
showed peak tailing, especially for M3G. A sharper 
peak shape could not be obtained by using a higher 
flow rate, which was limited by the viscosity of 
100 
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Figure 5.111.13 LT1C trace (above mass 200) and 
morphine-3-glucuronide (M3G) mass spectrum generated in 
the PSP(+) ion mode. The sample of 200ng of M3G was 
introduced via the column by-pass inlet. The mobile 
phase was methanol: ammonium acetate buffer (0 .1M), 1: 1 
v/v, and the TSP/PSP probe temperature was 200 oC. 
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Figure 5. I I 1.14 Computer reconstructed total ion 
current chromatogram from HPLC-MS of a mixture of M3G, 
morphine and nalorphine (200ng of each on column). The 
LC-MS interphase was operated in PSP(+) ion mode, the 
mobile phase was methanol:acetonitrile:ammonium acetate 
buffer (0.05M). 8:15:77 v/v/v, adjusted to pH 4.0 with 
acetic acid; the flow rate was Iml/min. The chromatogr-
araphy was performed on an ODs-Hypersil 25cm X 4.6mm ID 
column and the TSP/PSP probe temperature was 200 o C. 
I I I . 
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the mobile phase containing acetic acid, which 
resulted in a high back pressure. However, the 
addition of ACN permitted a flow rate of 0.8ml/min 
to be used for the separation with a pump pressure 
of 188 bar. Acetonitrile/buffer mobile phases 
permitted higher flow rates but peak tailing was 
more pronounced. 
Mobile Phases Containing Diethylamine 
Further work was conducted to optimize the mobile 
phase for the separation of morphine, nalorphine and M3G 
based on solvent constituents as described above with the 
addition of diethylamine (DEA) as a volatile base to 
compete with the drugs for acidic sites on the silica 
surface caused by the presence of unsubstituted hydroxyl 
groups. The amount of the DEA added to the mobile phase, 
based on a buffer of ammonium acetate and organic solvent, 
was critical. Increasing the concentration of DEA was 
gradually accompanied by decreases in retention time and 
loss of resolution. Concentrations in the range 0.1-0.5% 
of DEA in the buffer produced early elution of M3G, 
morphine and nalorphine with narrow separation, usable for 
identification and quantification purposes on recon-
structed ion chromatogram of each compound, but the peak 
tailing was not eliminated. Increasing the concentration 
of DEA to more than 0.5% led to elution of the above drugs 
with the solvent front, but gave good sharp peaks for 
late-eluting drugs such as buprenorphine, which normally 
require gradient elution for best results. The 
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use of DEA in water-only based mobile phase gave similar 
results as those in the previous sections, namely that the 
response was very poor and that analyte could not be 
readily detected. 
Both ammonium acetate and DEA resulted in a 
slightly basic mobile phase, which, after passing through 
the HPLC column to the LC-MS interface caused a gradual 
increase in the back pressure, after only a few runs. 
This partial blockage necessitated gradual lowering of the 
flow rate so as not to exceed the pressure limit of the 
HPLC column. 
5.111.10 CLEANING OF SOURCE AND PROBE 
Blocking of the capillary tubing in the probe was 
rarely caused by insoluble 
of the in-l ine f i I ter and 
particles due to 
the fused silica 
the presence 
column. The 
major cause of blocking was the use of basic mobile phase 
which dissolved silica material from the HPLC column. The 
heated probe precipitated these materials after 
evaporation of the solvent. A solution of citric acid was 
efficient in clearing the partial blockage caused by this 
type of precipi tate. However, caution had to be exercised 
when using this solution since prolonged application with 
excessive heat occasionally resulted in perforation of the 
capillary tubing. Once complete blockage had occurred, 
the tubing was replaced wi th a new length of capi llary, 
fixed in place with silver solder, which was a relatively 
easy procedure. Careful application of the solder was 
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required to avoid "dry" joints for 
A recently available modification of 
the capillary can be screwed into 
proper conductivity. 
the probe in which 
the probe should be 
easier and faster to repair. Also, a new modification of 
the source by the addition of a desolvation chamber 
resulted ln reduced frequency of source cleaning. The 
source block was easily removable without interference 
from the source assembly, resulting in an easier and 
faster cleaning procedure. The probe tip used to get 
dirty quickly after switching to PSP mode due to the 
deposition of pyrolysed material. This charred material 
appeared ln mobile phases containing organic solvent, 
especially when ACN was included. The net effect was the 
appearance of unstable, spikey and irreproducible peaks 
with loss of sensitivity. Consequently, the use of such 
solvents in the PSP mode necessitated cleaning both the 
source block and the probe tip at the end of the working 
day. Also, careful attention was required to monitor the 
temperature of the probe, which changed as a result of 
changing the solvent unless the probe control was manually 
adjusted. 
- 267 -
S. IV DIS C U S S ION 
S. IV. 1 INTRODUCTION 
Recent applications of the TSP LC-MS interface 
suggest that such an interface has special advantages. 
These include the ability to interface a conventional HPLC 
to a mass spectrometer. where up to 2ml/min of aqueous 
eluent can be introduced. It provides very mild 
ionization conditions while the latest modification on 
this interface. the PSP ionization mode. should provide 
both ionization and structural information for the analyte 
without the need for an external source of ionization or 
restriction in the mobile phases as in the TSP mode. 
Understanding the limitations and 
parameters controlling 
pre-requisite for full 
the TSP/PSP 
advantage to 
interface for routine applications. 
the operational 
interface is a 
be taken of the 
5 . IV. 2 EFFECT OF PROBE TEMPERATURE 
The mass spectral peak profiles in the PSP mode 
were smoother and more stable than those obtained in the 
TSP mode. which was a direct result of the generation and 
ionization processes. The ions were transported in an 
aerosol jet of droplets and vapour and sampled at the 
sampling orifice. The plasmaspray was operated at higher 
temperatures which resulted in a finer aerosol jet and 
consequently more homogenous sampling. The high operating 
temperature also resulted in more sensitivity for analytes 
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of low volatility and lowered 
volatility components of the 
these led to lower background 
detection limit. 
the dependence on the high 
mobile phase. Together, 
noise and hence a better 
However, very high probe temperatures resul ted in 
lower sensitivity to analytes, which might be due to 
sample pyrolysis [351]. Furthermore, prolonged operation 
at high temperature could cause both deposition of solids 
within the capillary, leading to blockage and coating of 
the tip with pyrolysed, non-conducting material leading to 
an interruption in the plasma discharge. Neverthless. 
relatively high probe temperatures could be used to induce 
fragmentation without significant loss of sensitivity 
[312,352]. This was not true for all drugs examined: 
indomethacin and buprenorphine showed only minor 
variations while flupenthixol and triazolam gave the same 
mass spectra at different temperatures examined. Others-
morphine, amitryptiline and cannabidiol - were resistant 
to significant fragmentation. The different sensitivities 
obtained for the limited range of drugs examined at 
various probe temperatures, indicate that no fixed probe 
temperature can be applied for optimum response for all 
analytes. However, the temperature in PSP mode is not as 
critical as in TSP mode and this interface can be used for 
screening for the presence of a limited group of drugs 
with a wide range of sensitivities that might be low or 
nil for an unknown, Moreover, there is no single test 
compound or test mixture tha t wou ld be ideal for 
optimizing the probe temperature. 
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Initial tuning of the mass spectrometer on the 
protonated ammonium acetate ion is commonly used in TSP 
mode. Throughout the limited work carried out in this 
mode such tuning was satisfactory (Figure 5.III.2(b»: 
the intensity of [MH]+ of amitriptyline followed that of 
the buffer ion when the probe temperature was varied. 
This can be explained by the fact that TSP ionization is 
similar to conventional CI, which depends on the reagent 
gas, ion/molecule reaction rate constant, sample 
concentration and reaction time to yield the analyte ions 
[305,351]. This tuning maximizes the yield of buffer ions 
and hence the (secondary) analyte molecule ions. Such 
tuning is not always valuable in PSP mode (Figure 
5.111.3), which does not depend on solvent ions for 
optimum response but depends on the volatility of the 
analyte as discussed earlier. 
5. IV. 3 EFFECT OF SOURCE TEMPERATURE 
A symmetrical peak is an important requirement for 
good chromatography. The source temperature should be 
kept at a high temperature to maintain the volatilized 
analyte molecules emerging from the probe in the vapour 
phase, otherwise low volatility high molecular weight 
material tends to condense on the source block, which will 
be followed by gradual re-evaporation leading to peak 
tailing. This was evident when PEG was introduced to the 
mass spectrometer, where a high source temperature was 
needed to clear the deposited high molecular weight 
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material from the source block. This was less obvious for 
the examined drugs. However. no thermal degradation was 
observed at the source temperatures examined beyond what 
resulted from the probe temperature. 
5. IV. 4 EFFECT OF DISCHARGE VOLTAGE 
Increased sensitivity was observed by raising the 
discharge voltage and this could be explained by increased 
ionization of the analyte by the glow discharge. However. 
the irreproducibility and instability of response which 
was also observed with higher discharge voltages might be 
because the rate of ionization was not as stable and 
homogeneous as under normal operation. Higher voltages 
are not required during normal PSP operation and there is 
no added value with respect to structural information for 
the analyte. Also. the increase in noise level 
accompanying the rIse in analyte response did not improve 
the detection limit. 
5. IV. 5 EFFECT OF MOBILE PHASE CONSTITUENTS 
The literature has frequently addressed the effects 
of ammonium acetate buffer [334.353] and mobile phase 
constituents on thermospray ionization and response. 
Plasmaspray ionization depends on glow discharge 
(discharge ionization) [312,354,355] where the response 
should be independent of the mobile phase constituents for 
its optimum response. 
contradict the earlier 
However. the resul ts presented here 
work, at least in respect of the 
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examined drugs. A significant improvement in response was 
produced by the introduction of increasing amounts of 
ammo n i u mac eta t e b u f fer , s i mil art 0 T S P [ 3 3 4 , 3 3 9] but i n 
this case, the optimum response occurred at higher levels 
of buffer concentration than those expected for TSP. 
These findings suggest that both modes of ionization (TSP 
and PSP) might be occurring simultaneously, especially if 
the probe tip was dirty and glow discharge ionisation was 
inhibited. Similarly, organic modifiers have enhanced the 
ionisation efficiency and ion beam stability, both of 
which were higher in the presence of ACN than MeOH. 
Mobile phases containing either solvent were better than 
an aqueous solution alone. These results could be 
explained by an easier ejection of the ions from the 
droplets of a highly organic solvent system than from an 
aqueous system. The decrease of the droplet surface 
tension with the increase of probe temperature will 
further lower the barrier to desorption of the ions from 
the droplet as described for TSP ionization [306]. 
However, the optimum solvent system for TSP/PSP ionisation 
should be determined together with its suitability for 
optimum chromatographic separation of the analytes of 
interest. 
5 . IV. 5 
O.3ng 
LC-MS 
SENSITIVITY AND REPRODUCIBILITY 
The sensitivity obtained for buprenorphine (1.2 and 
by full scanning and SIR, respectively) by PSP(+) 
was more or less similar to the detection limit 
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quoted for TSP, although better and poorer sensitivities 
have been reported for different groups of compounds, 
ranging from pg-ng levels. It is important to recognize 
that TSP ionization can be particularly sensitive for 
certain analytes but frustratingly insensitive for others 
[323]. Plasmaspray ionization should be better due to its 
mode of operation and several compounds should be assessed 
to define their detection limit before a conclusion is 
drawn on the overall sensitivity. However, sensitivity 
and reproducibility can be further improved by careful 
optimization of the operating parameters such as probe 
temperature, flow rate and mobile phase constitutents as 
well as by using a clean source and sampling cone, clean 
probe tip with clearly opened probe capillary and a smooth 
flow from the HPLC pump. These usually affect the ability 
of the ionization and ion sampling processes to produce a 
stable ion beam. 
S.IV.7 DRUGS AMENABLE TO LC-MS 
The spectra obtained under PSP(+) mode show that 
PSP is a soft ionization method for most of the examined 
drugs (Table S. 111.6) where the protonated molecular ion 
was either the base peak or even the only ion. This could 
be used to obtain molecular weight information. Other 
drugs showed significant fragmentation which could aid in 
structural elucidation of 
to fragmentation found 
the molecule. This was similar 
in TSP [322,347,353] where the 
fragmentation occurs due to thermal degradation. 
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Similarly, a common fragmentation process was the loss of 
water from the protonated parent molecule or a daughter 
ion [329]. A few compounds such as morphine, codeine and 
nalorphine showed ammoniated adduct 
of the base peak. The glucuronic 
ions at less than 10% 
acid fragment of M3G 
also formed an adduct with ammonia. These occurrences 
resemble gas phase reactions in CI where the protonation 
or ammoniation of the molecule depends on its proton 
affinity (PA). Protonated species are observed when the 
PA exceeds that of ammonia, and adduct ions are observed 
when the PA is less than that of ammonia [324]. The 
presence of both products in the PSP mode of operation 
suggests that the ionization process was a mixture of PSP 
and TSP ionization. 
The selection of positive or negative ions is an 
important deciding factor for sensitivity. For example, 
barbiturates gave very low sensitivity PSP(+) but very 
good sensitivity in the PSP(-) mode: similar results were 
reported for barbiturates using TSP ionization [339,356]. 
High sensitivity in negative ion MS can be obtained for 
compounds which have a high electron capturing affinity, 
such as organochlorine pesticides [337]. This mode has 
also been used for the identification of steroid 
glucuronides using TSP [327]. 
Therefore, in a case where a negative result was 
obtained in the analysis of an unknown compound, it 1S 
important to consider that 
as the probe temperature 
the 
or 
operating conditions such 
the mode of ionization 
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(positive or negative) were possibly not suitable for that 
compound. It would be ideal if a mass spectrometer with 
an LC-MS interface could be operated in PSP(+) and PSP(-) 
alternatively, similar to GC-MS, but this is not possible 
due to the incompatibility of tuning the mass spectrometer 
in both modes at the same time. 
The spectra obtained in 
were dominated by the presence 
peak. Other fragments resulted 
PSP(-) for barbiturates 
of (M-1)- as the base 
from the loss of alkyl 
groups from the parent molecule. For example, in the 
spectrum of amylobarbitone m/z 225 is (M-1) and ions at 
m/z 155 and 197 result from the loss of the isopentyl and 
ethyl groups from parent molecule, respectively. However, 
a more comprehensive drug list should be examined using 
different modes to compile libraries for the drugs 
commonly encountered in forensic toxicology, to be used as 
a reference for identification of unknowns. 
5. IV. 8 HPLC-MS 
From the previous discussion, several points have 
to be considered before introducing the HPLC effluent to 
the mass spectrometer via a TSP/PSP LC-MS interface, for 
efficient and trouble-free operation. Firstly, only 
volatile buffers and volatile ion pair reagents can be 
used, if required, to prevent precipitation of involatile 
material inside the probe. Secondly, although the use of 
this interface in PSP mode should be applicable to all 
solvents, the optimum response requires the presence of 
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ammonium acetate buffer with an organic modifier. 
Thirdly, albeit this interface can permit up to 2ml/min of 
mobile phase to be introduced to mass spectrometer, the 
presence of an HPLC column was the limiting factor, 
because the back pressure generated by the column and by 
the resistance in the probe capillary should not exceed 
the packing pressure of the column, which is usually 200 
bar, otherwise the packing material would be distorted. 
The aims of using LC-MS were to take full advantage 
of its application as described earlier and to complement 
rou tine HPLC a pp I ica t ions f or fur ther ident i fica t ion and 
unequivocal confirmation. A special interest was taken in 
drug metabolites, sush as morphine glucuronides. where the 
presence of 6-monoacetyl morphine-3-glucuronide could 
confirm a previous heroin intake [81]. 
However, modification of an HPLC procedure to suit 
this LC-MS interface was not always easy. The mobile 
phase for hypnotic and anticonvulsant drug separation was 
modified by direct exchange of the non-volatile buffer 
with ammonium acetate [349]. LC-MS application was 
hampered by the limitation on the mobile phase flow rate 
due to high back pressure. and one mode of ionization 
[PSP(-) or PSP(+)] was insufficient to detect all the 
applied drugs. 
It was not possible to obtain as good a 
chromatographic separation of morphine and its metabolite 
M3G as in previously described methods [96.357]. The pH 
of the LC-MS mobile phase could not be lowered to pH 2.1 
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using ammonium acetate/acetic acid, because the latter is 
a weak acid with a pK of 4.8 at 25° [358], whereas in 
a 
the published method phosphate buffer was used. Another 
problem was that a single probe temperature could not be 
used to give optimum response for morphine and M3G 
simultaneously and thus to identify them from their intact 
protonated molecular ion. The diethylamine could be used 
to produce reasonable chromatography of the basic drugs. 
Even if incomplete separation of drugs was present, the 
known analytes could be quantified or distinguished by 
monitoring the abundance of selected ions In the mass 
spectra. 
partially 
However, basic mobile phases containing DEA, 
dissolved the silica material in the column, 
followed by deposition and partial blockage of the probe 
which limited the flow rate. Changes in the flow rate 
will lead to irreproducible retention times which 
otherwise could be used with the molecular weight or full 
mass spectrum for identification. 
Identification of drugs without chromatography 
could be done by loop only injection in a manner similar 
to flow injection analysis, where biological fluids such 
as gastric lavage and urine could be tested without 
extensive purification. Such identification requires the 
existence of a library of drug spectra, although complex 
mixtures might be confusing. 
The above presentation has shown that, although TSP 
LC-MS is the most popular interface [359] and is suited to 
conventional HPLC, which can be further expanded to normal 
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phase using PSP mode, none of the available LC-MS 
interfaces is as effective as the established GC-MS 
interface. Also, the work has shown that only by 
understanding the parameters controlling the LC-MS 
interface can all its advantages be utilized. 
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C HAP T E R S I X 
CONCLUSIONS 
In this study, work was carried out in three areas 
of Forensic Toxicology to develop methods which can be 
used for routine analyses of drugs and solvents in 
biological samples, either clinically derived or from 
autopsy. As time allowed these were applied to samples 
from real cases. 
In the first study, a solid phase extraction 
procedure was evaluated for the extraction of basic drugs 
from whole blood samples. This method was based on the 
extraction of the sample through two different colums of 
solid phase material. The first column was packed with 
Extrelut (diatomaceous) material where the buffered blood 
sample was absorbed by the Extrelut. The drugs were eluted 
into a second column containing a cation exchange sorbent 
(Bond-Elut SCX) where the drugs were adsorbed, purified 
and finally recovered. The extracts were analysed 
following preparation of EDMS derivatives by capillary 
GC-EIMS using full scan and SIR acquisition modes. A clean 
extract was obtained. The extraction efficiency and 
reproducibility (as S.D.) for the model drug morphine in 
spiked blood samples were 92±5% and 95±4% at 35 and 
560ng/ml, respectively. For buprenorphine these were 
83±5% and 87±4% at 0.5 and 8ng/ml, respectively. For 
other drugs evaluated, the recovery was better than 80%. 
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This method was very sensitive. Buprenorphine could 
be detected by SIR-MS down to the low picogram level. The 
procedure was mainly applied for routine analysis of 
morphine and buprenorphine as well as other basic drugs. 
It had no limitations on its application to post-mortem 
blood. However, 
the analysis of 
resul ts wi th 
procedures. 
further application on a larger scale to 
these drugs is needed to correlate the 
those obtained with other established 
The silylating reagents EDMS-I and DETMDS 
demonstrated the ability to derivatize several drugs where 
both N-EDMS and O-EDMS derivatives were obtained. The 
extra methylene group in the product compared to the 
analogous TMS derivatives can increase the RRT or 
retention index of a drug as an aid to separation from 
interferences and identification of unknown substances. 
Derivatization using this reagent is rapid, similar to the 
analogous TMS donor reagents. It can be applied for 
routine GC and GC-MS analysis. However, to make 
identification easy and rapid, a library of retention 
indices and mass spectra of EDMS-drug derivatives for the 
commonly encountered drugs In forensic toxicology is 
required. Once these are prepared, an SIR procedure could 
be constructed to include a wide range of these drugs in 
separate groups by careful selection of their retention 
time windows and their representative masses. This 
procedure could be used as a screening method for the 
selected drugs without losing the sensitivity and the 
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quantification ability of SIR-MS. 
In the second study, two extraction methods were 
assessed for the analysis of paint solvents in blood, 
where C8 to 
model compounds 
materials. The 
n-alkane hydrocarbons were used as 
due to their presence in the paint 
first method was based on solvent 
extraction using high purity diethyl ether to extract 
b I 0 0 d sam pIe s aft e r sat u rat i n g the I a t t e r wit h a mm 0 n i u m 
carbonate. The extraction efficiency of such a procedure 
ranged from 70-91% with a reproducibility (S.D.) of 
11-18%. The volume of the final extract recovered was 
reduced to O.lml and aliquots were analysed by GC or 
GC-MS. 
method, 
This approach limited the sensitivity of 
its application 
the 
for which in turn limited 
occupational monitoring where low blood levels of solvents 
are expected. 
The other method was based on stripping the solvents 
from the blood sample by a dynamic head space technique 
(DHS). When the elution flask was placed in a water bath 
at 97 0 , an extraction efficiency better than 90% was 
produced. The recovered solvents were trapped on a 
Tenax-GC column and were subsequently transferred in total 
to the GC column. The chromatogram was free from 
interference from a solvent front or other extraction 
solvent residues. The absolute sensitivity is determined 
by the instrument on which the analysis is performed and 
where GC-MS is used a sensitivity down to the pg level can 
be obtained. However, a rna jor problem existed in the use 
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of this technique in an open laboratory environment and 
the presence of high background levels of contaminating 
solvents in the extraction and desorption system limited 
the determination of the sensitivity limit. even after 
these systems were cleaned. In future work. such systems 
should be reconstructed with new components and kept in an 
isolated room away from laboratory and atmospheric solvent 
contamination. 
The DHS method was applied to a pilot study for 
occupational monitoring of a group of painters to assess 
the presence of paint solvents in their blood. Two venous 
blood samples were collected at 
end of a working week. They 
several solvents similar to 
the beginning and a t the 
showed the presence of 
those present in paint 
material. The levels in the second series of samples were 
higher than those of the first series. The differences 
between the levels of the two samples were statistically 
significant 
The levels 
clearance of 
for n-nonane. n-undecane and alkylbenzene. 
in the first sample indicated incomplete 
these solvents from the body during the 
weekend. while the higher level ln the second samples 
indicated the uptake during the working week. However. a 
clean extraction system and clean glass sample vials for 
blood samples are required for accurate results. Once the 
analysis is free from contamination. in a future study the 
uptake of a solvent can be quantified and its hazards can 
be assessed. Other parameters will also be needed for 
accurate assessment. Examples of parameters which can 
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affect solvent uptake include details of work practice, 
history, 
well as 
physical status, past and 
smoking habit, alcohol and 
present clinical 
drug intake as 
including a matching control group. 
In the third study a thermospray/plasmaspray 
(TSP/PSP) LC-MS interface was assessed for its application 
to HPLC-MS in forensic toxicology using the plasmaspray 
ionization mode. Initially the operating parameters which 
control the sensitivity of the interface were evaluated. 
The probe temperature was critical for sensitivity and the 
extent of the fragmentation pattern of a compound. 
Although, during the PSP mode of operation the sensitivity 
was not severely reduced over a wide range of operating 
temperatures for a similar group of drugs, when an optimum 
sensitivity 
individually 
According 
plasmaspray 
that it has 
is required, the probe temperature has to be 
optimized for that particular drug. 
to the literature, another benefit of 
mode operation over that of thermospray is 
no restriction on the solvent used for LC-MS 
but it was nevertheless found that the sensitivity can be 
influenced according to the solvent system used. Mobile 
phases con ta ining ammonium aceta te buf fer produced bet ter 
sensitivity and peak stability which indicate that the 
ionization mechanism which occurred was a mixture of 
thermospray and plasmaspray ionization. Inclusion of 
organic modifier also improved the sensitivity further and 
acetonitrile was better than methanol in producing such an 
effect. This was probably due to the easier ejection of 
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the lons from the droplets coming out from the probe tip 
when they were composed of a mixed organic/aqueous solvent 
system rather than from a purely aqueous system. Another 
benefit of acetonitrile was the reduction of the back 
pressure on the HPLC pump which was generated from the 
column and the resistance inside the heated probe. This 
back pressure limited the flow rate used in HPLC-MS, which 
was in the range of lml/min, although the efficiency of 
the vacuum system can permit up to 2ml/min of solvent to 
be introduced to the mass spectrometer. 
Mobile phases containing ammonium acetate buffer or 
diethylamine produced slightly basic solvent 
which, once passed through 
stationary phase in the HPLC 
dissolution of this material 
the substituted 
column, resulted in 
which precipitated 
systems 
silica 
slight 
in the 
heated probe. This was the main cause of probe blockage 
and required frequent maintenance. Also, the presence of 
acetonitrile in the solvent system led to rapid loss of 
sensitivity due to the charring of the source and the 
probe tip which 
HPLC-MS 
required frequent dismantling and 
cleaning. was evaluated using three model 
mixtures of basic drugs, barbi turates and opiates. The 
optimum 
tha t of 
buffer, 
detector, 
chromatography obtained had poorer quality than 
conventional HPLC using, for example, phosphate 
but using the mass spectrometer as an HPLC 
chromatography can be useful for identification 
and quantification purposes. 
The mass spectra obtained were 
molecular weight information and gave 
mainly useful for 
little structural 
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Both negative and positive ion mass spectrometry can 
be used in plasmaspray, separately, but not alternately 
during acquisition. This limits the universality of mass 
spectrometric detection using the TSP/PSP interface for a 
screening procedure for unknown drugs where these might 
only be detected with sufficient sensitivity using one 
mode of ionization only, such as barbiturates, which 
require the negative ion mode. 
Another benefit of this interface, and where it can 
be used for a quick identification, is when clean samples 
suspected of containing only a few drugs are analysed 
using the by-pass inlet of the LC-MS. The compilation of 
a library of mass spectra acquired under specified 
conditions for the commonly encountered drugs in forensic 
toxicology could make these identifications rapid and 
reliable. 
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Appendix 1 Presents the listing of fragments above 
3% of the base peak 09{ained in EI or CI of the following 
compounds: 
1. 
2 . 
3 . 
4 . 
5 . 
6 . 
7 . 
8 . 
9 . 
10. 
11. 
12. 
13. 
14. 
15. 
16. 
17. 
18. 
19. 
20. 
21. 
22. 
23. 
24. 
25. 
26. 
27. 
Bis-TMS-morphine. 
Bis-EDMS-morphine. 
3 -M'I'BS-morphine. 
Bis-MTBS-morphine. 
Bis-EDMS-morphine (CI). 
Bis-EDMs-nalorphine. 
Bis-EDMS-nalorphine (CI). 
EDMS-buprenorphine. 
EDMS-buprenorphine (CI). 
EDMS-dehydrobuprenorphine 
EDMS-monoacetylmorphine. 
MTBS-codeine. 
EDMS-codeine. 
O-EDMS-pentazocine. 
BIS-EDMS-etorphine. 
O-EDMS-temazepam. 
O-EDMS-lormetazepam. 
O-EDMS-flupenthixol. 
N-EDMS-desmethyldiazepam. 
Bis-O-EDMS-cannabidiol. 
O-EDMS-testosterone. 
Dextromethorphan. 
Methadone. 
Caffeine. 
Dextromoramide. 
Dipipanone. 
Amitriptyline. 
BXS-Yill<;-llJj(lpp~ytyr ~XS-to~-NORPHlHE 3-PlTBS-fIIORPHlHE BIS~TBS-~ORPHlHE 
rr.us % Base Mass % Base MiSs Z Base Mass % Base 
!!:i9 7.3 58 3.2 55 6.4 56 3.7 
70 5.7 59 71.8 57 9.3 57 4.7 
73 100.0 59 9.2 58 17.1 59 7.0 
74 8.5 68 6.0 59 19.4 73 93.9 
75 . 15.2 61 5.2 7e 13.2 74 14.0 
77 4.2 7a 6.B 73 39.B 75 17.5 
79 5.0 73 5.6 74 13.1 77 3.1 
81 3.1 75 13.6 75 213.9 79 3.0 
94 5.5 87 41.2 81 12.8 81 4.8 
96 3.4 as 3.2 82 6.2 96 8.5 
129 3.1 89 5.9 94 8.9 115 3.1 
146 35.13 94 7.8 96 9.5 133 11.4 
147 7.3 133 4.a 96 7.a 146 16.4 
179 3.9 146 44.3 115 7.3 147 24.7 
196 45.9 147 5.9 124 21.2 148 3.5 
197 :7 .1 165 .$.4 133 8.7 177 4.4 
203 3.9 t~ . . 142 7.5 191 13.0 .... 
205 3.6 193 3.3 146 7.6 192 3.1 
207 15.2 283 5.4 162 27.1 193 8.9 
208 3.4 200 4.4 163 13.0 203 4.6 
216 7.5 207 6.6 165 6.6 285 5.8 
217 3.3 20a 3.2 179 10.7 287 56.9 
220 16.2 210 51.7 181 6.1 2aB 22.4 
221 7.5 211 la.2 186 7.0 209 16.4 
229 4.0 216 11.1 191 10.1 216 6.2 
232 3.4 217 6.1 193 8.7 220 3."8 
234 27.5 219 6.7 203 12.9 221 11.6 
235 5.4 220 17.8 204 7.1 222 4.7 
236 62.5 221 7.5 205 8.9 225 3.7 
237 24.7 229 5.8 207 59.5 229 4.6 
238 5.3 230 4.5 200 16.9 231 3.0 
246 9.1 231 6.7 2a9 12.3 238 18.2 
253 4.5 232 5.0 216 18.8 239 3.0 
266 6.5 '=!34 24.S 217 11.13 249 3.1 
2137 6.9 235 9.3 220 6.4 251 3.5 
269 3.1 236 3.3 229 32.2 253 4.3 
270 3.1 246 4.2 23.0 14.2 255 4.0 
272 5.2 248 35.7 231 11.9 262 9.0 
281 12.1 249 7.7 232 9.5 2S3 3.4 
282 4.8 25e 81.2 241 6.6 265 5.8 
283 3.5 251 41.7 242 7.4 2613 6.8 
287 25.1 252 10.3 243 11.0 267 22.4 
288 13.3 253 5.4 2413 6.a 268 5.8 
293 4.1 254 3.5 253 10.1 269 4.8 
324 15.5 255 4.8 2!34 8.3 272 9.3 
325 4.1 257 3.2 255 12.4 276 6.9 
340 4.3 2S0 8.5 256 9.0 278 29.2 
355 4.5 262 3.1 257 10.a 279 
11.7 
356 7.4 264 3.1 258 6.8 2BB 
" 3.4 
357 4.4 266 7.4 259 7.1 
2Bl 56.1 
~~7 1~_~ 2SS HL5 282 23.6 371 12.1 268 5.0 267 16.4 2B3 13.8 372 !.'\.3 269 4.9 2S8 8.4 2B4 5.5 373 3.5 270 4.8 269 9.2 2B5 4.8 401 18.0 272 6.7 270 8.0 295 3.9 402 5.5 280 4.4 271 10.6 323 3.6 414 38.6 281 12.5 272 19.7 324 7.1 415 13.1 282 5.3 273 7.7 325 7.8 416 4.2 283 5.8 281 17.2 326 3.13 428 13.2 2B4 5.8 2B2 9.8 327 7.4 429 72.9 286 4.7 2B3 14.2 329 6.0 430 27.1 295 9.8 2B4 10.S 335 32.6 431 8.9 2B6 4.8 285 24.S 33S 8.6 
297 4.5 286 8.9 337 3.5 
298 3.S 29$ 8.9 339 4.a 
~1 36.0 324 15.1 340 3.8 
302 10.9 325 7.0 341 29.0 
3e7 6.1 3?9 19.9 342 9.9 
312 3.5 330 9.1 343 7.3 
314 3.1 342 le0.0 355 22.3 
'324 17.4 343 31.1 356 7.9 
325 4.1 344 11.4 357 4.8 
32S 4.1 36S 7.3 3SS 4.8 
338 12.8 382 S.4 382 6.3 
339 4.0 384 7.1 385 3.1 
340 3.2 398 8.7 397 3.4 
354 13.1 399 57.8 398 4.6 
355 3.3 400 21.9 339 7.3 
369 3.7 401 8.3 401 3.2 
370 10.6 411 
q4_5 
371 8.6 414 38.4 
385 21.6 415 
15.4 
386 6.1 416 
3.3 
398 4.0 429 
16.2 
1~q 1~_~ 438 6.7 
400 16.5 431 4.7 
401 5.9 454 4.2 
428 54.4 455 5.4 
429 57.9 456 1Oe.0 
439 25.3 457 44.8 
431 7.0 458 16.7 
442 37.0 485 11.0 
443 14.0 486 3.6 
444 4.2 4sa 7.8 
455 3.7 503 
3.8 
456 24.S '.512 
"7.1 
457 10e.a 51~ 
21.2 
49.9 514 /.8 
20.3 
3.4 
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BIS-E~s-mORPHIHE eel) BIS-EO~S-HAlORPHIHE BIS-EOPIS-HALORPHIHE eel) 
Plass % Bast Mass % Base IGSs Z Base 61 5.8 56 3.8 61 9.5 63 6.6 59 77.9 63 9.3 67 413.13 613 6.1 67 713.6 68 7.7 61 5.7 68 14.0 69 56.2 70 5.7 69 100.13 70 26.4 73 5.1 70 46.1 71 44.13 75 13.5 71 77.4 72 7.2 84 7.13 72 113.7 75 24.5 85 12.5 73 5.5 79 10.8 87 49.2 75 CS.4 81 19.2 88 3.8 79 18.9 82 4.6 89 6.8 813 4.5 83 22.9 122 6.7 81 36.0 84 8.5 165 3.1 82 9.3 85 39.3 179 3.9 83 41.0 86 4.5 195 4.1 84 17.4 87 14.13 203 4.2 85 68.6 89 6.3 205 3.7 86 11.2 95 6.8 216 8.8 87 12.9 97 7.13 217 5.8 89 5.6 1135 47.4 218 7.7 93 4.7 106 6.9 219 3.9 95 12.13 1137 5.3 229 4.6 96 5.5 146 5.1 230 4.9 97 14.13 2137 43.1 231 5.5 98 4.8 2138 12.13 232 9.9 105 49.7 2139 8.1 236 31.7 1136 6.1 2113 8.4 237 5.4 1137 5.8 220 5.4 243 3.4 1139 7.13 223 49.8 247 4.4 123 4.8 224 14.3 248 7.6 2137 85.3 225 9.4 253 5.2 208 25.1 248 5.8 254 3.8 209 16.1 25e CS.l 255 5." 223 95.13 251 13.3 256 3.7 224 29.2 252 4.4 257 4.6 225 17.9 266 5.13 2G0 5.5 267 4.6 267 8.13 261 3.7 281 19.4 268 4.3 266 7.8 282 5.2 269 4.8 267 12.7 295 4.4 281 12.2 268 5.9 297 11.2 
282 4.4 269 -4-.8 380 17.9 
295 5.5 . 270 3.6 381 5.4 
296 5.13 274 36.4 483 7.4 
297 11.9 275 7.8 484 7.4 
298 4.8 276 6.1 
324 5.6 2S0 4.8 
326 6.0 281 11.2 
353 9.2 282 5.5 
354 lee.0 283 5.9 
355 42.1 286 !5.e 
356 19.4 290 3.8 
357 4.2 295 10.9 
385 5.7 29S 5.1 
396 5.1 297 4.7 
3.98 5.2 . 298 5.3 
399 9.4 307 6.2 
4ee 6.7 308 3.1 
428 17.5 309 3.3 
429 16.9 3113 6.13 
430 7.3 312 3.5 
442 12.1 327 37.1 
443 5.0 328 11.3 
456 12.8 338 46.8 
457 56.13 339 16.2 
458 55.3 340 7.6 
459 27.4 3513 15.1 
460 113.3 '=l1=;1 ~.7 
500 21.5 364 5.2 
501 9.13 369 4.2 371 5.2 
3Sa 6.13 
383 3.2 
385 17.6 
38S 4.7 
387 3.1 
3S6 9.2 
398 5.5 
399 13.9 
4eo 13.1 
401 5.7 
428 3.8 
442 74.8 
443 34.9 
444 I?q 
454 ~.0 
455 23.0 
456 13.0 
468 25.1 
46:9 9.0 
482 15.7 
483 100.9 
484 59.3 
21.9 
3.8 
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~n~S-BUPREHORPHIHE EOlIIS -BUPREHORPH I HE < C I ) [DMS-BUPRENORPHlHE, THE DEHYDRATED FOR~ 
Plass % Base ~hu t Ba~,. PlUs % Basil 55 58.8 81 3.6 55 71.1 56 9.0 63 2.4 56 7.2 57 20.3 67 29.1 57 17.3 59 29.1 6a .6.5 59 35.4 73 3.6 69 43.2 73 !5 .1 75 5.6 70 21.1 75 7.7 83 10.2 71 34.2 84 35.9 84 30.1 72 5.5 87 13.1 87 16.1 73 3.0 110 9.0 101 9.9 79 7.7 147 3.9 110 4.3 81 15.0 205 4.1 207 4.2 82 4.3 207 9.6 216 3.9 83 la.9 208 3.1 281 4.5 84 10.6 209 3.4 295 3.9 85 30.9 216 4.3 
297 3.9 86 3.9 267 3.4 
299 3.4 93 2.4 281 5.1 325 4.4 95 6.4 282 4.6 
422 6.5 96 3.3 283 4.9 
424 6.1 97 6.9 284 4.2 
438 11.8 98 6.8 297 3.6 
452 21.3 99 2.1 299 4.1 
453 8.5 1013 2.0 301 4.5 
464 100.0 HH 2.0 349 5.1 
465 48.3 105 4.4 356 4.1 
46B 16.8 107 2.4 422 11.7 
492 14.9 1139 4.1 423 4.1 
493 4.9 111 3.2 424 7.2 
494 5.1 112 2.2 432 3.4 
496 40.3 121 2.2 448 5.4 
497 15.7 123 3.1 464 23.6 
498 3.5 137 2.2 465 6.8 
50S 41.4 193 3.1 478 7.7 
5137 17.8 207 8S.7 4B0 4. t 
608 4.7 208 28.5 492 4.1 
520 21.2 209 20.4 494 40.1 
521 10.0 210 3.2 495 12.2 
522 4.0 223 10e.0 504 6.8 
524 9.7 224 32.9 506 100.0 
535 7.5 225 23.1 507 41.1 
536 3.5 226 3.9 50S 9.3 
538 7.4 267 2.0 520 88.3 
553 8.0 281 24.4 521 35.S 
282 7.6 522 7.2 
283 5.4 534 22.9 
297 15.6 635 77.6 
298 4.8 536 30.6 
299 3.4 537 6.9 
355 4.4 
371 2.0 
452 3.1 
464 6.3 
465 2.4 
496 5.4 
504 7.1 
!5e5 4.4 
50S 10.2 
5e7 4.9 
500 2.8 
520 3.1 
521 2.5 
522 5.2 
534 2.7 
535 7.6 
536 29.6 
537 15.3 
538 6.6 
553 2.7 
554 3.2 
578 2.2 
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ED~S-~ONOACETYL~RPHIHE j>iT65-CODt.lHE EOIIIS -COO[ I HE O-EO~-PENTAZOClHE filass % Base Mass filiSs Z Bue % Bast PJass % Base 59 16.3 59 55 11.2 59 8.9 5.8 59 14.2 78 4.1 70 3.~ 56 6.4 68 3.1 75 7.1 73 43.4 57 46.5 69 14.4 81 3.8 74 3.5 58 3.9 78 18.9 ~ 13.15 !5S 44.6 71 5.8 87 4.7 94 6.1 59 6.9 84 124 7.2 3.1 115 3.7 60 3.6 87 146 4.6 8.3 162 7.1 146 12.6 61 3.4 119 18.4 165 3.1 165 3.9 69 5.8 113 11.2 166 3.6 178 20.4 713 19.1 115 4.13 179 7.4 71 29.4 128 3.5 284 18.2 188 4.9 73 6.6 129 4.13 285 4.1 284 4.1 ~ 9.8 138 3.5 287 5.8 207 3.1 7l 4.13 141 3.4 216 !5.7 216 3.5 83 4.4 157 4.13 217 3.2 229 8.1 85 17.2 163 3.5 229 3.3 ?~ ?!"I.? 87 27.3 164 14.7 229 3.8 236 4.5 89 6.4 164 3.6 230 3.2 238 15.1 91 4 .1 171 4.3 231 3.8 239 !5.S &4 113.7 178 19.6 259 3.4 254 3.7 99 4.7 189 4.2 253 3.8 255 3.15 IH5 7.4 193 4.6 2613 4.8 266 3.1 127 4.7 199 3.9 266 7.9 270 3.6 128 3.3 201 5.7 267 10.3 276 4.6 141 4.13 293 4.7 268 4.2 280 5.4 143 3.7 215 18.8 269 3.1 281 3.1 144 4.4 216 3.8 280 3.9 282 8.0 146 29.1 217 5.7 281 5.3 283 3.6 147 6.4 228 3.3 282 4.5 285 15.3 152 6.5 229 16.9 283 4.6 286 4.7 153 4.1 238 5.3 284' 3.5 298 4.1 163 3.2 231 11302 285 3.5 299 3.5 185 6.6 232 19.7 294 4.4 313 100.9 175 3.4 233 18.9 295 4.2 314 27.7 178 71.9 234 4.8 296 9.4 315 6.5 179 27.4 243 3.9 297 9.8 355 3.5 180 4.0 244 4.3 301 44.5 356 56.3 181 5.1 245 23.6 382 18.6 357 15.6 185 4.9 246 18.8 312 4.6 358 3.6 188 14.7 247 9.4 324 10.9 412 3.5 189 4.8 248 5.4 325 3.4 413 4.2 199 5.7 258 51.6 338 5.4 196 3.7 259 51.6 342 11.9 199 3.4 260 43.9 353 3.3 2134 3.3 261 12.2 354 74.3 285 3.3 271 5.6 355 22.8 287 4.6 272 4.3 356 17.1 218 54.5 273 5.2 357 3.4 211 9.5 274 18.7 378 6.3 212 4.9 286 6.9 384 4.5 214 9.8 289 9.9 412 7.4 216 4.2 302 26.2 413 1139.9 221 3.4 303 1913.8 414 35.5 223 3.9 3134 313 .1 415 8.9 225 4.3 305 6.8 
229 37.2 316 22.1 
230 9.2 317 5.1 
235 7.1 328 12.9 
228 3.3 329 4.7 
239 4.5 342 113.6 
248 3.3 354 3.3 
242 3.9 356 613.7 
248 37.6 357 18.2 
249 9.3 358 4.2 
250 3.2 369 4.4 
253 3.3 370 44.6 
254 4.9 371 36.4 
255 4.9 372 9.7 
266 6.4 
268 4.2 
269 4.13 
270 3.13 
280 11.3 
281 6.8 
282 11.1 
283 4.9 
2S5 3.2 
295 3.9 
298 3.2 
299 3.5 
313 21.3 
314 5.13 
327 12.3 
328 8.1 
329 3.3 
342 3.1 
356 6.6 
357 20.1 
358 5.3 
370 15.2 
371 3.4 
3S3 4.2 
384 20.9 
~ 1013.0 
386 28.6 
387 7.1 
1 
- 316 -I: 
;1I1<'11~ ~~;--~~'=;-TEAA2EPM o -EDfIIS -LORfIIETAZEPAPI o -E[)fIlS -FllJPEHTH I XOL 
Plass % Basil Jl1ass f BaSt IGSs % Base Mass % Base 55 9.4 58 3.5 57 3.4 55 4.6 56 5.6 55 58.1 58 5.6 56 8.5 57 10.6 sa 4.1 59 97.1 58 4.0 58 12.4 61 5.6 60 7.9 59 18.0 55 33.4 75" 12.3 61 7.8 70 16.9 60 3.4 77 10.8 75 20.8 73 3.8 61 8.9 87 19.8 77 4.8 75 3.8 67 4.1 89 3.3 87 31.6 82 5.9 70 3.7 102 8.4 89 3.8 87 11.7 71 3.2 116 4.9 93 4.5 97 27.5 73 21.7 125 3.5 lee 3.5 98 40.6 75 16.6 130 9.4 102 6.1 99 7.0 77 4.1 151 4.5 111 5.8 125 15.6 80 3.6 152 4.2 115 4.8 130 3.9 87 15.9 164 9.6 117 3.3 186 3.5 89 4.5 165 10.3 125 5.0 214 4.8 91 5.8 177 7.4 130 4.0 221 13.5 94 5.2 178 13.6 138 3.1 222 6.3 95 3.9 179 3.1 150 3.0 227 5.0 96 4.0 179 6.4 151 3.2 229 le0.0 121 16.9 180 4.0 163 4.1 230 30.2 128 3.9 193 4.2 164 3.7 231 8.9 129 4.4 205 4.8 165 5.9 234 3.0 132 3.5 219 4.7 17S 3.1 265 5.1 133 16.0 221 6.8 In 11.6 289 6.2 135 4.2 226 3.0 178 14.5 ~1 8.1 145 5.2 228 6.4 179 3.2 355 3.e 147 5.8 239 6.9 179 6.6 403 5.1 148 6.0 241 3.5 180 3.5 491 4.2 150 8.2 253 3.9 181 4.2 595 3.6 162 34.3 254 8.a 182 4.9 163 9.5 255 40.3 180 3.4 164 32.9 256 58.0 183 3.8 174 4.7 257 52.3 207 J.O 177 3.2 258 27.1 219 3.3 193 7.4 259 14.3 226 3.6 203 5.5 271 4.8 239 4.8 205 3.5 282 6.4 253 8.9 207 se.l 283 se.6 254 5.1 208 14.3 284 14.3 255 9.6 216 5.4 285 22.4 25S 5.S 217 3.1 286 4.1 269 4.3 
221 3.7 329 3.S 288 3.7 
222 3.1 343 3.0 289 27.6 
230 4.0 357 10a.0 290 16.5 
231 5.7 358 34.9 291 34.0 
232 12.9 359 4S.2 292 12.3 
235 3.4 360 12.6 293 12.8 
243 4.9 381 3.1 294 3.0 
247 '10.2 371 14.8 317 51.6 
248 5.2 372 3.6 31B 10.3 
25e 37.6 373 5.3 319 34.5 
253 5.1 3S5 3.9 320 5.6 
259 3.6 386 17.7 321 5.9 
26e 5.8 387 5.9 363 3.7 
261 15.5 388 6.4 385 5.4 
262 3.5 391 100.0 
266 4.9 392 31.6 
272 10e.0 393 n.l 
273 20.7 394 22.7 
274 8.1 395 16.9 
280 3.1 396 3.7 
281 33.0 405 13.6 
282 5.8 406 3.8 
283 4.7 407 9.4 
284 4.2 420 3.6 
286 38.6 
287 10.3 
288 5.3 
296 7.8 
297 7.6 
300 3.1 
302 13.1 
303 4.4 
309 3.2 
311 6.5 
322 3.2 
323 9.6 
327 3.2 
. 327 3.4 
337 3.4 
343 3.5 
353 3.4 
354 33.6 
355 ~:§ 387 
368 20.7 
369 6.3 
382 15.1 
383 6.1 
384 9.8 
3.% ~.~ 
'lIe 81.5 
411 27.9 
412 5.3 
464 4.8 
4sa 18.9 
- ~J.I 
H-EomS-DESmETHYLOIAZEPAA BIS-o-EOAS~IDIOL O-E~-TESTOSTEROHE DEXTROIIl£THORfWf.I 
M<1ss % Base IitaSs Z Base MaSs % Base Mus % Bast 51 4.2 55 6.7 53 7.8 55 4.0 58 5.7 59 57.9 55 19.6 58 9.2 59 lee.e 60 6.3 58 5.2 59 98.2 613 7.2 61 3.6 59 82.4 60 6.0 61 4.13 67 3.5 613 6.4 67 3.2 65 4.1 68 19.9 61 22.0 /0 5.13 75 6.5 75 9.5 65 4.0 75 3.4 7l 7.e 81 3.3 67 15.2 7/ 4.9 87 29.1 87 46.5 S9 3.4 79 3.2 88 3.2 88 6.2 73 6.3 82 7.4 89 3.9 89 4.1 75 69.7 91 7.5 913 3.1 93 6.8 76 5.7 94 3.4 91 21.6 107 6.3 7/ . 16.7 115 14.1 92 3.8 109 5.6 78 3.4 116 3.3 100 3.4 121 3.6 79 26.1 117 3.1 1133 3.8 133 5.2 89 3.4 121 5.6 116 3.8 215 3.e 81 14.6 122 3.9 117 3.3 245 3.8 87 49.9 127 4.7 130 3.7 258 5.1 B8 4.4 128 15.8 146 8.8 2S6 4.6 89 12.6 129 8.8 1513 3.1 314 3.2 91 31.0 131 4.1 163 4.6 315 18.7 92 15.3 1315 <4.4 1913 5.1 316 5.2 93 22.6 136 3.0 2137 4.2 335 3.4 94 3.9 141 11.0 227 11.3 95 12.6 142 3.6 
228 3.8 347 13.0 lei 17.6 143 3.1 348 3.6 144 5.3 229 5.3 349 5.6 103 4.13 145 4.8 241 3.4 352 16.9 105 24.4 146 6.0 269 3.8 106 4.8 
313 5.9 353 5.9 107 13.5 147 5.2 361 3.13 148 7.8 327 24.3 363 7.5 109 4.1 le0 76.5 328 6.1 365 32.13 115 31.9 151 7.2 329 8.5 366 12.7 116 4.7 1~2 4.1 341 11.8 367 5.1 117 8.7 153 5.8 342 4.2 378 5.2 119 14.4 154 3.2 343 4.7 379 15.4 120 4.6 155 1·~? 355 85.9 380 7.4 121 9.8 157 3.5 356 54.6 389 4.2 122 5.7 H5S 15.9 357 42.9 403 5.6 123 7.5 159 9.3 358 19.9 417 8.3 124 113.8 160 15.6 129 6.2 359 4.5 418 100.0 130 4.a 161 7.a 419 47.1 131 14.1 162 9.3 420 22.8 132 3.3 165 4.2 421 5.5 133 11.4 1/0 3.1 458 4.13 134 6.5 171 40.2 471 4.6 135 5.1 172 17.9 486 11.7 136 4.7 In 5.3 487 4.6 143 1ea.a 174 16.2 
144 21.8 175 7.a 
145 19.3 18t 3.A 
146 9.6 183 3.4 
147 27.7 184 8.4 
148 9.5 !.~!:' ~.,L 
149 6.7 186 3.7 
155 3.2 IB8 3.4 
157 6.5 197 3.4 198 5.3 15B 4.2 199 4.1 159 7.a 200 3.3 161 4.6 2132 3.B 162 3.1 203 22.8 171 9.9 211 3.1 173 4.1 212 29.6 174 5.1 213 29.2 175 3.4 214 49.4 183 6.8 215 B .1 1B5 6.B 22R R.7 187 4.2 242 12.3 195 3.13 256 11.7 197 5.6 
199 3.B 269 3.B 
2113 4.7 270 /2.2 
211 5.13 271 lee.e 
213 6.5 272 IB.9 
226 13.4 
227 10.3 
229 8.9 
229 7.9 
242 5.3 
251 5.e 
252 4.e 
253 6.4 
255 5.13 
269 13.B 
270 39.? 
271 7.3 
318 16.9 
319 3.9 
331 9.2 
332 5.7 
345 79.~ 
346 25.5 
347 5.6 
359 14.13 
3613 3.3 
374 44.2 
f~ J 
I'IETHAOONE 
Miss % BU4t 
56 11.2 
57 6.5 
70 8.7 
71 8.S 
72 lee.a 
?3 23.2 
// 4.4 
85 9.13 
86 3.5 
91 17.2 
1135 S.5 
115 8.5 
117 4.9 
152 3.3 
165 15.2 
166 3.13 
167 3.4 
178 113.4 
179 9.4 
180 6.3 
193 3.9 
195 4.6 
223 13.6 
294 9.8 
CAFTElHE 
Mass 
55 
56 
67 
68 
81 
82 
109 
110 
136 
137 
165 
193 
194 
195 
% Base 
41.1 
3.1 
32.6 
3.5 
4.1 
25.1 
55.4 
6.4 
5.1 
6.9 
4.7 
11.3 
1130.0' 
10.2 
DEXTROfIIORAtIIl DE 
Mass % Base 
55 3.6 
56 5.2 
70 3.1 
91 4.7 
98 11.9 
10a 79.1' 
HH 6.1 
l' ... ~.J 6.5 
!2i? '11.3 
l?O 
--
'!.~ 
185 14.8 
18S :" .1 
167 6.2 
178 5.7 
179 4.6 
193 6 .1 
194 11.4 
195 4.6 
2e7 3.1 
236 8.3 
264 4.3 
265 lee.a 
266 29.1 
30'S 9.6 
-
318 -
OlPIPAHOHE 
Mass % Base 
55 3.5 
56 5.7 
57 3.3 
69 4.4 
91 7.6 
10'5 3.6 
119 12.13 
111 3.4 
112 lea.a 
113 19.4 
115 4.S 
117 3.3 
165 8.8 
178 6.6 
11'9 6.4 
180 4.4 
223 8.9 
334 16.3 
335 4.9 
GLAEGOW 
'-'::;'1i '/::'.LSm 
1UBRARY J 
flIlIITRIPTYLlHE 
Mass 2! Base 
58 lae.a 
59 5.1 
189 2.1 
2132 4.9 
203 3.7 
215 3.5 
217 2.4 
